Update March 22 - March 28, 2021, Dr. Peter J. Lansberg MD, PhD

Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics

COVID-19 publications - Week 12 2021 1080 Publications

PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected]

Reliable on-line resources for Covid 19

WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap)

Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance

Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database COVID-19 prevention network Covid-Plex trial - (plasma exchange & convalescent plasma trial)

The Covid-Plex trial is an investigator initiated, multicenter, parallel-group, open-label randomized clinical trial aiming to randomize patients with severe COVID-19 to standard care or standard care plus plasmapheresis and convalescent plasma.

If you are interested to participate Please contact Wladimir Szpirt, Nicholas Carlson Anders, or Perner Bo Feldt-Rasmussen. Depts. Of Intensive Care Therapy and Nephrology, Copenhagen University Hospital Rigshospitalet, Denmark

Covid-Plex trial

Mainstream Media

New York Times - Corona update A decline in testing may be masking the spread of the virus in some states. Why We Redesigned the Virus Trackers Merkel’s Latest Pandemic Challenge: Leading as a Lame Duck What the History of Pandemics Can Teach Us About Resilience Factory Mix-Up Ruins Up to 15 Million Vaccine Doses From Johnson & Johnson As Virus and Economic Woes Ravage Brazil, Bolsonaro Improvises and Confounds Macron Returns France to Lockdown as Vaccinations Lag The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents See How Rich Countries Got to the Front of the Vaccine Line

Washington Post - Corona update Vaccines are reaching poor countries, but can’t cover the cost of administering them What you need to know aboutthe coronavirus variants Coronavirus vaccines are coming for kids — but studies have to be finished first Biden, health officials sound alarm as signs of covid surge proliferate Pfizer, Moderna vaccines are 90% effective after two doses in study ‘Vaccine passports’ are on the way, but developing them won’t be easy AstraZeneca says its vaccine is 76 percent effective in an updated company analysis Vaccinated mothers pass covid antibodies to babies in utero and through breastmilk A harmless vaccine side effect could mimic cancer in mammograms These children had covid-19. Now, they have long-haul symptoms.

Guardian - Corona update Sicily health chief quits over 'faked data' – as it happened Senior Tories join Jeremy Corbyn to oppose Covid passports ahead of trials Covid vaccine scheme 'unacceptably slow' in Europe, says WHO Step by step: England's roadmap for easing Covid lockdown Long Covid: snapshot poll finds more than 1m people with symptoms in UK

Key Articles

1. Effects of the COVID-19 pandemic on out-of-hospital cardiac arrest care in Detroit. Am J Emerg Med 2021; 46:90-96Mathew S, Harrison N, Chalek AD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33740572 Allergic reactions have been reported in those that received COVID-19 vaccines. Severe, anaphylactic reactions are rare but have been reported in patients with a medical history of allergic reactions. Based on data collected in the UK and US, the number of reported severe allergic reactions was 4.5 per million vaccinated patients who received the mRNA-based COVID-19 vaccines by February 2, 2021. This is higher when compared to the generally expected number of severe allergic reactions to vaccinations of 1 in 1 million.

2. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell 2021; Garcia-Beltran WF, Lam EC, St Denis K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33743213 Re-infections with the SARS-CoV-2 virus are uncommon but can occur, and with over 200 million infected individuals globally, a large number of patients are at risk. The risk factors for severe re-infections were analyzed in this Mexican cohort of laboratory-confirmed recurrences. Severe infections were observed in 14.7%, and overall fatality in 4.3% of the patients. Risk factors for severe re-infections were age, severely symptomatic disease during the primary infection, obesity, diabetes type 2, and asthma.

3. Association between electrocardiographic features and mortality in COVID-19 patients. Ann. Noninvasive Electrocardiol. 2021:e12833Antwi- Amoabeng D, Beutler BD, Singh S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33742501 Thrombotic complications are recognized as a leading cause of morbidity and mortality in COVID-19 patients. This hypercoagulable state is multi-factorial and intimately associated with the host immune response to viral infection, triggering disruption of the tightly regulated balance between thrombosis and fibrinolysis. An increase in anti-fibrinolytic factors like PAI-1, TAFI is implicated in the observed microvascular fibrin deposition. Based on these findings, fibrinolytic agents are currently investigated to improve outcomes in patients with thrombotic complications.

4. [Pathogenesis, diagnosis, prevention and treatment of disseminated intravascular coagulation syndrome in COVID-19 infection]. Ter. Arkh. 2020; 92:51-56Vorobyev PA, Momot AP, Krasnova LS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33720604

5. Cardiovascular Health and Disease in the Context of COVID-19. Cardiol Res 2021; 12:67-79Umbrajkar S, Stankowski RV, Rezkalla S, Kloner RA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33738009

6. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2021; Talasaz AH, Sadeghipour P, Kakavand H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33741176

7. Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study. Clin Infect Dis 2021; Sheehan MM, Reddy AJ, Rothberg MB. http://www.ncbi.nlm.nih.gov/pubmed/? term=33718968

8. COVID-19 and the human innate immune system. Cell 2021; Schultze JL, Aschenbrenner AC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33743212

9. The laboratory findings and different COVID-19 severities: a systematic review and meta-analysis. Ann. Clin. Microbiol. Antimicrob. 2021; 20:17Kazemi E, Soldoozi Nejat R, Ashkan F, Sheibani H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33726761

10. A Review of the Evidence for Corticosteroids in COVID-19. J. Pharm. Pract. 2021:897190021998502Johns M, George S, Taburyanskaya M, Poon YK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33719698

11. Clinician guide to COVID-19 diagnostics. Arch. Dis. Child. Educ. Pract. Ed. 2021; Iro MA, Umpleby H, Pelosi E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33737403

12. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February. Euro Surveill 2021; 26Grint DJ, Wing K, Williamson E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33739254

13. Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients. J. Cardiovasc. Comput. Tomogr. 2021; Giannini F, Toselli M, Palmisano A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33744175

14. Reinfection, recurrence, or delayed presentation of COVID-19? Case series and review of the literature. J Infect Public Health 2021; 14:474- 477Elzein F, Ibrahim A, Alshahrani F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33743368

15. Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits. Expert Rev. Anti Infect. Ther. 2021; Banerjee A, Ganguly U, Saha S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33739215

Basic Science (57 articles)

1. Game of "crowning" season 8: RAS and reproductive hormones in COVID-19 - can we end this viral series? Arch. Med. Sci. 2021; 17:275-284Cismaru AC, Cismaru LG, Nabavi SF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747262 2. There is no evidence of SARS-CoV-2 laboratory origin: Response to Segreto and Deigin (https://doi.org/10.1002/bies.202000240). Bioessays 2021:e2000325Tyshkovskiy A, Panchin AY. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751609 3. The SARS-CoV-2 receptor and other key components of the Renin- Angiotensin-Aldosterone System related to COVID-19 are expressed in enterocytes in larval zebrafish. Biol Open 2021; 10Postlethwait JH, Massaquoi MS, Farnsworth DR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757938 4. Backbone chemical shift spectral assignments of SARS coronavirus-2 non- structural protein nsp9. Biomol NMR Assign 2021:1-7E FD, Puglisi R, Korn SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755914 5. New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals. Biosci Trends 2021; Chen J, Lu H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746183 6. Human cell-dependent, directional, time-dependent changes in the mono- and oligonucleotide compositions of SARS-CoV-2 genomes. BMC Microbiol. 2021; 21:89Iwasaki Y, Abe T, Ikemura T. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757449 7. Dual inhibition of CB(1) R and iNOS as a potential novel approach to the pharmacological management of acute and long COVID-19. Br. J. Pharmacol. 2021; Cinar R, Iyer MR, Kunos G. http://www.ncbi.nlm.nih.gov/pubmed/? term=33769552 8. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS- CoV-2. Cell 2021; McCallum M, De Marco A, Lempp FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761326 9. Sarbecovirus ORF6 proteins hamper induction of interferon signaling. Cell Rep. 2021; 34:108916Kimura I, Konno Y, Uriu K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765414 10. Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients. Cell Rep. 2021; 34:108915Li Y, Ma ML, Lei Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761319 11. Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies. Comput. Biol. Med. 2021; 132:104325Skariyachan S, Gopal D, Muddebihalkar AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751995 12. Revealing the mechanism of SARS-CoV-2 spike protein binding with ACE2. Comput Sci Eng 2020; 22:21-29Xie Y, Du D, Karki CB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762895 13. Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control. Drug Deliv Transl Res 2021; Yang KC, Lin JC, Tsai HH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748879 14. Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses. Emerg Infect Dis 2021; 27:1015-1022Ghai RR, Carpenter A, Liew AY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770472 15. Experimental SARS-CoV-2 Infection of Bank Voles. Emerg Infect Dis 2021; 27:1193-1195Ulrich L, Michelitsch A, Halwe N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754987 16. Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19). Emergent Mater 2021:1-21Ertas YN, Mahmoodi M, Shahabipour F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748672 17. Peptide microarray based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development. Eur. J. Immunol. 2021; Holenya P, Lange PJ, Reimer U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772767 18. Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalisation rate, February 2021, Rio Grande do Sul, Southern Brazil. Euro Surveill 2021; 26Martins AF, Zavascki AP, Wink PL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769251 19. Comparison of Biocartis IDYLLA ™ cartridge assay with Qiagen GeneReader NGS for detection of targetable mutations in EGFR, KRAS/NRAS, and BRAF genes. Exp. Mol. Pathol. 2021:104634Haiduk T, Brockmann M, Tillmann RL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773991 20. Non-optimal codon usage preferences of coronaviruses determine their promiscuity for infecting multiple hosts. Febs j 2021; Carmi G, Gorohovski A, Mukherjee S, Frenkel-Morgenstern M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33756061 21. Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients. Front Genet 2021; 12:626642Biswas N, Kumar K, Mallick P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767730 22. Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double- Dealing in COVID-19. Front. Immunol. 2021; 12:602130Lindner HA, Velásquez SY, Thiel M, Kirschning T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746948 23. The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic. Front. Immunol. 2021; 12:637651Shah P, Canziani GA, Carter EP, Chaiken I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767706 24. Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review. Front. Pharmacol. 2020; 11:585331Lem FF, Opook F, Lee DJH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746739 25. SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin. Gene 2021:145596Pereira F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766711 26. Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis. Heliyon 2021; 7:e06515Bhowmik D, Nandi R, Prakash A, Kumar D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748510 27. Covid-19 and the need for more history and philosophy of RNA. Hist Philos Life Sci 2021; 43:42Guttinger S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759005 28. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 2021; Szabo PA, Dogra P, Gray JI et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33765436 29. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity 2021; Zheng H, Rao AM, Dermadi D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765435 30. A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase. Int. J. Biol. Macromol. 2021; Khan S, Attar F, Bloukh SH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766591 31. The Use Of Ultrapure Molecular Hydrogen Enriched With Atomic Hydrogen In Apparatuses Of Artificial Lung Ventilation In The Fight Against Virus COVID- 19. Int J Hydrogen Energy 2021; Zolotarenko AD, Zolotarenko AD, Veziroglu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746342 32. A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19. Int. J. Med. Sci. 2021; 18:1866-1876Zhang X, Gao R, Zhou Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746604 33. SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2. J. Biochem. 2021; Kiseleva AA, Troisi EM, Hensley SE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774672 34. Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs. J Biomol Struct Dyn 2021:1-18Ishola AA, Adewole KE, Tijjani H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749538 35. In silico screening of therapeutic potentials from Strychnos nux-vomica against the dimeric main protease (M(pro)) structure of SARS-CoV-2. J Biomol Struct Dyn 2021:1-19Kumar B, Parasuraman P, Murthy TPK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759690 36. Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease. J Biomol Struct Dyn 2021:1-16Varadharajan V, Arumugam GS, Shanmugam S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764269 37. Risk stratification by long non-coding RNAs profiling in COVID-19 patients. J Cell Mol Med 2021; Cheng J, Zhou X, Feng W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759345 38. Evaluation of kinetics and thermodynamics of interaction between immobilized SARS-CoV-2 nucleoprotein and specific antibodies by total internal reflection ellipsometry. J. Colloid Interface Sci. 2021; 594:195- 203Plikusiene I, Maciulis V, Ramanaviciene A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761394 39. Study on the mechanism of active components of Liupao tea on 3CL(pro) based on HPLC-DAD fingerprint and molecular docking technique. J. Food Biochem. 2021:e13707Ni WJ, Chen XX, Wei SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760271 40. Discovery of a SARS-CoV-2 variant 1 from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan. J Infect 2021; Hirotsu Y, Omata M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766552 41. Platforms for Personalized Polytherapeutics Discovery in COVID-19. J. Mol. Biol. 2021:166945Hopkins C, Onweni C, Zambito V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753053 42. IgV somatic mutation of human anti-SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity. JCI Insight 2021; Garcia de Mattos Barbosa M, Liu H, Huynh D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33769311 43. Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore- Washington metropolitan area. JCI Insight 2021; 6Thielen PM, Wohl S, Mehoke T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749660 44. Peptide substrate screening for the diagnosis of SARS-CoV-2 using fluorescence resonance energy transfer (FRET) assay. Mikrochim. Acta 2021; 188:137Alhadrami HA, Hassan AM, Chinnappan R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763734 45. Efficient and Robust Metallic Nanowire Foams for Deep Submicrometer Particulate Filtration. Nano Lett 2021; Malloy J, Quintana A, Jensen CJ, Liu K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759526 46. Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking. Nat Prod Res 2021:1-6Wang WX, Zhang YR, Luo SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769143 47. SUMO: a novel target for anti-coronavirus therapy. Pathog Glob Health 2021:1- 8Ryu HY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769223 48. The virology of SARS-CoV-2. Pneumologe 2020; 17:378-384Hoehl S, Ciesek S. 49. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing. Proc Natl Acad Sci U S A 2021; 118He X, Quan S, Xu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766889 50. Extracellular vesicles: Their emerging roles in the pathogenesis of respiratory diseases. Respir Investig 2021; Yamada M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753011 51. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models. Rev Med Virol 2021; Egilmezer E, Rawlinson WD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763936 52. Analyzing knowledge entities about COVID-19 using entitymetrics. Scientometrics 2021:1-19Yu Q, Wang Q, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746309 53. Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example. Theor. Biol. Med. Model. 2021; 18:10Zhao S, Lou J, Cao L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750399 54. Interferon system deficiencies exacerbating severe pandemic virus infections. Trends Microbiol. 2021; Stertz S, Hale BG. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757684 55. In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity. Vascul. Pharmacol. 2021:106856Maiti S, Banerjee A, Kanwar M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746069 56. The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein. Virology 2021; 559:1-9Chen X, Rostad CA, Anderson LJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774551 57. A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery. Virusdisease 2021:1-9Rutwick Surya U, Praveen N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758772

Biomarkers - Genetics (116 articles)

1. Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis. Adv. Nutr. 2021; Kazemi A, Mohammadi V, Aghababaee SK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751020 2. Are saliva and deep throat sputum as reliable as common respiratory specimens for SARS-CoV-2 detection? A systematic review and meta-analysis. Am. J. Infect. Control 2021; Khiabani K, Amirzade-Iranaq MH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774101 3. Detection of SARS-CoV-2 RNA in the corneal epithelium of a patient after recovery from COVID-19. Am J Ophthalmol Case Rep 2021; 22:101074Kuo IC, Mostafa HH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748538 4. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality. Ann Intensive Care 2021; 11:50Lim A, Radujkovic A, Weigand MA, Merle U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751264 5. Do we cause false positives? An experimental series on droplet or airborne SARS-CoV-2 contamination of sampling tubes during swab collection in a test center. Antimicrob Resist Infect Control 2021; 10:51Scheier T, Shah C, Huber M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750477 6. A novel classifier architecture based on deep neural network for COVID-19 detection using laboratory findings. Appl Soft Comput 2021; 106:107329Göreke V, Sarı V, Kockanat S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758581 7. A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2. Biochem. Biophys. Res. Commun. 2021; 553:165-171Kruse RL, Huang Y, Smetana H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33773139 8. A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs. Biochem. Biophys. Res. Commun. 2021; 553:25-29Zhang Y, Niu G, Flisikowska T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756342 9. MR-proAdrenomedullin as predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19. Biomarkers 2021:1-20Roedl K, Jarczak D, Fischer M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754916 10. Challenges of SERS technology as a non-nucleic acid or -antigen detection method for SARS-CoV-2 virus and its variants. Biosens. Bioelectron. 2021; 181:113153Sitjar J, Liao JD, Lee H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33761416 11. Multiplex quantitative detection of SARS-CoV-2 specific IgG and IgM antibodies based on DNA-assisted nanopore sensing. Biosens. Bioelectron. 2021; 181:113134Zhang Z, Wang X, Wei X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761415 12. Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients. BMC Infect. Dis. 2021; 21:299Li G, Du L, Cao X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761881 13. Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study. BMC Med 2021; 19:72Au Yeung SL, Zhao JV, Schooling CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757497 14. Greater public health impact of COVID-19 antigen detection tests. BMC Med 2021; 19:82Kowada A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757504 15. Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report. BMC Pediatr. 2021; 21:138Paul G, Chad R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752624 16. Efficacy of COVID-19 outbreak management in a skilled nursing facility based on serial testing for early detection and control. Braz. J. Infect. Dis. 2021:101570Garibaldi PMM, Ferreira NN, Moraes G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773990 17. Interim guidance on the use of the Abbott Panbio™ COVID-19 Antigen Rapid Test. Can. Commun. Dis. Rep. 2021; 47:17-22. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767600 18. Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose. Clin. Appl. Thromb. Hemost. 2021; 27:1076029621996445Wang Z, Du Z, Zhao X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760664 19. COVID-19: Prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies. Clin Case Rep 2021; 9:1397-1401Yousaf M, Hameed M, Alsoub H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768853 20. Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands. Clin Chem 2021; Tang MS, Farnsworth CW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772260 21. Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients. Clin Chem Lab Med 2021; Ponti G, Roli L, Oliva G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768762 22. Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19. Clin Immunol 2021; 226:108716Satyam A, Tsokos MG, Brook OR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774179 23. Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19. Clin Infect Dis 2021; McEllistrem MC, Clancy CJ, Buehrle DJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768222 24. Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2. Clin Infect Dis 2021; Wu P, Liu F, Chang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772573 25. SARS-CoV-2 antibody seroprevalence in NHS healthcare workers in a large double-sited UK hospital. Clin Med (Lond) 2021; Ken-Dror G, Wade C, Sharma SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757988 26. RGD-binding integrins and TGF-β in SARS-CoV-2 infections - novel targets to treat COVID-19 patients? Clin Transl Immunology 2021; 10:e1240Carvacho I, Piesche M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747508 27. Computational analysis of functional monomers used in molecular imprinting for promising COVID-19 detection. Comput Theor Chem 2021:113215Cubuk H, Ozbil M, Cakir Hatir P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747754 28. Morphologic Changes in Circulating Blood Cells of COVID-19 Patients. Cureus 2021; 13:e13416Kaur G, Sandeep F, Olayinka O, Gupta G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758711 29. COVID-19 Reinfection in the Face of a Detectable Antibody Titer. Cureus 2021; 13:e14033Roy S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767941 30. ACE2 as a key target for treatment of COVID-19 related cardiovascular diseases: current progress and prospect. Curr. Drug Targets 2021; Li S, Cai B, Ma W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745431 31. Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication. Cytokine 2021; 142:155496Gowda P, Patrick S, Joshi SD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773396 32. Pharmacists in schools and day care centers: Almost 80 Saarland pharmacies perform rapid antigen tests for SARS-CoV-2. Deutsche Apotheker Zeitung 2021; 161Saar M. 33. Speed jabs precision: Frequently repeated antigen tests can help bring the pandemic under control. Deutsche Apotheker Zeitung 2021; 161Schlenger R. 34. CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine. Drug Metab Pers Ther 2021; Salem Hareedy M, Rashad SM, Hetta HF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770833 35. E-gene RT-PCR Crossing Point Value and Other Biochemical Parameters as Useful Markers of Death Risk in COVID-19 Patients. Ejifcc 2021; 32:98- 104Bellés-Bellés A, Bernal M, Gómez-Arbonés J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753979 36. Rare variants increase the risk of severe COVID-19. Elife 2021; 10van de Veerdonk FL, Netea MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752797 37. Risk for International Importations of Variant SARS-CoV-2 Originating in the United Kingdom. Emerg Infect Dis 2021; 27Du Z, Wang L, Yang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760727 38. Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva. Emerg Infect Dis 2021; 27:1146-1150Ott IM, Strine MS, Watkins AE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754989 39. Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples. Emerg Infect Dis 2021; 27Watkins AE, Fenichel EP, Weinberger DM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755009 40. Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19). Emergent Mater 2021:1-21Ertas YN, Mahmoodi M, Shahabipour F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748672 41. Association between urinary per- and poly-fluoroalkyl substances and COVID- 19 susceptibility. Environ Int 2021; 153:106524Ji J, Song L, Wang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773143 42. Estimation of the incubation period of COVID-19 using viral load data. Epidemics 2021; 35:100454Ejima K, Kim KS, Ludema C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773195 43. Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests. Eur. J. Cancer 2021; 148:328-339van Dam P, Huizing M, Roelant E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33773276 44. Peptide microarray based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development. Eur. J. Immunol. 2021; Holenya P, Lange PJ, Reimer U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772767 45. DNA genotyping of the ABO gene showed a significant association of the A- group (A1/A2 variants) with severe COVID-19. Eur J Intern Med 2021; Gómez J, Albaiceta GM, García-Clemente M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33750629 46. Screening of COVID-19 in outpatient children with cancer or solid organ transplantation: preliminary report. Eur. J. Pediatr. 2021:1-5Cleto-Yamane TL, Rodrigues-Santos G, de Magalhães-Barbosa MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768332 47. Comparison of Biocartis IDYLLA ™ cartridge assay with Qiagen GeneReader NGS for detection of targetable mutations in EGFR, KRAS/NRAS, and BRAF genes. Exp. Mol. Pathol. 2021:104634Haiduk T, Brockmann M, Tillmann RL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773991 48. Perspective: Diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection. Expert Rev. Clin. Immunol. 2021; Ameratunga R, Woon ST, Jordan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745411 49. Circulating Calprotectin as a Biomarker of COVID-19 Severity. Expert Rev. Clin. Immunol. 2021; Mahler M, Meroni PL, Infantino M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750254 50. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages. Faseb j 2021; 35:e21441Recchiuti A, Patruno S, Mattoscio D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749902 51. Machine Learning Approaches Reveal That the Number of Tests Do Not Matter to the Prediction of Global Confirmed COVID-19 Cases. Front Artif Intell 2020; 3:561801Khan MHR, Hossain A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748745 52. Prediction of Sepsis in COVID-19 Using Laboratory Indicators. Front Cell Infect Microbiol 2020; 10:586054Tang G, Luo Y, Lu F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747973 53. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019. Front. Endocrinol. (Lausanne) 2021; 12:604100Gao F, Zheng KI, Yan HD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763027 54. Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C). Front. Immunol. 2021; 12:648546Feketea G, Vlacha V, Bocsan IC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763085 55. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification. Front. Immunol. 2021; 12:653489Grolmusz VK, Bozsik A, Papp J, Patócs A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763088 56. The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients. Front. Immunol. 2021; 12:632814Luo H, Jia T, Chen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763078 57. Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment. Front. Immunol. 2021; 12:598799Wu J, Shen J, Han Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746945 58. Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS- CoV-2 Reinfection in Patients From Mumbai, India. Front Med (Lausanne) 2021; 8:631769Shastri J, Parikh S, Agrawal S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768104 59. Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama. Front Med (Lausanne) 2021; 8:616106Villarreal A, Rangel G, Zhang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748157 60. Proteinuria as a Biomarker for COVID-19 Severity. Front. Physiol. 2021; 12:611772Ouahmi H, Courjon J, Morand L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767630 61. An Update on Advances in COVID-19 Laboratory Diagnosis and Testing Guidelines in India. Front Public Health 2021; 9:568603Kumar KSR, Mufti SS, Sarathy V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748054 62. The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis. Front Public Health 2021; 9:624559Teshome A, Adane A, Girma B, Mekonnen ZA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748066 63. Deployable Telescopic Tubular Mechanisms With a Steerable Tongue Depressor Towards Self-Administered Oral Swab. Front Robot AI 2021; 8:612959Kumar KS, Nguyen TD, Kalairaj MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763455 64. Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19. Glob Med Genet 2021; 8:7-10Khodavirdipour A, Piri M, Jabbari S, Khalaj-Kondori M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748818 65. An imperfect test for a virus can Be worse than No test at all. Health Econ. 2021; Whitmeyer M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763902 66. Variation of quantified infection rates of mixed samples to enhance rapid testing during an epidemic. Health Syst (Basingstoke) 2021; 10:24-30Kadri U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763226 67. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis. Health Technol. Assess. 2021; 25:1-68Stevenson M, Metry A, Messenger M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764295 68. Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein. Heliyon 2021; 7:e06564Alai S, Gujar N, Joshi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758785 69. Variants in ACE2 and TMPRSS2 Genes Are Not Major Determinants of COVID- 19 Severity in UK Biobank Subjects. Hum. Hered. 2021:1-3Curtis D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752217 70. Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies. Hypertens. Res. 2021; Kai H, Kai M, Niiyama H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750913 71. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity 2021; Zheng H, Rao AM, Dermadi D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765435 72. Severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody: Seroprevalence among contacts of COVID-19 cases. Indian J. Public Health 2021; 65:5-10Prakash O, Solanki B, Sheth JK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753682 73. COVID-19 Pandemic: Review of Contemporary and Forthcoming Detection Tools. Infect Drug Resist 2021; 14:1049-1082Oishee MJ, Ali T, Jahan N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762831 74. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19. Int Immunopharmacol 2021; 95:107568Ahmadi M, Pashangzadeh S, Mousavi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765612 75. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19. Int Immunopharmacol 2021; 95:107586Delshad M, Tavakolinia N, Pourbagheri- Sigaroodi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765611 76. Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France. Int J Infect Dis 2021; Mboumba Bouassa RS, Veyer D, Péré H, Bélec L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746093 77. Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process. Int. J. Lab. Hematol. 2021; Rolla R, Puricelli C, Bertoni A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33749995 78. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19. iScience 2021:102322Andolfo I, Russo R, Lasorsa VA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748697 79. Neutrophil-to-Lymphocyte Ratio, derived Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio as risk factors in critically ill COVID-19 patients, a single centered study. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S595-s601Noor A, Akhtar F, Tashfeen S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754514 80. Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19. J Biomol Struct Dyn 2021:1-17Jafari Porzani S, Konur O, Nowruzi B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749496 81. Correlation of Automated Chemiluminescent Method with Enzyme-Linked Immunosorbent Assay (ELISA) Antibody Titers in Convalescent COVID-19 Plasma Samples: Development of Rapid, Cost-Effective Semi-Quantitative Diagnostic Methods. J. Blood Med. 2021; 12:157-164Mendoza R, Silver M, Zuretti AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762863 82. Risk stratification by long non-coding RNAs profiling in COVID-19 patients. J Cell Mol Med 2021; Cheng J, Zhou X, Feng W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759345 83. Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2021; 1171:122641Nguyen R, Goodell JC, Shankarappa PS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756448 84. The diagnostic value of platelet distribution width in patients with mild COVID- 19. J. Clin. Lab. Anal. 2021:e23703Wang Y, Fan Z, Wang S, Zhuang C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772893 85. Hemophagocytic Lymphohistiocytosis in the Emergency Department: Recognizing and Evaluating a Hidden Threat. J. Emerg. Med. 2021; Morrissette K, Bridwell R, Lentz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745765 86. Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune response. J. Immunol. Methods 2021:113043Mylemans M, Van Honacker E, Nevejan L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773989 87. Discovery of a SARS-CoV-2 variant 1 from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan. J Infect 2021; Hirotsu Y, Omata M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766552 88. Co-morbidity and blood group type risk in coronavirus disease 2019 patients: A case-control study. J Infect Public Health 2021; 14:550-554Badedi M, Makrami A, Alnami A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756193 89. COVID-19 infection, inception and immunity: Observations and recommendations in the light of vitamin D? J Infect Public Health 2021; 14:444- 445Dixit V, Garg B, Mehta N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751982 90. Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City. J Matern Fetal Neonatal Med 2021:1-5Hernández-Cruz RG, Sánchez-Cobo D, Acevedo-Gallegos S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771080 91. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a non- epidemic region, Japan: A hospital-based study on May, 2020. J Med Virol 2021; Nakamura A, Ando S, Endo H, Sato R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33760273 92. Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19. J. Mol. Cell. Biol. 2021; Yang J, Zhong M, Zhang E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751111 93. Arkansans' Preferred COVID-19 Testing Locations. J. Prim. Care Community Health 2021; 12:21501327211004289McElfish PA, Willis DE, Bryant-Moore K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771056 94. Increased HIV testing in people who use drugs hospitalized in the first wave of the COVID-19 pandemic. J. Subst. Abuse Treat. 2021; 124:108266Zubiago J, Murphy M, Guardado R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771274 95. Usefulness of a multiplex immunodot in case of discordant results between automated COVID-19 serological assays. J. Virol. Methods 2021:114129Reza S, Mehdi K, Antoine A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745966 96. Optimizing COVID-19 testing capabilities and clinical management using pathology informatics. JAMIA Open 2020; 3:523-529Chamala S, Flax S, Starostik P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754137 97. IgV somatic mutation of human anti-SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity. JCI Insight 2021; Garcia de Mattos Barbosa M, Liu H, Huynh D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33769311 98. Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore- Washington metropolitan area. JCI Insight 2021; 6Thielen PM, Wohl S, Mehoke T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749660 99. RT-PCR Screening Tests for SARS-CoV-2 with Saliva Samples in Asymptomatic People: Strategy to Maintain Social and Economic Activities while Reducing the Risk of Spreading the Virus. Keio J. Med. 2021; Oba J, Taniguchi H, Sato M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746151 100. Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors. Kidney Blood Press. Res. 2021:1-5Cahova M, Kveton M, Petr V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756485 101. Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity. Life Sci 2021; 276:119410Posadas-Sánchez R, Sánchez-Muñoz F, Martin CAG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774023 102. Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options. Mediterr. J. Hematol. Infect. Dis. 2021; 13:e2021016Agrati C, Bordoni V, Sacchi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747397 103. "Transient plasma cell dyscrasia in COVID-19 patients linked to IL-6 triggering.". Microbes Infect 2021:104808Farina A, Labriola R, Ialongo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753206 104. Peptide substrate screening for the diagnosis of SARS-CoV-2 using fluorescence resonance energy transfer (FRET) assay. Mikrochim. Acta 2021; 188:137Alhadrami HA, Hassan AM, Chinnappan R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763734 105. Night shift schedule alters endogenous regulation of circulating cytokines. Neurobiol Sleep Circadian Rhythms 2021; 10:100063Liu PY, Irwin MR, Krueger JM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748539 106. Detection methods for SARS-CoV-2 in tissue. Pathologe 2021:1-8von Stillfried S, Boor P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770236 107. The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays. Pract Lab Med 2021; 25:e00212Swadźba J, Bednarczyk M, Anyszek T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748381 108. Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing. Proc Natl Acad Sci U S A 2021; 118He X, Quan S, Xu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766889 109. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection. Public Health 2021; 193:113-115Murillo-Zamora E, Mendoza-Cano O, Delgado-Enciso I, Hernandez-Suarez CM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774512 110. A comprehensive insight into the role of zinc deficiency in the renin- angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients. Saudi J. Biol. Sci. 2021; Gouda AS, Adbelruhman FG, Elbendary RN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746538 111. Validation and Performance Comparison of Two SARS-CoV-2 IgG/IgM Rapid Tests. Saudi J. Biol. Sci. 2021; Naser Al Awaji N, Talal Ahmedah H, Mohammed Alsaady I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746537 112. Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example. Theor. Biol. Med. Model. 2021; 18:10Zhao S, Lou J, Cao L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750399 113. Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation. Transfus. Apher. Sci. 2021:103118Pandey HC, Dhiman Y, C SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752991 114. A possible role for ST2 as prognostic biomarker for COVID-19. Vascul. Pharmacol. 2021:106857Ragusa R, Basta G, Del Turco S, Caselli C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746068 115. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients. Virol J 2021; 18:52Chansaenroj J, Yorsaeng R, Posuwan N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33750394 116. Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel. Wellcome Open Res 2020; 5:139Adams ER, Ainsworth M, Anand R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3374843

Children (33 articles)

1. Preparedness strategies in neonatology units during the COVID-19 pandemic: A survey conducted at maternity centers in Argentina. Arch. Argent. Pediatr. 2021; 119:76-82Geffner SC, Ávila AS, Etcharrán ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749192 2. The impact of the COVID-19 pandemic on child health and the provision of Care in Paediatric Emergency Departments: a qualitative study of frontline emergency care staff. BMC Health Serv. Res. 2021; 21:279Conlon C, McDonnell T, Barrett M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766026 3. The severity and atypical presentations of COVID-19 infection in pediatrics. BMC Pediatr. 2021; 21:144Saleh NY, Aboelghar HM, Salem SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765980 4. SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year- old child. BMJ Case Rep. 2021; 14Renganathan A, Garg A, Chowdhary S, Raj D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762287 5. COVID-19-associated multisystem inflammatory syndrome in children presenting uniquely with sinus node dysfunction in the setting of shock. Cardiol. Young 2021:1-3Tomlinson LG, Cohen MI, Levorson RE, Tzeng MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745461 6. E-gene RT-PCR Crossing Point Value and Other Biochemical Parameters as Useful Markers of Death Risk in COVID-19 Patients. Ejifcc 2021; 32:98- 104Bellés-Bellés A, Bernal M, Gómez-Arbonés J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753979 7. Multisystem Inflammatory Syndrome in Children, Chile, May-August 2020. Emerg Infect Dis 2021; 27Niño-Taravilla C, Otaola-Arca H, Lara-Aguilera N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760725 8. The interplay between environmental exposures and COVID-19 risks in the health of children. Environ. Health 2021; 20:34Sly PD, Trottier BA, Bulka CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771185 9. The impact of school closure and social isolation on children in vulnerable families during COVID-19: a focus on children's reactions. Eur. Child Adolesc. Psychiatry 2021:1-11Larsen L, Helland MS, Holt T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770275 10. Risk and protective factors related to children's symptoms of emotional difficulties and hyperactivity/inattention during the COVID-19-related lockdown in France: results from a community sample. Eur. Child Adolesc. Psychiatry 2021; Moulin F, El-Aarbaoui T, Bustamante JJH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751230 11. Screening of COVID-19 in outpatient children with cancer or solid organ transplantation: preliminary report. Eur. J. Pediatr. 2021:1-5Cleto-Yamane TL, Rodrigues-Santos G, de Magalhães-Barbosa MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768332 12. Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C). Front. Immunol. 2021; 12:648546Feketea G, Vlacha V, Bocsan IC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763085 13. Distinct Characteristics of COVID-19 Infection in Children. Front Pediatr 2021; 9:619738Han X, Li X, Xiao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748041 14. Heterogeneous Recommendations for School Attendance in Children With Chronic Kidney Diseases During the COVID-19 Pandemic in Europe. Front Pediatr 2021; 9:646595Schild R, Hopf L, Loos S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748050 15. Presenting or Spinning Facts? Deconstructing the U.S. Centers for Disease Control Statement on the Importance of Reopening Schools Under COVID-19. Front Public Health 2021; 9:645229Benzian H, Johnston M, Stauf N, Niederman R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768087 16. 'Now my life is stuck!': Experiences of adolescents and young people during COVID-19 lockdown in South Africa. Glob Public Health 2021:1-17Gittings L, Toska E, Medley S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750269 17. Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction. Hematol Rep. 2021; 13:8874Bin Ali T, Elyamany G, Nojoom M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747414 18. Airway management in children with COVID-19. Hong Kong Med. J. 2021; Leung KKY, Ku SW, Fung RCM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33750741 19. A case of bradycardia during SARS CoV-2 infection in a 14-year-old child. Infect Dis (Lond) 2021:1-4Kilicaslan O, Isancli DK, Ulutas OY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760677 20. Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR. Infect Dis (Lond) 2021:1-9Tsujimoto Y, Terada J, Kimura M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760699 21. COVID-19 quarantine: Psychological impact and support for children and parents. Ital. J. Pediatr. 2021; 47:58Demaria F, Vicari S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750452 22. Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease. Ital. J. Pediatr. 2021; 47:71Dipasquale V, Passanisi S, Cucinotta U et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33761992 23. Socioeconomic inequality in child mental health during the COVID-19 pandemic: First evidence from China. J. Affect. Disord. 2021; 287:8-14Li W, Wang Z, Wang G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761325 24. The experiences of mothers of children and young people with intellectual disabilities during the first COVID-19 lockdown period. J Appl Res Intellect Disabil 2021; Rogers G, Perez-Olivas G, Stenfert Kroese B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759291 25. Who is at a Higher Risk? A brief review of Recent Evidence on comorbidities in children infected with COVID-19. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S695-s700Qamar MA, Sajid MI, Dhillon RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754534 26. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia. J Infect Public Health 2021; 14:446-453Alharbi M, Kazzaz YM, Hameed T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765595 27. Coronavirus disease in children: A multicentre study from the Kingdom of Saudi Arabia. J Infect Public Health 2021; 14:543-549Kari JA, Shalaby MA, Albanna AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756192 28. Families With Children With Neurodevelopmental Disorders During COVID-19: A Scoping Review. J. Pediatr. Psychol. 2021; Shorey S, Lau LST, Tan JX et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758930 29. [The position of children in the pandemic and the role of COVID-19 in their lives]. Nephrol. Ther. 2021; Zaloszyc A, Tsimaratos M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771462 30. Claims and reasons about mild COVID- 19 infection in children. New Microbes New Infect 2021:100864Falahi S, Abdoli A, Kenarkoohi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747533 31. Canadian Adolescents' Internalized Symptoms in Pandemic Times: Association with Sociodemographic Characteristics, Confinement Habits, and Support. Psychiatr. Q. 2021:1-17Tardif-Grenier K, Archambault I, Dupéré V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768414 32. Management of COVID-19 in an adolescent demonstrates lasting effects of extreme prematurity on pulmonary function. Respir Med Case Rep 2021; 33:101394Sobelman CS, Valentine SL, Kremer T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758746 33. Frequently Asked Questions (FAQ) on children and corona lockdown - An argumentation aid. Z. Kinder. Jugendpsychiatr. Psychother. 2021; 49:146-150Kölch M, Schepker R.

Clinical Features (53 articles)

1. Quality of life and safety impact of COVID-19 associated smell and taste disturbances. Am. J. Otolaryngol. 2021; 42:103001Coelho DH, Reiter ER, Budd SG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773440 2. The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic. BMC Infect. Dis. 2021; 21:249Tan JK, Leong D, Munusamy H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750347 3. The severity and atypical presentations of COVID-19 infection in pediatrics. BMC Pediatr. 2021; 21:144Saleh NY, Aboelghar HM, Salem SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765980 4. Severe urticarial rash as the initial symptom of COVID-19 infection. BMJ Case Rep. 2021; 14Pagali S, Parikh RS. http://www.ncbi.nlm.nih.gov/pubmed/? term=33766974 5. Predictors of clinical deterioration in patients with suspected COVID-19 managed in a 'virtual hospital' setting: a cohort study. BMJ Open 2021; 11:e045356Francis NA, Stuart B, Knight M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757955 6. Early recognition of PIMS-TS: a single centre retrospective review. BMJ Paediatr Open 2021; 5:e001011Mistry R, Scanlon N, Hibberd J, Fuller F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768168 7. The prevalence of asymptomatic COVID-19 infection in cancer patients. A cross-sectional study at a tertiary cancer center in New York City. Cancer Treat Res Commun 2021; 27:100346Ibrahim M, Natarajan V, Murthy P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756172 8. Severe oropharyngeal dysphagia following COVID-19: a case report. Clin Case Rep 2021; 9:1539-1543De Vincentis G, Ferrari C, Guerini Rocco D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768884 9. Huge carbuncle leading to necrotizing fasciitis in the COVID-19 pandemic era. Clin Case Rep 2021; 9:1583-1586Gheisari M, Baghani M, Ganji R, Forouzanfar MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768893 10. Unexpected urological presentation of COVID-19 in a 41-year-old female: A case report. Clin Case Rep 2021; 9:1691-1693Haghighi R, Hashemi SA, Abaszade Ganji A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768916 11. Management considerations for a critically ill 26-gestational week patient with COVID-19: A case report. Clin Case Rep 2021; 9:1721-1724Khatib MY, Olagundoye VO, Elshafei MS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768922 12. Atypical manifestations of coronavirus disease 2019 (COVID-19)-associated autoimmune thrombotic thrombocytopenic purpura. Clin Case Rep 2021; 9:1402-1404Law L, Ho G, Cen D, Stenger J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768854 13. The great pretender-Bell's palsy secondary to SARS-CoV-2? Clin Case Rep 2021; 9:1175-1177Neo WL, Ng JCF, Iyer NG. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768805 14. Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2. Clin Infect Dis 2021; Wu P, Liu F, Chang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772573 15. Revisiting the Utility of Dilated Fundus Exams in Patients with Neovascular Age-Related Macular Degeneration Receiving Regular Intravitreal Injections. Clin. Ophthalmol. 2021; 15:1129-1131Antaki F, Milad D, Dirani A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746511 16. Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19). Cureus 2021; 13:e13429Banwait R, Singh D, Blanco A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758716 17. Dermoscopy in the COVID-19 Era: Magnifying the Gap for Clinicians. Dermatol Pract Concept 2021; 11:e2021069Hussain K, Marghoob AA, Patel NP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747633 18. PM(10) correlates with COVID-19 infections 15 days later in Arequipa, Peru. Environ. Sci. Pollut. Res. Int. 2021:1-7Wannaz ED, Larrea Valdivia AE, Reyes Larico JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761077 19. Estimation of the incubation period of COVID-19 using viral load data. Epidemics 2021; 35:100454Ejima K, Kim KS, Ludema C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773195 20. Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers. Eur Arch Otorhinolaryngol 2021:1- 7Riestra-Ayora J, Yanes-Diaz J, Esteban-Sanchez J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774737 21. Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS- CoV-2 Reinfection in Patients From Mumbai, India. Front Med (Lausanne) 2021; 8:631769Shastri J, Parikh S, Agrawal S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768104 22. Distinct Characteristics of COVID-19 Infection in Children. Front Pediatr 2021; 9:619738Han X, Li X, Xiao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748041 23. Olfactory Dysfunction in Frontline Health Care Professionals During COVID-19 Pandemic in Brazil. Front. Physiol. 2021; 12:622987Sbrana MF, Fornazieri MA, Bruni-Cardoso A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767631 24. Diversity of Cardiac and Gastrointestinal Presentations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series. Glob Pediatr Health 2021; 8:2333794x21996613Shikhare AR, Iqbal RM, Tariq R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748343 25. Prevalence of SARS-CoV-2 Specific Antibodies in Asymptomatic Hemodialysis Patients. Immunol. Invest. 2021:1-12Etemadi J, Bordbar S, Soltani-Zangbar MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752550 26. A Clinical Study of Smell Disorders in COVID-19 Patients in a Tertiary Care Hospital in Pondicherry: A Cross Sectional Study. Indian J Otolaryngol Head Neck Surg 2021:1-6Karthikeyan P, Sivanand N, Vijayan N, Latheef MN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747892 27. Olfactory Dysfunction is Associated with More Severe Clinical Course in COVID-19. Indian J Otolaryngol Head Neck Surg 2021:1-6Tabari A, Golpayegani G, Tabari A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747891 28. Investigation of structural, treatment and clinical characteristics of COVID-19 along with the challenges caused by its prevalence. Infect Disord Drug Targets 2021; Doagooyan M, Alavizadeh SH, Akhtari J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749564 29. Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients in a MERS-CoV Referral Hospital during the Peak of the Pandemic. Int J Infect Dis 2021; Barry M, Althabit N, Akkielah L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33771671 30. Exertional hypoxia in patients without resting hypoxia is an early predictor of moderate to severe COVID-19. Intern Emerg Med 2021:1-7Bhasin A, Bregger M, Kluk M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770368 31. An analysis of patient self-reported COVID-19 symptoms during the first wave of the pandemic in Ireland. Ir. J. Med. Sci. 2021:1-4Gibbons C, Hussain M, O'Keeffe DT, Simpkin AJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768443 32. Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave. J. Alzheimers Dis. 2021; Harb AA, Chen R, Chase HS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749656 33. Clinical and virological course of SARS-CoV 2 infected patients in a tertiary care hospital in Pakistan. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S602- s606Hussain A, Satti L, Hanif F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33754515 34. Rheumatological manifestations in patients hospitalized with COVID-19 in a tertiary care setting. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S691- s694Mustafa SH, Farooq MU, Iqbal F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33754533 35. Clinical Characteristics, Mortality and Associated risk factors in COVID-19 patients reported in ten major hospitals of Khyber Pakhtunkhwa, Pakistan. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S633-s639UlHaq Z, Shahzad M, Khattak MI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754522 36. ConceptWAS: a high-throughput method for early identification of COVID-19 presenting symptoms and characteristics from clinical notes. J. Biomed. Inform. 2021:103748Zhao J, Grabowska ME, Eric Kerchberger V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774203 37. Coronavirus disease in children: A multicentre study from the Kingdom of Saudi Arabia. J Infect Public Health 2021; 14:543-549Kari JA, Shalaby MA, Albanna AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756192 38. Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City. J Matern Fetal Neonatal Med 2021:1-5Hernández-Cruz RG, Sánchez-Cobo D, Acevedo-Gallegos S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771080 39. Outcomes among 10,314 hospitalized COVID-19 patients at a tertiary care government hospital in Delhi, India. J Med Virol 2021; Malhotra V, Basu S, Sharma N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755238 40. Characteristics of taste dysfunction in COVID-19 subjects coming from two different countries. J. Neurovirol. 2021; Pendolino AL, Ottaviano G, Scarpa B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751487 41. Prevalence of Dysphonia in Non hospitalized Patients with COVID-19 in Lombardy, the Italian Epicenter of the Pandemic. J. Voice 2021; Cantarella G, Aldè M, Consonni D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766419 42. The Impact of Coronavirus Disease 2019 (COVID-19) on Dual-Physician Couples: A Disproportionate Burden on Women Physicians. J Womens Health (Larchmt) 2021; Soares A, Thakker P, Deych E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751922 43. Acute urticaria as the initial presentation of COVID-19 in a pediatric patient. JAAD Case Rep 2021; Le NK, Brooks JP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748378 44. Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) without Interruption. Mediterr. J. Hematol. Infect. Dis. 2021; 13:e2021022Demeter J, Weisinger J, Nagy Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747403 45. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19. Neurol Sci 2021:1-6Bax F, Lettieri C, Marini A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755815 46. Testing olfactory dysfunction in acute and recovered COVID-19 patients: a single center study in Italy. Neurol Sci 2021:1-7Pasquini J, Maremmani C, Salvadori S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768438 47. Claims and reasons about mild COVID- 19 infection in children. New Microbes New Infect 2021:100864Falahi S, Abdoli A, Kenarkoohi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747533 48. Oral manifestations accompanying and related to COVID-19: overlooking the obvious. Oral Dis 2021; Anaya-Saavedra G. http://www.ncbi.nlm.nih.gov/pubmed/? term=33772953 49. Onset of dermatomyositis in close association with COVID-19 - a first case reported. Rheumatology (Oxford) 2021; Borges NH, Godoy TM, Kahlow BS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757122 50. Cutaneous manifestations of COVID-19 in Mexican patients: A case series and review of literature. SAGE Open Med Case Rep 2021; 9:2050313x21997194Palomo-Pérez JC, Vega-Memije ME, Aguilar-Blancas D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747514 51. Acute Polyneuropathy in an Outpatient Context During the SARS-CoV-2 Pandemic: A Brief Case Serie Report. SN Compr Clin Med 2021:1-3de Francisco Moure J, Torres Ramón I, Almárcegui Lafita C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748675 52. COVID-19 presenting with diarrhea in a heart transplant patient. Turk Gogus Kalp Damar Cerrahisi Derg 2021; 29:119-121Işık ME, Günay D, Aksüt M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768991 53. Conjunctivitis as initial presenting symptom in a COVID-19 patient. Vis J Emerg Med 2021; 23:100997Eid MM, Al Khalaf BN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33754132

CNS (20 articles)

1. 2021 Alzheimer's disease facts and figures. Alzheimers Dement 2021; 17:327- 406. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756057 2. [Acute psychotic episodes related to the COVID-19 pandemic]. Ann. Med. Psychol. (Paris) 2021; Doufik J, Ouhmou M, Bouraoua I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753949 3. Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report. BMC Infect. Dis. 2021; 21:298Werner J, Reichen I, Huber M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761897 4. Concomitant Guillain-Barre syndrome with COVID-19: a case report. BMC Neurol. 2021; 21:135Mackenzie N, Lopez-Coronel E, Dau A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757457 5. A young man presenting with encephalopathy and seizures secondary to SARS-CoV-2. BMJ Case Rep. 2021; 14Jalil BA, Ijaz M, Khan AM, Ledbetter TG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762283 6. Lesson of the month: Severe leukoencephalopathy by SARS-CoV-2. Clin Med (Lond) 2021; 21:155-157Sanz-Canalejas L, Polidura-Arruga MDC, Yus-Fuertes M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762380 7. Neuroleptic Malignant Syndrome After Re-introduction of Atypical Antipsychotics in a COVID-19 Patient. Cureus 2021; 13:e13428Espiridion ED, Mani V, Oladunjoye AO. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763319 8. Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine. Cureus 2021; 13:e13426Waheed S, Bayas A, Hindi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758714 9. Mysterious neuro-COVID: Causes of persistent neurological symptoms are unresolved. Deutsche Apotheker Zeitung 2021; 161Feldmeier H. 10. Outcomes of seizures, status epilepticus, and EEG findings in critically ill patient with COVID-19. Epilepsy Behav. 2021; 118:107923Danoun OA, Zillgitt A, Hill C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770609 11. COVID-19-Related Neuropsychiatric Symptoms in Patients With Alcohol Abuse Conditions During the SARS-CoV-2 Pandemic: A Retrospective Cohort Study Using Real World Data From Electronic Health Records of a Tertiary Hospital. Front. Neurol. 2021; 12:630566Varela Rodríguez C, Arias Horcajadas F, Martín-Arriscado Arroba C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746884 12. One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms. Int. J. Audiol. 2021:1-11Almufarrij I, Munro KJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750252 13. COVID-19-Associated Acute Brain Dysfunction Related to Sepsis. J. Clin. Med. Res. 2021; 13:82-91Tong DM, Zhou YT, Wang YW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747322 14. Optic neuritis following SARS-CoV-2 infection. J. Neurovirol. 2021:1-5Rodríguez- Rodríguez MS, Romero-Castro RM, Alvarado-de la Barrera C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755923 15. COVID-19 and Parkinson's Disease: What We Know So Far? J. Parkinsons Dis. 2021; Artusi CA, Romagnolo A, Ledda C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749619 16. Families With Children With Neurodevelopmental Disorders During COVID-19: A Scoping Review. J. Pediatr. Psychol. 2021; Shorey S, Lau LST, Tan JX et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758930 17. Nervous System Involvement in COVID-19: a Review of the Current Knowledge. Mol. Neurobiol. 2021; Norouzi M, Miar P, Norouzi S, Nikpour P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765290 18. Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series. Mult Scler Relat Disord 2021; 51:102900Kaya Tutar N, Omerhoca S, Coban E, Kale N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770573 19. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19. Neurol Sci 2021:1-6Bax F, Lettieri C, Marini A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755815 20. Acute Polyneuropathy in an Outpatient Context During the SARS-CoV-2 Pandemic: A Brief Case Serie Report. SN Compr Clin Med 2021:1-3de Francisco Moure J, Torres Ramón I, Almárcegui Lafita C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748675

Coagulation (19 articles)

1. Three cases of spontaneous major bleeding in patients with a COVID-19 infection. Acta Chir. Belg. 2021:1-4Vos CG, Gravendeel J, Keller B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769205 2. COVID-19 and Coagulopathy. Am. J. Respir. Cell Mol. Biol. 2021; Inoue KI, Sagawa T, Takano H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770450 3. Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy. Anaesth Crit Care Pain Med 2021:100841Attallah N, Gupta S, Madhyastha R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746074 4. MR-proAdrenomedullin as predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19. Biomarkers 2021:1-20Roedl K, Jarczak D, Fischer M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754916 5. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug. BMC Pulm. Med. 2021; 21:102D'Elia E, Gori M, Grosu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761886 6. Double-edged sword effect of anticoagulant in COVID-19 infection. BMJ Case Rep. 2021; 14Ohn MH, Ng JR, Ohn KM, Luen NP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753396 7. Pulmonary embolism confounded with COVID-19 suspicion in a catatonic patient presenting to anesthesia for ECT: a case report. Braz J Anesthesiol 2021; Naik BN, Singh N, Aditya AS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33766683 8. Aggregometry and thromboelastography to identify the timing to trach a COVID-19 patient receiving both antiplatelet therapy and enoxaparin. Clin Case Rep 2021; 9:1049-1054Tescione M, Vadalà E, Marano G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768781 9. Renal failure and lung hemorrhage as a presentation of COVID-19 infection, a case report. Clin Case Rep 2021; 9:1123-1129Zamani N, Aloosh O, Ahsant S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768795 10. An Unusual Presentation of COVID-19: Hemorrhagic Pericardial Effusion With Tamponade Physiology. Cureus 2021; 13:e13438Foster B, Liaqat A, Chib A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758721 11. Is COVID-19 an Independent Risk Factor for Heparin-Induced Thrombocytopenia? Cureus 2021; 13:e13425Madala S, Krzyzak M, Dehghani S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758713 12. Covid-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis. Eur. J. Clin. Invest. 2021:e13559Gabbai-Armelin PR, de Oliveira AB, Ferrisse TM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33772772 13. Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:647917Gratz J, Wiegele M, Maleczek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768106 14. Heparin-induced thrombocytopenia and COVID-19. Hematol Rep. 2021; 13:8857Sartori M, Cosmi B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747413 15. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications. J Am Coll Surg 2021; Meizoso JP, Moore HB, Moore EE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766727 16. Massive biventricular thrombi complicating new-onset heart failure in a patient with suspected COVID-19. J Cardiol Cases 2021; Ozer M, Abbasi F, Mahdi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754079 17. Intracranial microhemorrhages in the setting of COVID-19: what we know so far. Neuroradiol. J. 2021:19714009211004144Benson JC, Hunt CH, Klaas JP, Kallmes DF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765876 18. Surgical Considerations in the Treatment of Axillary-Subclavian Venous Thrombosis in the Era of COVID-19. Vasc. Endovascular Surg. 2021:15385744211002803Mukherjee D, Kittner J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757394 19. COVID-19: A Time Like No Other in (the Department of) Neurological Surgery. World Neurosurg 2021; 148:256-262Pannullo SC, Guadix SW, Souweidane MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770848

Complications (69 articles)

1. Three cases of spontaneous major bleeding in patients with a COVID-19 infection. Acta Chir. Belg. 2021:1-4Vos CG, Gravendeel J, Keller B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769205 2. A rare complication of Covid-19: Spontaneous pneumothorax following pneumomediastinum; case report. Am J Emerg Med 2021; Bozan Ö, Atiş Ş E, Çekmen B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750666 3. MR-proAdrenomedullin as predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19. Biomarkers 2021:1-20Roedl K, Jarczak D, Fischer M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754916 4. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug. BMC Pulm. Med. 2021; 21:102D'Elia E, Gori M, Grosu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761886 5. Acute coronary thrombosis as a complication of COVID-19. BMJ Case Rep. 2021; 14Genovese L, Ruiz D, Tehrani B, Sinha S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753377 6. Predictors of clinical deterioration in patients with suspected COVID-19 managed in a 'virtual hospital' setting: a cohort study. BMJ Open 2021; 11:e045356Francis NA, Stuart B, Knight M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757955 7. Pulmonary embolism confounded with COVID-19 suspicion in a catatonic patient presenting to anesthesia for ECT: a case report. Braz J Anesthesiol 2021; Naik BN, Singh N, Aditya AS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33766683 8. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Rep Med 2021:100229Buehler PK, Zinkernagel AS, Hofmaenner DA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748789 9. Success and complications of endotracheal intubation in critical care settings under COVID-19 protocols. Cjem 2021; Dullemond K, Renschler C, Trojanowski J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751491 10. Synchronous presentation of COVID-19 pneumonia and pulmonary embolism. Clin Case Rep 2021; 9:1663-1666Poursadegh F, Davoudian N, Mozdourian M, Abdollahi F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768910 11. Renal failure and lung hemorrhage as a presentation of COVID-19 infection, a case report. Clin Case Rep 2021; 9:1123-1129Zamani N, Aloosh O, Ahsant S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768795 12. Lung abscess as a complication of COVID-19 infection, a case report. Clin Case Rep 2021; 9:1130-1134Zamani N, Aloosh O, Ahsant S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768796 13. COVID-19 as a trigger of acute attacks in people with hereditary angioedema. Clin. Exp. Allergy 2021; Belbézier A, Arnaud M, Boccon-Gibod I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772888 14. Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19. Clin Immunol 2021; 226:108716Satyam A, Tsokos MG, Brook OR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774179 15. COVID-19 Associated Pulmonary Aspergillosis: Do We Have the CAPAcity to Improve Outcomes? Clin Infect Dis 2021; Baddley JW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754152 16. A specialised cardiorespiratory team approach in the intensive care management of COVID-19 patients: benefit on mortality, diagnosis and management. Clin Med (Lond) 2021; 21:101-106Anwar A, Ramos-Bascon N, Crerar-Gilbert AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762367 17. Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19. Clin. Neurophysiol. 2021; 132:1138-1143Versace V, Sebastianelli L, Ferrazzoli D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774378 18. Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19). Cureus 2021; 13:e13429Banwait R, Singh D, Blanco A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758716 19. An Unusual Presentation of COVID-19: Hemorrhagic Pericardial Effusion With Tamponade Physiology. Cureus 2021; 13:e13438Foster B, Liaqat A, Chib A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758721 20. First Cases of Multisystem Inflammatory Syndrome following SARS-CoV-2 infection in Adults in Germany. Deutsche Medizinische Wochenschrift 2021; Rieper K, Sturm A. 21. COVID-19 and Alcohol Poisoning: A Fatal Competition. Disaster Med Public Health Prep 2021:1-10Heidari M, Sayfouri N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762062 22. Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020. Emerg Infect Dis 2021; 27Heaney AK, Head JR, Broen K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755007 23. Multisystem Inflammatory Syndrome in Children, Chile, May-August 2020. Emerg Infect Dis 2021; 27Niño-Taravilla C, Otaola-Arca H, Lara-Aguilera N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760725 24. COVID-19-Associated Mold Infection in Critically Ill Patients, Chile. Emerg Infect Dis 2021; 27Rabagliati R, Rodríguez N, Núñez C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760726 25. Perception of level of knowledge, skills, and safety before and after training to perform videolaryngoscopy with the Intubox barrier system for airway management in patients with COVID-19. Emergencias 2021; 33:93-99Adánez Martínez MG, Leal Costa C, García López JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750049 26. Covid-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis. Eur. J. Clin. Invest. 2021:e13559Gabbai-Armelin PR, de Oliveira AB, Ferrisse TM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33772772 27. Screening of COVID-19 in outpatient children with cancer or solid organ transplantation: preliminary report. Eur. J. Pediatr. 2021:1-5Cleto-Yamane TL, Rodrigues-Santos G, de Magalhães-Barbosa MC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768332 28. Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C). Front. Immunol. 2021; 12:648546Feketea G, Vlacha V, Bocsan IC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763085 29. The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients. Front. Immunol. 2021; 12:632814Luo H, Jia T, Chen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763078 30. Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:647917Gratz J, Wiegele M, Maleczek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768106 31. Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction. Hematol Rep. 2021; 13:8874Bin Ali T, Elyamany G, Nojoom M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747414 32. Heparin-induced thrombocytopenia and COVID-19. Hematol Rep. 2021; 13:8857Sartori M, Cosmi B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747413 33. Airway management in children with COVID-19. Hong Kong Med. J. 2021; Leung KKY, Ku SW, Fung RCM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33750741 34. Relational Learning Improves Prediction of Mortality in COVID-19 in the Intensive Care Unit. IEEE Trans Big Data 2021; 7:38-44Wanyan T, Vaid A, De Freitas JK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768136 35. Meeting oxygen requirements of rural India: A self-contained solution. Indian J. Public Health 2021; 65:82-84Madaan N, Paul BC, Guleria R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753697 36. ACE2 correlates with immune infiltrates in colon adenocarcinoma: Implication for COVID-19. Int Immunopharmacol 2021; 95:107568Ahmadi M, Pashangzadeh S, Mousavi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765612 37. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents 2021:106324Lai CC, Chen SY, Ko WC, Hsueh PR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746045 38. Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients in a MERS-CoV Referral Hospital during the Peak of the Pandemic. Int J Infect Dis 2021; Barry M, Althabit N, Akkielah L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33771671 39. Multisystem inflammatory syndrome in children (MIS-C) and retropharyngeal edema: A case series. Int J Pediatr Otorhinolaryngol 2021; 144:110667Daube A, Rickert S, Madan RP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752089 40. Post COVID-19 large pneumatocele: clinical and pathological perspectives. Interact. Cardiovasc. Thorac. Surg. 2021; Hamad AM, El-Saka HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764376 41. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications. J Am Coll Surg 2021; Meizoso JP, Moore HB, Moore EE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766727 42. Massive biventricular thrombi complicating new-onset heart failure in a patient with suspected COVID-19. J Cardiol Cases 2021; Ozer M, Abbasi F, Mahdi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754079 43. Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review. J. Chemother. 2021:1-10Nahshon C, Segev Y, Schmidt M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769233 44. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Expert Recommendations from The Korean Society for Thoracic and Cardiovascular Surgery. J Chest Surg 2021; 54:2-8Jeong IS, Kim WH, Baek JH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767006 45. Hemopneumothorax as an Unusual and Delayed Complication of Coronavirus Disease 2019 Pneumonia. J Chest Surg 2021; Sayan M, Turk MS, Ozkan D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767017 46. The effects of the COVID-19 pandemic on efficiency and airway management. J. Clin. Anesth. 2021; 71:110239Shackleford V, McGuire JA, Uraco AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773160 47. COVID-19-Associated Acute Brain Dysfunction Related to Sepsis. J. Clin. Med. Res. 2021; 13:82-91Tong DM, Zhou YT, Wang YW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747322 48. Risk of COVID-19 Infection, Hospitalization, and Mortality in Patients with Psoriasis Treated by Interleukin-17 Inhibitors. J Dermatolog Treat 2021:1- 28Kridin K, Schonmann Y, Solomon A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33759683 49. Hemophagocytic Lymphohistiocytosis in the Emergency Department: Recognizing and Evaluating a Hidden Threat. J. Emerg. Med. 2021; Morrissette K, Bridwell R, Lentz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745765 50. Coronavirus disease 2019 and dengue: two case reports. J Med Case Rep 2021; 15:171Hilmy AI, Dey RK, Imad HA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771221 51. Successful treatment of intubation-induced severe neurogenic post- extubation dysphagia using pharyngeal electrical stimulation in a COVID-19 survivor: a case report. J Med Case Rep 2021; 15:148Traugott M, Hoepler W, Kitzberger R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752743 52. Optic neuritis following SARS-CoV-2 infection. J. Neurovirol. 2021:1-5Rodríguez- Rodríguez MS, Romero-Castro RM, Alvarado-de la Barrera C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755923 53. Bleeding Risk by Intensity of Anticoagulation in Critically Ill Patients with COVID-19: A Retrospective Cohort Study. J Thromb Haemost 2021; Halaby R, Cuker A, Yui J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774903 54. New threatening of SARS-CoV-2 co-infection and strategies to fight the current pandemic. Med Drug Discov 2021:100089Goel N, Ahmad R, Fatima H, Khare SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748740 55. Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series. Mult Scler Relat Disord 2021; 51:102900Kaya Tutar N, Omerhoca S, Coban E, Kale N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770573 56. Acute Presentation of Third Ventricular Cavernous Malformation following COVID-19 Infection in a Pregnant Woman: A Case Report. Neurochirurgie 2021; Saberi H, Tanha RR, Derakhshanrad N, Soltaninejad MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771616 57. The second wave of desaturation in COVID-19. New Microbes New Infect 2021:100866Alghizzawi MI, Ata F, Yousaf Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758668 58. Blood stream infections during the first wave of COVID-19. A short microbiological retrospective picture at Papa Giovanni XXIII Hospital, Bergamo, Italy. New Microbiol. 2021; 44:51-58Cuntrò M, Manisco A, Guarneri D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755185 59. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19. Orbit 2021:1-4Dallalzadeh LO, Ozzello DJ, Liu CY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752571 60. Viral Infectivity in Patients Undergoing Tracheotomy With COVID-19: A Preliminary Study. Otolaryngol Head Neck Surg 2021:1945998211004255George MM, McIntyre CJ, Zhou J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752547 61. German recommendations for treatment of critically ill patients with COVID-19 —version 3: S1-guideline. Pneumologe 2020; 17:406-425Kluge S, Janssens U, Welte T et al. 62. COVID-19: The role of intensive care. Public Health Forum 2021; 29:11- 14Hanisch V. 63. Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter? Rev. Esp. Quimioter. 2021; Suarez-de-la-Rica A, Serrano P, De-la-Oliva R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764004 64. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis. Sci. Prog. 2021; 104:368504211000906Giri M, Puri A, Wang T, Guo S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752530 65. Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study. Thorax 2021; Pérez-Mies B, Gómez-Rojo M, Carretero-Barrio I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758071 66. COVID-19 and the liver: an adverse outcome pathway perspective. Toxicology 2021; 455:152765Vinken M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771662 67. Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance. Trans. R. Soc. Trop. Med. Hyg. 2021; Rodríguez-Baño J, Rossolini GM, Schultsz C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772597 68. Fatal coincidence of inapparent SARS-CoV-2 infection and drug toxicity in the field of immunosuppression in a 33-year old woman. Vnitr. Lek. 2021; 67:51- 56Faktorová X, Horniaková L, Sedlačko J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752392 69. Extracorporeal membrane oxygenation for coronavirus disease 2019- associated acute respiratory distress syndrome: Report of two cases and review of the literature. World J Clin Cases 2021; 9:1953-1967Wen JL, Sun QZ, Cheng Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748247

Cured – Recovered (16 articles)

1. Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients. BMC Infect. Dis. 2021; 21:299Li G, Du L, Cao X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761881 2. 'Long COVID': persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect. Dis. 2021; 21:304Osikomaiya B, Erinoso O, Wright KO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765941 3. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug. BMC Pulm. Med. 2021; 21:102D'Elia E, Gori M, Grosu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761886 4. Feasibility of an online platform delivery of pulmonary rehabilitation for individuals with chronic respiratory disease. BMJ Open Respir Res 2021; 8Lewis A, Knight E, Bland M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762360 5. COVID-19 Reinfection in the Face of a Detectable Antibody Titer. Cureus 2021; 13:e14033Roy S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767941 6. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife 2021; 10Chioh FW, Fong SW, Young BE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752798 7. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow- up study. ESC Heart Fail 2021; Fayol A, Livrozet M, Boutouyrie P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773099 8. Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS- CoV-2 Reinfection in Patients From Mumbai, India. Front Med (Lausanne) 2021; 8:631769Shastri J, Parikh S, Agrawal S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768104 9. Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge. Int Immunopharmacol 2021; 95:107579Hong LX, Liu L, Lin A, Yan WH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756229 10. Increase in Frailty in Nursing Home Survivors of Coronavirus Disease 2019: Comparison With Noninfected Residents. J. Am. Med. Dir. Assoc. 2021; Greco GI, Noale M, Trevisan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757725 11. First documented reinfection of SARS-COV-2 in second wave from Pakistan. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S704-s705Ul-Haq Z, Khan A, Fazid S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754536 12. Recurrent COVID-19 in Hemodialysis: A Case Report of 2 Possible Reinfections. Kidney Med 2021; Krishna VN, Ahmad M, Overton ET, Jain G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748738 13. Is there a post-COVID syndrome? Pneumologe 2020; 17:398-405Lamprecht B. 14. Strengthening health system building blocks: configuring post-COVID-19 scenario in Pakistan. Prim. Health Care Res. Dev. 2021; 22:e9Shaikh BT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762035 15. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection. Public Health 2021; 193:113-115Murillo-Zamora E, Mendoza-Cano O, Delgado-Enciso I, Hernandez-Suarez CM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774512 16. Follow-up care after COVID-19 and its related concerns. Vnitr. Lek. 2021; 67:30- 36Radvan M, Bartečků E, Sýkorová U et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752388

Cardiovascular disease (54 articles)

1. The effect of the COVID-19 pandemic on emergency department visits for serious cardiovascular conditions. Am J Emerg Med 2021; 47:42-51Pines JM, Zocchi MS, Black BS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770713 2. A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs. Biochem. Biophys. Res. Commun. 2021; 553:25-29Zhang Y, Niu G, Flisikowska T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756342 3. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug. BMC Pulm. Med. 2021; 21:102D'Elia E, Gori M, Grosu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761886 4. Acute coronary thrombosis as a complication of COVID-19. BMJ Case Rep. 2021; 14Genovese L, Ruiz D, Tehrani B, Sinha S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753377 5. Double-edged sword effect of anticoagulant in COVID-19 infection. BMJ Case Rep. 2021; 14Ohn MH, Ng JR, Ohn KM, Luen NP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753396 6. SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year- old child. BMJ Case Rep. 2021; 14Renganathan A, Garg A, Chowdhary S, Raj D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762287 7. Lateral ST-elevation myocardial infarction after donation of COVID-19 convalescent plasma in a naïve donor. BMJ Case Rep. 2021; 14Shams P, Tipoo FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762295 8. Pulmonary embolism confounded with COVID-19 suspicion in a catatonic patient presenting to anesthesia for ECT: a case report. Braz J Anesthesiol 2021; Naik BN, Singh N, Aditya AS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33766683 9. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic. Cardiovasc. Diabetol. 2021; 20:69Moreno R, Díez JL, Diarte JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757510 10. Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic. Catheter. Cardiovasc. Interv. 2021; Mohamed MO, Curzen N, de Belder M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33764676 11. Use of a novel implantable cardioverter-defibrillator multisensor algorithm for heart failure monitoring in a COVID-19 patient: A case report. Clin Case Rep 2021; 9:1178-1182Bontempi L, Cerini M, Salghetti F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768806 12. Synchronous presentation of COVID-19 pneumonia and pulmonary embolism. Clin Case Rep 2021; 9:1663-1666Poursadegh F, Davoudian N, Mozdourian M, Abdollahi F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768910 13. COVID-19 infection complicated by acute ST-elevation myocardial infarction. Clin Imaging 2021; 78:117-120Fu T, Mamaliga G, Pierce JD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774577 14. A specialised cardiorespiratory team approach in the intensive care management of COVID-19 patients: benefit on mortality, diagnosis and management. Clin Med (Lond) 2021; 21:101-106Anwar A, Ramos-Bascon N, Crerar-Gilbert AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762367 15. Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19). Cureus 2021; 13:e13429Banwait R, Singh D, Blanco A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758716 16. COVID-19 Outcomes Amongst Patients With Pre-existing Cardiovascular Disease and Hypertension. Cureus 2021; 13:e13420Chakinala RC, Shah CD, Rakholiya JH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763316 17. An Unusual Presentation of COVID-19: Hemorrhagic Pericardial Effusion With Tamponade Physiology. Cureus 2021; 13:e13438Foster B, Liaqat A, Chib A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758721 18. ACE2 as a key target for treatment of COVID-19 related cardiovascular diseases: current progress and prospect. Curr. Drug Targets 2021; Li S, Cai B, Ma W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745431 19. Case Selection During the COVID-19 Pandemic: Who Should Go to the Cardiac Catheterization Laboratory? Curr. Treat. Options Cardiovasc. Med. 2021; 23:27Vemmou E, Nikolakopoulos I, Brilakis ES et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758493 20. Caseload and cardiopulmonary arrest management by an out-of-hospital emergency service during the COVID-19 pandemic. Emergencias 2021; 33:100- 106Navalpotro-Pascual JM, Fernández Pérez C, Peinado Vallejo FA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750050 21. Cardiac performance in patients hospitalized with COVID-19: a 6 month follow- up study. ESC Heart Fail 2021; Fayol A, Livrozet M, Boutouyrie P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773099 22. Focal ST-segment elevation without coronary occlusion: myocardial infarction with no obstructive coronary atherosclerosis associated with COVID-19-a case report. Eur Heart J Case Rep 2021; 5:ytaa532Meizinger C, Klugherz B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768195 23. Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:647917Gratz J, Wiegele M, Maleczek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768106 24. Do Cellular Entry Mechanisms of SARS-Cov-2 Affect Myocardial Cells and Contribute to Cardiac Injury in COVID-19 Patients? Front. Physiol. 2021; 12:630778Balse E, Hatem SN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33767634 25. Diversity of Cardiac and Gastrointestinal Presentations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series. Glob Pediatr Health 2021; 8:2333794x21996613Shikhare AR, Iqbal RM, Tariq R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748343 26. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail. Rev. 2021:1-11Castiello T, Georgiopoulos G, Finocchiaro G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761041 27. Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies. Hypertens. Res. 2021; Kai H, Kai M, Niiyama H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750913 28. Changing Pattern of Congenital Heart Disease Care During COVID-19 Pandemic. Indian J Pediatr 2021:1-6Sachdeva S, Saxena A, Shakya S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754311 29. A case of bradycardia during SARS CoV-2 infection in a 14-year-old child. Infect Dis (Lond) 2021:1-4Kilicaslan O, Isancli DK, Ulutas OY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760677 30. Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy. Int J Cardiol 2021; Rognoni A, D'Ascenzo F, Solli M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766626 31. A super learner ensemble of 14 statistical learning models for predicting COVID-19 severity among patients with cardiovascular conditions. Intell Based Med 2021:100030Ehwerhemuepha L, Danioko S, Verma S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748802 32. Intensive cardiac care unit admission trends during the COVID-19 outbreak in Italy: a multi-center study. Intern Emerg Med 2021:1-10Campanile A, Verdecchia P, Ravera A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768468 33. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications. J Am Coll Surg 2021; Meizoso JP, Moore HB, Moore EE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766727 34. Impact of COVID-19 on exercise pathophysiology. A combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol (1985) 2021; Baratto C, Caravita S, Faini A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33764166 35. Emergency CABG for a migrated stent in a COVID-19 positive patient. J. Card. Surg. 2021; Parra JF, Vinck EE, Sánchez O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768558 36. Massive biventricular thrombi complicating new-onset heart failure in a patient with suspected COVID-19. J Cardiol Cases 2021; Ozer M, Abbasi F, Mahdi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754079 37. Cardiac surgery outcome during the COVID-19 pandemic: a retrospective review of the early experience in nine UK centres. J. Cardiothorac. Surg. 2021; 16:43Sanders J, Akowuah E, Cooper J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752706 38. EACTA/SCA Recommendations for the Cardiac Anesthesia Management of Patients With Suspected or Confirmed COVID-19 Infection: An Expert Consensus From the European Association of Cardiothoracic Anesthesiology and Society of Cardiovascular Anesthesiologists With Endorsement From the Chinese Society of Cardiothoracic and Vascular Anesthesiology. J Cardiothorac Vasc Anesth 2021; Guarracino F, Shernan SK, Tahan ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766471 39. QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19. J. Clin. Pharm. Ther. 2021; Koh HM, Chong PF, Tan JN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768612 40. Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France. J Med Vasc 2021; 46:90-92Lanéelle D, Dadon M, Quere I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752851 41. Implementing the SNIS recommendations for neurointerventional emergent care in the setting of COVID-19: impact on stroke metrics and patient outcomes. J. Neurointerv. Surg. 2021; Atchie B, Jarvis S, Stoddard E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758066 42. Comments on coronavirus positive patients presenting with stroke-like symptoms. J. Stroke Cerebrovasc. Dis. 2021:105741Au SCL, Ko CKL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752950 43. Novel treatment concepts for heart failure: Study highlights 2020. Kardiologe 2021; 15:121-126Birner C, Laufs U, Frey N. 44. Development of cardiovascular medicine 2020: cardiac magnetic resonance imaging. Kardiologe 2021; 15:147-152von Knobelsdorff F. 45. Advances in cardiovascular medicine 2020: Ischemic heart diseases. Kardiologe 2021; 15:92-100Werner N, Neumann FJ. 46. Intracranial microhemorrhages in the setting of COVID-19: what we know so far. Neuroradiol. J. 2021:19714009211004144Benson JC, Hunt CH, Klaas JP, Kallmes DF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765876 47. The frequency of arrhythmias in COVID-19 patients, a study in the Shahid Mostafa Khomeini Hospital of Ilam from March to August 2020. New Microbes New Infect 2021:100867Mohammadyari E, Ahmadi I, Mohammadyari A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758669 48. QTc prolongation in COVID-19 patients treated with Hydroxychloroquine, Chloroquine, Azithromycin, or Lopinavir/Ritonavir: A systematic review and meta-analysis. Pharmacoepidemiol. Drug Saf. 2021; Diaz-Arocutipa C, Brañez- Condorena A, Hernandez AV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772933 49. High-dose ACEi might be harmful in COVID-19 patients with serious respiratory distress syndrome by leading to excessive bradykinin receptor activation. Physiol Int 2021; Székács B, Várbíró S, Debreczeni L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764894 50. A comprehensive insight into the role of zinc deficiency in the renin- angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients. Saudi J. Biol. Sci. 2021; Gouda AS, Adbelruhman FG, Elbendary RN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746538 51. CvDeep-COVID-19 Detection Model. SN Comput Sci 2021; 2:145Ingle VA, Ambad PM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754141 52. COVID-19 presenting with diarrhea in a heart transplant patient. Turk Gogus Kalp Damar Cerrahisi Derg 2021; 29:119-121Işık ME, Günay D, Aksüt M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768991 53. Surgical Considerations in the Treatment of Axillary-Subclavian Venous Thrombosis in the Era of COVID-19. Vasc. Endovascular Surg. 2021:15385744211002803Mukherjee D, Kittner J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757394 54. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J. Diabetes 2021; 12:215-237Viswanathan V, Puvvula A, Jamthikar AD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758644

Diagnosis (9 articles)

1. A novel classifier architecture based on deep neural network for COVID-19 detection using laboratory findings. Appl Soft Comput 2021; 106:107329Göreke V, Sarı V, Kockanat S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758581 2. Coronavirus disease 2019 (COVID-19): diagnosis and prognosis. Blood Genom 2020; 4:96-107Wang X, Zhou Y, Liu L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768219 3. Deep-chest: Multi-classification deep learning model for diagnosing COVID-19, pneumonia, and lung cancer chest diseases. Comput. Biol. Med. 2021; 132:104348Ibrahim DM, Elshennawy NM, Sarhan AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774272 4. COVID-19 and the Le Chatelier's principle. Diagnosis (Berl) 2021; Diamandis EP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770825 5. Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19. Glob Med Genet 2021; 8:7-10Khodavirdipour A, Piri M, Jabbari S, Khalaj-Kondori M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748818 6. COVID-19 Pandemic: Review of Contemporary and Forthcoming Detection Tools. Infect Drug Resist 2021; 14:1049-1082Oishee MJ, Ali T, Jahan N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762831 7. Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease. Ital. J. Pediatr. 2021; 47:71Dipasquale V, Passanisi S, Cucinotta U et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33761992 8. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia. J Infect Public Health 2021; 14:446-453Alharbi M, Kazzaz YM, Hameed T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765595 9. Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion. Mil Med Res 2021; 8:22Adedokun KA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761986

DM-MS-Obesity (20 articles)

1. Association of body mass index with severity and mortality of COVID-19 pneumonia: a two-center, retrospective cohort study from Wuhan, China. Aging (Albany NY) 2021; 13Wu X, Li C, Chen S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761466 2. Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study. BMC Med 2021; 19:72Au Yeung SL, Zhao JV, Schooling CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757497 3. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic. Cardiovasc. Diabetol. 2021; 20:69Moreno R, Díez JL, Diarte JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757510 4. Determinants of Increased Fibrinogen in COVID-19 Patients With and Without Diabetes and Impaired Fasting Glucose. Clin. Appl. Thromb. Hemost. 2021; 27:1076029621996445Wang Z, Du Z, Zhao X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760664 5. Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations. Clin. Nutr. 2021; 40:1637-1643Cava E, Neri B, Carbonelli MG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765600 6. COVID-19 deaths correlate with blood glucose level: The German Diabetes Society warns. Deutsche Apotheker Zeitung 2021; 161. 7. Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19. Diabetes Metab. J. 2021; Rhee SY, Lee J, Nam H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752274 8. The J-shaped relationship between body mass index and mortality in patients with COVID-19: A dose-response meta-analysis. Diabetes Obes. Metab. 2021; Huang HK, Bukhari K, Peng CC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33764660 9. Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with Coronavirus disease 2019 (COVID-19). Endocr. J. 2021; Okauchi Y, Matsuno K, Nishida T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762519 10. Diabetes is associated with higher mortality and severity in hospitalized patients with COVID-19. Excli j 2021; 20:444-453Moghaddam Tabrizi F, Rasmi Y, Hosseinzadeh E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746672 11. Physiological and Immunological Causes of the Susceptibility of Chronic Inflammatory Patients to COVID-19 Infection: Focus on Diabetes. Front. Endocrinol. (Lausanne) 2021; 12:576412Rahmani-Kukia N, Abbasi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746897 12. SARS-CoV-2 during pregnancy: Severe course in the case of overweight and comorbidities. Geburtshilfe Frauenheilkd. 2021; 81:240-241. 13. COVID-19 and pregnancy: Case series with diabetes co-morbidity from the registry study ‘Covid-19 Related Obstetric and Neonatal Outcome Study‘ (CRONOS). Gynakologe 2021; Kleinwechter H, Groten T, Schäfer-Graf U et al. 14. Clinical characteristics and risk factors for disease severity and mortality of COVID-19 patients with diabetes mellitus in Kazakhstan: A nationwide study. Heliyon 2021; 7:e06561Dyusupova A, Faizova R, Yurkovskaya O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763618 15. Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases. Int J Clin Pharm 2021; Koufakis T, Pavlidis AN, Metallidis S, Kotsa K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751323 16. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study. Life Sci 2021:119371Cheng X, Xin S, Chen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745895 17. Protecting Individuals Living with Overweight and Obesity: Attitudes and Concerns Towards COVID-19 Vaccination in Canada. Obesity (Silver Spring) 2021; Vallis M, Glazer S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774916 18. Obesity, ethnicity and risk of critical care, mechanical ventilation and mortality in patients admitted to hospital with COVID-19: Analysis of the ISARIC CCP- UK cohort. Obesity (Silver Spring) 2021; Yates T, Zaccardi F, Islam N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755331 19. Diabetes and COVID-19: Diseases of racial, social and glucose intolerance. World J. Diabetes 2021; 12:198-205Chowdhury TA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758642 20. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J. Diabetes 2021; 12:215-237Viswanathan V, Puvvula A, Jamthikar AD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758644

Education and training and science (59 articles)

1. Medical Histopathology Laboratories: Remote Teaching in Response to COVID-19 Pandemic. Acad Pathol 2021; 8:2374289521998049Sharma R, King TS, Hanson ER, Fiebelkorn K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763534 2. Internal Medicine Clerkship Amidst COVID-19 Pandemic: A Cross-Sectional Study of the Clinical Learning Experience of Undergraduate Medical Students at Makerere University, Uganda. Adv Med Educ Pract 2021; 12:253-262Bongomin F, Olum R, Nakiyingi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746525 3. Is the COVID-19 Pandemic a High-Risk Period for College Student Alcohol Use? A Comparison of Three Spring Semesters. Alcohol. Clin. Exp. Res. 2021; Jaffe AE, Kumar SA, Ramirez JJ, DiLillo D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33755213 4. A lost generation? The impact of the COVID-19 pandemic on early career ASD researchers. Autism Res. 2021; Harrop C, Bal V, Carpenter K, Halladay A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759380 5. Research progress of traditional Chinese medicine against COVID-19. Biomed. Pharmacother. 2021; 137:111310Ren W, Liang P, Ma Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761591 6. Global health on the front lines: an innovative medical student elective combining education and service during the COVID-19 pandemic. BMC Med. Educ. 2021; 21:186Altillo BSA, Gray M, Avashia SB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773585 7. Professional roles and relationships during the COVID-19 pandemic: a qualitative study among US clinicians. BMJ Open 2021; 11:e047782Butler CR, Wong SPY, Vig EK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766845 8. How do we share data in COVID-19 research? A systematic review of COVID- 19 datasets in PubMed Central Articles. Brief. Bioinform. 2021; 22:800-811Zuo X, Chen Y, Ohno-Machado L, Xu H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757278 9. The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19. Clin Infect Dis 2021; Eckstein L, Rid A, Kamuya D, Shah SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758912 10. Concerns with and recommendations for COVID-19 research related to asymptomatic infection and mask wearing. Clin Infect Dis 2021; Escandón K, Ulrich AK, Chou R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754646 11. Letter to the editor: Respiratory rehabilitation in elderly patients with COVID- 19: A randomized controlled study. Complement. Ther. Clin. Pract. 2021:101368Bressi B, Paltrinieri S, Fugazzaro S, Costi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762161 12. Pharmacists in schools and day care centers: Almost 80 Saarland pharmacies perform rapid antigen tests for SARS-CoV-2. Deutsche Apotheker Zeitung 2021; 161Saar M. 13. Simplifying language is inclusive and improves access to up-to-date scientific information Response to: Hosseini and Akbarzadeh. Persisting on readability could provoke the risk of misinformation: A COVID-19 pandemic concern. Disaster Med Public Health Prep 2021:1-3Basch CH, Mohlman J, Hillyer GC, Garcia P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766157 14. Public knowledge and adherence to hand hygienic guidelines for the prevention of SARS-CoV-2 transmission: A cross-sectional survey from Pakistan. Disaster Med Public Health Prep 2021:1-16Yaseen MO, Saif A, Khan TM, Yaseen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762050 15. Perception of level of knowledge, skills, and safety before and after training to perform videolaryngoscopy with the Intubox barrier system for airway management in patients with COVID-19. Emergencias 2021; 33:93-99Adánez Martínez MG, Leal Costa C, García López JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750049 16. Willingness to Treat Covid-19 Disease: What Do Medical & Nursing Students Perceive? Ethics Med Public Health 2021:100651Lian CW, Wing CBF, Zahari ANB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754125 17. The impact of COVID-19 pandemic on radiology residents in Northern Italy. Eur Radiol 2021:1-11Cavalieri S, Spinetta M, Zagaria D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755754 18. The Arab region's contribution to global COVID-19 research: Bibliometric and visualization analysis. Global Health 2021; 17:31Zyoud SH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766073 19. The impact of the COVID-19 pandemic on students' feelings at high school, undergraduate, and postgraduate levels. Heliyon 2021; 7:e06465Camacho- Zuñiga C, Pego L, Escamilla J, Hosseini S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768174 20. Masks, mechanisms and Covid-19: the limitations of randomized trials in pandemic policymaking. Hist Philos Life Sci 2021; 43:43Muller SM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765198 21. Relational Learning Improves Prediction of Mortality in COVID-19 in the Intensive Care Unit. IEEE Trans Big Data 2021; 7:38-44Wanyan T, Vaid A, De Freitas JK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768136 22. Bridging the gap between scientific discovery and clinical application during the COVID-19 epoch. Infect Dis Now 2021; Lacarra B, Mellon G, Perez IO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748806 23. The Impact of COVID-19 on Academic Department Chairs: Heightened Complexity, Accentuated Liminality, and Competing Perceptions of Reinvention. Innov High Educ 2021:1-16Gigliotti RA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746354 24. Prioritizing people and rapid learning in times of crisis: A virtual learning initiative to support health workers during the COVID-19 pandemic. Int. J. Health Plann. Manage. 2021; Engelbrecht B, Gilson L, Barker P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764595 25. Responding to the COVID-19 pandemic: University rankings or co-operatives as a strategy for developing an equitable and resilient post-secondary education sector? Int Rev Educ 2021:1-18Stack M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758429 26. Corona citizens' science project-repeated surveys of the Irish response to COVID-19 and subsequent lockdown and restrictive measures. Ir. J. Med. Sci. 2021:1-12Vellinga A, Mellotte M, Mealy PJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761094 27. A first look at perceived stress in southeastern university students during the COVID-19 pandemic. J. Am. Coll. Health 2021:1-4Hathaway ED, Peyer KL, Doyle KA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760712 28. Telemedicine access and higher educational attainment. J. Am. Coll. Health 2021:1-4Hollowell A, Swartz JJ, Proudman R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33759736 29. Changes in stress predict worse mental health outcomes for college students than does loneliness; evidence from the COVID-19 pandemic. J. Am. Coll. Health 2021:1-4Krendl AC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759704 30. Re-envisioning the role of student health centers in offering LGBTQIA + friendly and sex-positive services. J. Am. Coll. Health 2021:1-4Willenbrock D, Santella AJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759724 31. Undergraduate students' perception and satisfaction regarding online learning system amidst COVID-19 Pandemic in Pakistan. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S644-s650Ansar F, Ali W, Khattak A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754524 32. A Viral Crisis: Knowledge, Attitude And Practices Of Undergraduate Medical Students Of The Twin Cities Of Pakistan Towards Covid-19. J. Ayub Med. Coll. Abbottabad 2021; 33:89-96Bilal A, Khan AF, Ali Naqvi SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774961 33. The scope of dental education during COVID-19 pandemic: A systematic review. J. Dent. Educ. 2021; Santos GNM, da Silva HEC, Leite AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759214 34. Application of photogrammetry in forensic pathology education of medical students in response to COVID-19. J. Forensic Sci. 2021; Tóth D, Petrus K, Heckmann V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764562 35. The impact of COVID-19 on medical education: Experiences from one medical university in Taiwan. J Formos Med Assoc 2021; Liu CH, You-Hsien Lin H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757674 36. Healthcare staff perceptions towards influenza and potential COVID-19 vaccination in the 2020 pandemic context. J Hosp Infect 2021; Robbins T, Berry L, Wells F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746009 37. The Time is Now: A Call for Renewed Support of Infectious Disease Physician- Scientist Trainees in the COVID-19 Era. J Infect Dis 2021; Queen J, Karaba S, Albin J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770174 38. Human Challenge Trials: Ethical and Legal Issues for COVID-19 Research. J. Law Med. 2021; 28:311-322Freckelton I. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768743 39. Nursing Home Education During the COVID-19 Pandemic. J Med Educ Curric Dev 2021; 8:2382120521997096Ferguson CC, Figy SC, Manley NA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748421 40. Introducing JMM Profiles for the Journal of Medical Microbiology. J. Med. Microbiol. 2021; 70Fry NK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759740 41. Transition of Nurse Practitioner Faculty Practice and Student Clinicals to Telehealth: Response to the COVID-19 Pandemic. J. Nurse Pract. 2021; 17:317- 321Diegel-Vacek L, Cotler K, Reising V, Corbridge SJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746647 42. Five Steps to Integrating Telehealth Into APRN Curricula. J. Nurse Pract. 2021; 17:322-325Guenther J, Branham S, Calloway S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746648 43. The Experience of 2 Independent Schools With In-Person Learning During the COVID-19 Pandemic. J. Sch. Health 2021; Gillespie DL, Meyers LA, Lachmann M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768529 44. Different School Reopening Plans on Coronavirus Disease 2019 Case Growth Rates in the School Setting in the United States. J. Sch. Health 2021; Liu D, Lin G, Sun X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768584 45. JUE Insight: College student travel contributed to local COVID-19 spread. J Urban Econ 2020:103311Mangrum D, Niekamp P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746308 46. Impact of the COVID-19 pandemic on the career of junior doctors. Med. J. Aust. 2021; Johnston K, Tyson C, Danny I, Meyer L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772809 47. Designing and Implementing a Novel Virtual Rounds Curriculum for Medical Students' Internal Medicine Clerkship During the COVID-19 Pandemic. MedEdPORTAL 2021; 17:11106Sukumar S, Zakaria A, Lai CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768143 48. eLearning in Physical Therapy: Lessons Learned From Transitioning a Professional Education Program to Full eLearning During the COVID-19 Pandemic. Phys Ther 2021; Ng L, Seow KC, Mac Donald L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751113 49. Requirements for vocational training in times of the Covid-19-pandemic. Public Health Forum 2021; 29:61-63Schulenburg K. 50. Reshaping experiential education within Qatar University's Health Programs during the COVID-19 pandemic. Qatar Med J 2021; 2021:9Paravattil B, Zolezzi M, Carr AS, Al-Moslih A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763334 51. [COVID-19 and medical publications: How three articles have influenced the media and public decisions in France]. Rev. Med. Interne 2021; Péretz F, Bonini- Vuillod J, Grivaux M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771408 52. Analyzing knowledge entities about COVID-19 using entitymetrics. Scientometrics 2021:1-19Yu Q, Wang Q, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746309 53. Collaborative Overview of coronaVIrus impact on ORTHopaedic training in the UK (COVI - ORTH UK). Surgeon 2021; Jayatilaka MLT, As-Sultany M, Gabr A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762160 54. The time is now: role of pragmatic clinical trials in guiding response to global pandemics. Trials 2021; 22:229Almufleh A, Joseph J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761968 55. COVID-19 and slowdown of residents' activity: Feedback from a novel e- learning event and overview of the literature. Urologia 2021:3915603211001253Calcagnile T, Sighinolfi MC, Sarchi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749385 56. Urologic Education in the Era of COVID-19: Results from a Webinar-Based Reconstructive Urology Lecture Series. Urology 2021; Omil-Lima D, Fernstrum A, Gupta K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766718 57. Rapid commentary: Ethical implications for clinical trialists and patients associated with COVID-19 research. World J Psychiatry 2021; 11:58- 62Delanerolle G, Rathod S, Elliot K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33747803 58. Online offers of the competence centers for continuing education in times of COVID-19. Z. Allgemeinmed. 2021; 97:93-94. 59. Online teaching in family medicine: A challenge. Z. Allgemeinmed. 2021; 97:88- 91Lukaschek K, Sanftenberg L, Friemel C et al.

Elderly (20 articles)

1. "Celebrating old age": an obsolete expression during the COVID-19 pandemic? Medical, social, psychological, and religious consequences of home isolation and loneliness among the elderly. Arch. Med. Sci. 2021; 17:285- 295Burlacu A, Mavrichi I, Crisan-Dabija R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747263 2. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021; 21:199Walle-Hansen MM, Ranhoff AH, Mellingsæter M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752614 3. COVID-19: are the elderly prepared for virtual healthcare? BMJ Health Care Inform 2021; 28Ezzat A, Sood H, Holt J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753327 4. Will AstraZeneca be able to provide clinical trial data on its COVID-19 vaccine efficacy in older adults? Br. J. Clin. Pharmacol. 2021; Dal-Ré R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760277 5. Success and complications of endotracheal intubation in critical care settings under COVID-19 protocols. Cjem 2021; Dullemond K, Renschler C, Trojanowski J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751491 6. Aging and COVID-19 in Minority Populations: a Perfect Storm. Curr Epidemiol Rep 2021:1-9Walubita T, Beccia A, Boama-Nyarko E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747713 7. Suicidal Risk in Older Patients with Depression During COVID-19 Pandemic: a Case-Control Study. East Asian Arch Psychiatry 2021; 31:3-8Louie LLC, Chan WC, Cheng CPW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753570 8. Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with Coronavirus disease 2019 (COVID-19). Endocr. J. 2021; Okauchi Y, Matsuno K, Nishida T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762519 9. Media representation of older people's vulnerability during the COVID-19 pandemic in China. Eur J Ageing 2021:1-10Zhang J, Liu X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758584 10. Ageism in the time of COVID-19. Group Process Intergroup Relat 2021; 24:246- 252Swift HJ, Chasteen AL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746563 11. Increase in Frailty in Nursing Home Survivors of Coronavirus Disease 2019: Comparison With Noninfected Residents. J. Am. Med. Dir. Assoc. 2021; Greco GI, Noale M, Trevisan C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757725 12. The Fear of COVID-19 Infection in Older People. J. Geriatr. Psychiatry Neurol. 2021:8919887211002651Gokseven Y, Ozturk GZ, Karadeniz E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745357 13. Psychopathology in Elderly COVID-19 Survivors and Controls. J. Geriatr. Psychiatry Neurol. 2021:8919887211002664Mowla A, Ghaedsharaf M, Pani A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745373 14. Will the COVID-19 pandemic affect population ageing in Australia? J Popul Res (Canberra) 2021:1-15Wilson T, Temple J, Charles-Edwards E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758577 15. Role of vitamin D supplementation in aging patients with COVID-19. Maturitas 2021; Shakoor H, Feehan J, Al Dhaheri AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757717 16. Pneumonia in old age. Pneumologe 2021; Frohnhofen H, Stieglitz S. 17. [Pneumonia in old age]. Pneumologe (Berl) 2021:1-6Frohnhofen H, Stieglitz S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746676 18. [COVID-19 and functional dependence: cohort study of an outbreak in a nursing home for elderly.]. Rev. Esp. Salud Publica 2021; 95Causa R, Almagro Nievas D, Bermúdez Tamayo C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33767129 19. Respiratory viral infections in the elderly. Ther. Adv. Respir. Dis. 2021; 15:1753466621995050Watson A, Wilkinson TMA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749408 20. Changes in well-being and private support for older people: a closer look at the impact of the COVID-19 pandemic in early summer 2020. Zeitschrift fur Gerontologie und Geriatrie 2021; Brandt M, Garten C, Grates M et al.

Epidemiology (93 articles)

1. Coronavirus Disease 2019 (COVID-19) prevalence rates in reopened private schools in New York City: impact of diagnostic methods. Acta Paediatr 2021; Smith-Norowitz TA, Kohlhoff S, Hammerschlag MR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760250 2. Fractional unit-root tests allowing for a fractional frequency flexible Fourier form trend: predictability of Covid-19. Adv Differ Equ 2021; 2021:167Omay T, Baleanu D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747069 3. Excess mortality in the United States in 2020: Forecasting and Anomaly Detection. Am. J. Infect. Control 2021; Wiemken TL, Rutschman AS, Niemotka S, Prener CG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774102 4. COVID-19 Mortality in California Based on Death Certificates: Disproportionate Impacts Across Racial/Ethnic Groups and Nativity. Ann. Epidemiol. 2021; Garcia E, Eckel SP, Chen Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746033 5. Years of Potential Life Lost Secondary to COVID-19: Cook County, Illinois. Ann. Epidemiol. 2021; Lilly D, Akintorin S, Unruh LH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771693 6. A time-modulated Hawkes process to model the spread of COVID-19 and the impact of countermeasures. Annu Rev Control 2021; Garetto M, Leonardi E, Torrisi GL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746561 7. The effectiveness of contact tracing in mitigating COVID-19 outbreak: A model-based analysis in the context of India. Appl Math Comput 2021; 404:126207Kumar Das D, Khatua A, Kar TK, Jana S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758439 8. Sex Workers and Syndemics: A Population Vulnerable to HIV and COVID-19. Arch. Sex. Behav. 2021:1-10Rogers BG, Paradis-Burnett A, Nagel K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759058 9. Finding the real COVID-19 case-fatality rates for SAARC countries. Biosaf Health 2021; Shah MRT, Ahammed T, Anjum A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748737 10. Greater public health impact of COVID-19 antigen detection tests. BMC Med 2021; 19:82Kowada A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757504 11. Human mobility and poverty as key drivers of COVID-19 transmission and control. BMC Public Health 2021; 21:596Yechezkel M, Weiss A, Rejwan I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765977 12. A participatory modelling approach for investigating the spread of COVID-19 in countries of the Eastern Mediterranean Region to support public health decision-making. BMJ Glob Health 2021; 6Adib K, Hancock PA, Rahimli A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762253 13. Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Aden governorate, Yemen. BMJ Glob Health 2021; 6Koum Besson ES, Norris A, Bin Ghouth AS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758012 14. Association between socioeconomic status and self-reported, tested and diagnosed COVID-19 status during the first wave in the Northern Netherlands: a general population-based cohort from 49 474 adults. BMJ Open 2021; 11:e048020Zhu Y, Duan MJ, Dijk HH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753448 15. COVID-19 social-distancing measures altered the epidemiology of facial injury: a United Kingdom-Australia comparative study. Br. J. Oral Maxillofac. Surg. 2020; Hoffman GR, Walton GM, Narelda P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752920 16. Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant. Build. Environ. 2021; 196:107788Li Y, Qian H, Hang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746341 17. [COVID-19 in Schleswig-Holstein: infection epidemiological evaluations from March to September 2020]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021; Rose R, Scherer D, Maschkowitz G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748868 18. Familial cluster of asymptomatic COVID-19 cases in a First Nation community in Northern Saskatchewan, Canada. Can. Commun. Dis. Rep. 2021; 47:94- 96Lamichhane S, Gupta S, Akinjobi G, Ndubuka N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746617 19. COVID-19 outbreak among temporary foreign workers in British Columbia, March to May 2020. Can. Commun. Dis. Rep. 2021; 47:5-10Mema S, Frosst G, Hanson K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746615 20. Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data. Cancer Lett. 2021; 508:30-46Kong X, Qi Y, Huang J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757803 21. Forecasting of COVID-19 using deep layer Recurrent Neural Networks (RNNs) with Gated Recurrent Units (GRUs) and Long Short-Term Memory (LSTM) cells. Chaos Solitons Fractals 2021:110861ArunKumar KE, Kalaga DV, Kumar CMS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746373 22. Characteristics associated with household transmission of SARS-CoV-2 in Ontario, Canada: A cohort study. Clin Infect Dis 2021; Paul LA, Daneman N, Brown KA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751026 23. Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2. Clin Infect Dis 2021; Wu P, Liu F, Chang Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772573 24. Lockdown Britain: Evidence for reduced incidence and severity of some non- COVID acute medical illnesses. Clin Med (Lond) 2021; 21:e171-e178Allison MC, Doyle NA, Greene G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762383 25. SARS-CoV-2 antibody seroprevalence in NHS healthcare workers in a large double-sited UK hospital. Clin Med (Lond) 2021; Ken-Dror G, Wade C, Sharma SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757988 26. Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand. Clin Transl Immunology 2021; 10:e1261Whitcombe AL, McGregor R, Craigie A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747511 27. COVID-19 Australia: Epidemiology Report 37- Reporting period ending 14 March 2021. Commun Dis Intell (2018) 2021; 45. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752583 28. A fractional-order compartmental model for the spread of the COVID-19 pandemic. Commun Nonlinear Sci Numer Simul 2021; 98:105764Biala TA, Khaliq AQM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746459 29. Monitoring Scheme for Early Detection of Coronavirus and Other Respiratory Virus Outbreaks. Comput Ind Eng 2021:107235Haridy S, Maged A, Baker AW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746343 30. Modeling the role of clusters and diffusion in the evolution of COVID-19 infections during lock-down. Comput Mech 2021:1-12Bos WJT, Bertoglio JP, Gostiaux L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746320 31. Regional Differences in Mortality Rates During the COVID-19 Epidemic in Italy. Disaster Med Public Health Prep 2020:1-7Azzolina D, Lorenzoni G, Silvestri L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750493 32. SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, December 25, 2019-December 1, 2020. Disaster Med Public Health Prep 2021:1- 27Fung IC, Hung YW, Ofori SK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762027 33. Implications and Limitations of Social Distancing Strategies (SDS) to Mitigate the Impact of the COVID-19 Pandemic. Disaster Med Public Health Prep 2020:1- 2Goniewicz K, Burkle FM, Khorram-Manesh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769241 34. Successful Confinement of a Familial Cluster of COVID-19 in Qingdao, China, in the Early Phase of Pandemic. Disaster Med Public Health Prep 2020:1-2Jia J, Liang J, Xin X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752770 35. COVID-19: epidemiological situation of Argentina and its neighbor countries after three months of pandemic. Disaster Med Public Health Prep 2021:1- 23Ramírez ML, Martinez SM, Bessone CDV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762042 36. Risk for International Importations of Variant SARS-CoV-2 Originating in the United Kingdom. Emerg Infect Dis 2021; 27Du Z, Wang L, Yang B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760727 37. Detecting Rapid Spread of SARS-CoV-2 Variants, France, January 26-February 16, 2021. Emerg Infect Dis 2021; 27Haim-Boukobza S, Roquebert B, Trombert- Paolantoni S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769253 38. Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID- 19 Patients, Atlanta, Georgia, USA, March-April 2020. Emerg Infect Dis 2021; 27:1164-1168Pettrone K, Burnett E, Link-Gelles R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754981 39. Reconciling estimates of global spread and infection fatality rates of COVID- 19: an overview of systematic evaluations. Eur. J. Clin. Invest. 2021:e13554Ioannidis JPA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768536 40. Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe. Eur J Health Econ 2021; Amdaoud M, Arcuri G, Levratto N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751290 41. Area-level indicators of income and total mortality during the COVID-19 pandemic. Eur. J. Public Health 2021; Colombo FR, Alicandro G, La Vecchia C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749735 42. Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalisation rate, February 2021, Rio Grande do Sul, Southern Brazil. Euro Surveill 2021; 26Martins AF, Zavascki AP, Wink PL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769251 43. Machine Learning Approaches Reveal That the Number of Tests Do Not Matter to the Prediction of Global Confirmed COVID-19 Cases. Front Artif Intell 2020; 3:561801Khan MHR, Hossain A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748745 44. Global Geographic and Temporal Analysis of SARS-CoV-2 Haplotypes Normalized by COVID-19 Cases During the Pandemic. Front. Microbiol. 2021; 12:612432Justo Arevalo S, Zapata Sifuentes D, Huallpa CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746914 45. How SARS-CoV-2 and Comparable Pathogens Can Be Defeated in a Single Day: Description and Mathematical Model of the Carrier Separation Plan (CSP). Front Public Health 2021; 9:640009Epstein R, Houser C, Wang R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768086 46. Politics of disease control in Africa and the critical role of global health diplomacy: A systematic review. Health Promot Perspect 2021; 11:20-31Chattu VK, Knight WA, Adisesh A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758752 47. Fighting COVID-19 in the West Africa after experiencing the Ebola epidemic. Health Promot Perspect 2021; 11:5-11Gholizadeh P, Sanogo M, Oumarou A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758750 48. While flattening the curve and raising the line, Africa should not forget street vending practices. Health Promot Perspect 2021; 11:32-35Ogunkola IO, Imo UF, Obia HJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758753 49. Covid-19 transmission modelling of students returning home from university. Health Syst (Basingstoke) 2021; 10:31-40Harper PR, Moore JW, Woolley TE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763227 50. Variation of quantified infection rates of mixed samples to enhance rapid testing during an epidemic. Health Syst (Basingstoke) 2021; 10:24-30Kadri U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763226 51. Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein. Heliyon 2021; 7:e06564Alai S, Gujar N, Joshi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758785 52. What are the COVID-19 models modeling (philosophically speaking)? Hist Philos Life Sci 2021; 43:47Fuller J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33770267 53. Bertalanffy-Pütter models for the first wave of the COVID-19 outbreak. Infect Dis Model 2021; 6:532-544Brunner N, Kühleitner M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748553 54. Methodology for modelling the new COVID-19 pandemic spread and implementation to European countries. Infect Genet Evol 2021; 91:104817Maltezos S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774176 55. A comparative study of strategies for containing the COVID-19 pandemic in Gulf Cooperation Council countries and the European Union. Inform Med Unlocked 2021; 23:100547Alanezi F, Althumairi A, Aljaffary A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754126 56. Development and application of a new framework for infectious disease management at early stage of new epidemics: taking COVID-19 outbreak in China as an example. Int J Clin Pract 2021:e14174Li Z, Li C, Wu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759288 57. Mathematical model for COVID-19 management in crowded settlements and high-activity areas. Int J Dyn Control 2021:1-12Ssematimba A, Nakakawa JN, Ssebuliba J, Mugisha JYT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747709 58. Decreasing transmission and initiation of countrywide vaccination: Key challenges for future management of COVID-19 pandemic in Bangladesh. Int. J. Health Plann. Manage. 2021; Molla MMA, Disha JA, Yeasmin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764580 59. Incarcerated individuals' experiences of COVID-19 in the United States. Int J Prison Health 2021; ahead-of-printPettus-Davis C, Kennedy SC, Veeh CA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760428 60. A super learner ensemble of 14 statistical learning models for predicting COVID-19 severity among patients with cardiovascular conditions. Intell Based Med 2021:100030Ehwerhemuepha L, Danioko S, Verma S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748802 61. Basics of Developing a COVID-19 Reopening Roadmap: A Systematic Scoping Review. Iran J. Public Health 2021; 50:232-244Askarian M, Groot G, Taherifard E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747987 62. The Application of Hazard Vulnerability Analysis in the Prevention and Control of COVID-19 in Medical Institutions. Iran J. Public Health 2021; 50:271-279Ma L, Zou S, Liu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747990 63. Estimating The Possible Role Of Testing Capacity And Social Distancing In Predicting The Growth Rate Of Daily Covid-19 Cases. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S686-s690Haroon MZ, Khan SA, Khan SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754532 64. Visual analytics of COVID-19 dissemination in São Paulo state, Brazil. J. Biomed. Inform. 2021:103753Marcílio-Jr WE, Eler DM, Garcia RE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774202 65. Machine Learning Research Towards Combating COVID-19: Virus Detection, Spread Prevention, and Medical Assistance. J. Biomed. Inform. 2021:103751Shahid O, Nasajpour M, Pouriyeh S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771732 66. ConceptWAS: a high-throughput method for early identification of COVID-19 presenting symptoms and characteristics from clinical notes. J. Biomed. Inform. 2021:103748Zhao J, Grabowska ME, Eric Kerchberger V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774203 67. Factors Associated with Perceived Susceptibility to COVID-19 Among Urban and Rural Adults in Alabama. J. Community Health 2021; Scarinci IC, Pandya VN, Kim YI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751308 68. Impact of outdoor and indoor meteorological conditions on the COVID-19 transmission in the western region of Saudi Arabia. J. Environ. Manage. 2021; 288:112392Habeebullah TM, Abd El-Rahim IHA, Morsy EA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765578 69. COVID-19 infection, inception and immunity: Observations and recommendations in the light of vitamin D? J Infect Public Health 2021; 14:444- 445Dixit V, Garg B, Mehta N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751982 70. A region-specific clustering approach to investigate risk-factors in mortality rate during COVID-19: comprehensive statistical analysis from 208 countries. J. Med. Eng. Technol. 2021:1-6Garg P, Joshi D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750249 71. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a non- epidemic region, Japan: A hospital-based study on May, 2020. J Med Virol 2021; Nakamura A, Ando S, Endo H, Sato R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33760273 72. Excess Deaths Among Blacks and Latinx Compared to Whites During Covid- 19. J Racial Ethn Health Disparities 2021; Laurencin CT, Wu ZH, McClinton A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751484 73. Transmission Dynamics of COVID-19 in Nepal: Mathematical Model Uncovering Effective Controls. J. Theor. Biol. 2021:110680Adhikari K, Gautam R, Pokharel A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771611 74. JUE Insight: College student travel contributed to local COVID-19 spread. J Urban Econ 2020:103311Mangrum D, Niekamp P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746308 75. Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure. JCI Insight 2021; Demonbreun AR, McDade TW, Pesce LL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755598 76. Genomic diversity of SARS-CoV-2 during early introduction into the Baltimore- Washington metropolitan area. JCI Insight 2021; 6Thielen PM, Wohl S, Mehoke T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749660 77. Automated Travel History Extraction From Clinical Notes for Informing the Detection of Emergent Infectious Disease Events: Algorithm Development and Validation. JMIR Public Health Surveill 2021; 7:e26719Peterson KS, Lewis J, Patterson OV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759790 78. RT-PCR Screening Tests for SARS-CoV-2 with Saliva Samples in Asymptomatic People: Strategy to Maintain Social and Economic Activities while Reducing the Risk of Spreading the Virus. Keio J. Med. 2021; Oba J, Taniguchi H, Sato M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746151 79. Global dynamics of COVID-19 epidemic model with recessive infection and isolation. Math Biosci Eng 2021; 18:1833-1844Yuan R, Ma Y, Shen C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757213 80. Estimation of COVID-19 Under-Reporting in the Brazilian States Through SARI. New Gener Comput 2021:1-23Paixão B, Baroni L, Pedroso M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746335 81. Mechanisms of recurrent outbreak of COVID-19: a model-based study. Nonlinear Dyn 2021:1-17Han C, Li M, Haihambo N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758464 82. Self-organization of oscillation in an epidemic model for COVID-19. Physica A 2021; 573:125925Odagaki T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762798 83. Strengthening health system building blocks: configuring post-COVID-19 scenario in Pakistan. Prim. Health Care Res. Dev. 2021; 22:e9Shaikh BT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762035 84. Diagnostic model for the society safety under COVID-19 pandemic conditions. Saf Sci 2021; 136:105164Varotsos CA, Krapivin VF, Xue Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758466 85. [Development of the risk assessment system for preventive measures against COVID-19 at the workplace]. Sangyo Eiseigaku Zasshi 2021; Shimizu C, Tahara T, Ootani Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762507 86. [COVID-19 epidemic, a challenge successfully overcome by intensive care nurses]. Soins 2021; 66:35-37Constan A, Dransart C, Micaelli D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750556 87. Not quite a block party: COVID-19 street reallocation programs in Seattle, WA and Vancouver, BC. SSM Popul Health 2021; 14:100769Firth CL, Baquero B, Berney R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748391 88. The influence of urban, socio-economic, and eco-environmental aspects on COVID-19 cases, deaths and mortality: A multi-city case in the Atlantic Forest, Brazil. Sustain Cities Soc 2021; 69:102859Viezzer J, Biondi D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758745 89. Modelling the association between COVID-19 transmissibility and D614G substitution in SARS-CoV-2 spike protein: using the surveillance data in California as an example. Theor. Biol. Med. Model. 2021; 18:10Zhao S, Lou J, Cao L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750399 90. Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation. Transfus. Apher. Sci. 2021:103118Pandey HC, Dhiman Y, C SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752991 91. Projecting daily travel behavior by distance during the pandemic and the spread of COVID-19 infections - Are we in a closed loop scenario? Transp Res Interdiscip Perspect 2021; 9:100283Truong D, Truong MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763643 92. A comparison of COVID-19 secondary attack rate in household and close contacts compared to current risk stratification guidelines of the Kerala government. Trop. Doct. 2021:494755211002012Rathish B, Wilson A, Joy S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765905 93. Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use. Vaccine 2021; Shen M, Zu J, Fairley CK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3377139

Gastro-enterology (16 articles)

1. Adapting the modified barium swallow: modifications to improve safety in the setting of airborne respiratory illnesses like COVID-19. Abdom Radiol (NY) 2021:1-8Goldman AR, Pahade JK, Langton-Frost NA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772613 2. Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD. BMJ Open Gastroenterol 2021; 8Selinger CP, Fraser A, Collins P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753426 3. Pain in Chronic Pancreatitis During the COVID-19 Lockdown: Has It Given Us a New Dimension for Treatment? Cureus 2021; 13:e13423Parasar K, Mohan S, John AG, Anand U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763317 4. Endoscopic Retrograde Cholangiopancreatography During the COVID-19 Pandemic: Effects of Enhanced Personal Protective Equipment. Dig. Dis. Sci. 2021:1-7Düzenli T, Köseoğlu H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33755824 5. Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome Triggered by COVID-19. Eur J Case Rep Intern Med 2021; 8:002264Singh B, Kaur P, Maroules M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768072 6. Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation: An updated review until January 2021. Excli j 2021; 20:366-385Nabil A, Elshemy MM, Uto K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746667 7. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019. Front. Endocrinol. (Lausanne) 2021; 12:604100Gao F, Zheng KI, Yan HD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763027 8. Diversity of Cardiac and Gastrointestinal Presentations of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Case Series. Glob Pediatr Health 2021; 8:2333794x21996613Shikhare AR, Iqbal RM, Tariq R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748343 9. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut 2021; Kennedy NA, Goodhand JR, Bewshea C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753421 10. Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System. Gut 2021; Khan N, Mahmud N, Trivedi C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753416 11. Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease. Ital. J. Pediatr. 2021; 47:71Dipasquale V, Passanisi S, Cucinotta U et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33761992 12. The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis. J. Gastroenterol. 2021:1- 12Hayashi Y, Wagatsuma K, Nojima M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33759041 13. Inflammatory bowel disease and SARS-CoV-2 pandemic: current knowledge and recommendations. Scand. J. Gastroenterol. 2021:1-5Bekic D, Belosic Halle Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765405 14. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic. Scand. J. Gastroenterol. 2021:1-7Moum KM, Moum B, Opheim R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771086 15. COVID-19 and the liver: an adverse outcome pathway perspective. Toxicology 2021; 455:152765Vinken M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771662 16. COVID-19 presenting with diarrhea in a heart transplant patient. Turk Gogus Kalp Damar Cerrahisi Derg 2021; 29:119-121Işık ME, Günay D, Aksüt M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3376899 Guidelines (11 articles)

1. Interim guidance on the use of the Abbott Panbio™ COVID-19 Antigen Rapid Test. Can. Commun. Dis. Rep. 2021; 47:17-22. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767600 2. Optometry Australia's infection control guidelines 2020. Clin. Exp. Optom. 2021:1-18Hart KM, Stapleton F, Carnt N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33769228 3. An Update on Advances in COVID-19 Laboratory Diagnosis and Testing Guidelines in India. Front Public Health 2021; 9:568603Kumar KSR, Mufti SS, Sarathy V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748054 4. EACTA/SCA Recommendations for the Cardiac Anesthesia Management of Patients With Suspected or Confirmed COVID-19 Infection: An Expert Consensus From the European Association of Cardiothoracic Anesthesiology and Society of Cardiovascular Anesthesiologists With Endorsement From the Chinese Society of Cardiothoracic and Vascular Anesthesiology. J Cardiothorac Vasc Anesth 2021; Guarracino F, Shernan SK, Tahan ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766471 5. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Expert Recommendations from The Korean Society for Thoracic and Cardiovascular Surgery. J Chest Surg 2021; 54:2-8Jeong IS, Kim WH, Baek JH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767006 6. Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J. Obstet. Gynaecol. Res. 2021; Hayakawa S, Komine-Aizawa S, Takada K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754418 7. COVID-19 guidelines for the prioritization of operations for malignant thoracic diseases. Pneumologe 2020; 17:394-397Hekmat K, Bruns CJ. 8. German recommendations for treatment of critically ill patients with COVID-19 —version 3: S1-guideline. Pneumologe 2020; 17:406-425Kluge S, Janssens U, Welte T et al. 9. A comparison of COVID-19 secondary attack rate in household and close contacts compared to current risk stratification guidelines of the Kerala government. Trop. Doct. 2021:494755211002012Rathish B, Wilson A, Joy S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765905 10. The management of surgical patients in the emergency setting during COVID- 19 pandemic: the WSES position paper. World J Emerg Surg 2021; 16:14De Simone B, Chouillard E, Sartelli M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752721 11. DEGAM strategy paper on long-term management of the COVID-19 pandemic from the point of view of general practice. Z. Allgemeinmed. 2021; 97:44Dank V.

Imaging (24 articles)

1. A new approach for computer-aided detection of coronavirus (COVID-19) from CT and X-ray images using machine learning methods. Appl Soft Comput 2021; 105:107323Saygılı A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746657 2. Computing infection distributions and longitudinal evolution patterns in lung CT images. BMC Med. Imaging 2021; 21:57Gu D, Chen L, Shan F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757431 3. Application of quantitative lung ultrasound instead of CT for monitoring COVID-19 pneumonia in pregnant women: a single-center retrospective study. BMC Pregnancy Childbirth 2021; 21:259Deng Q, Cao S, Wang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771120 4. Deep learning diagnostic and risk-stratification pattern detection for COVID-19 in digital lung auscultations: clinical protocol for a case-control and prospective cohort study. BMC Pulm. Med. 2021; 21:103Glangetas A, Hartley MA, Cantais A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761909 5. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm. Med. 2021; 21:97So M, Kabata H, Fukunaga K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752639 6. Deep-chest: Multi-classification deep learning model for diagnosing COVID-19, pneumonia, and lung cancer chest diseases. Comput. Biol. Med. 2021; 132:104348Ibrahim DM, Elshennawy NM, Sarhan AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774272 7. Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine. Cureus 2021; 13:e13426Waheed S, Bayas A, Hindi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758714 8. Domain adaptation based self-correction model for COVID-19 infection segmentation in CT images. Expert Syst Appl 2021:114848Jin Q, Cui H, Sun C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746369 9. COVID-19: Automatic Detection from X-ray images by utilizing Deep Learning Methods. Expert Syst Appl 2021:114883Nigam B, Nigam A, Jain R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746370 10. Postmortem radiologic and pathologic findings in COVID-19: The Toronto experience with pre-hospitalization deaths in the community. Forensic Sci. Int. 2021; 322:110755Williams AS, Dmetrichuk JM, Kim P, Pollanen MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774384 11. Sonographic Diagnosis of COVID-19: A Review of Image Processing for Lung Ultrasound. Front Big Data 2021; 4:612561McDermott C, Łącki M, Sainsbury B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748752 12. COVID_SCREENET: COVID-19 Screening in Chest Radiography Images Using Deep Transfer Stacking. Inf Syst Front 2021:1-15Elakkiya R, Vijayakumar P, Karuppiah M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753967 13. Variations In Spectrum Of Covid-19 Ct Findings And Its Severity Scoring In A Tertiary Care Hospital Of Bahawalpur, Southern Punjab Pakistan. J. Ayub Med. Coll. Abbottabad 2021; 33:54-59Nisar S, Sarfraz L, Mumtaz F, Sidra K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774955 14. Diaphragm and Phrenic Nerve Ultrasound in COVID-19 Patients and Beyond: Imaging Technique, Findings, and Clinical Applications. J Ultrasound Med 2021; Patel Z, Franz CK, Bharat A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33772850 15. Development of cardiovascular medicine 2020: cardiac magnetic resonance imaging. Kardiologe 2021; 15:147-152von Knobelsdorff F. 16. A pathway for acute chest imaging in suspected or confirmed COVID-19. Med. J. Aust. 2021; Ngan D, McKeen S, Gun M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774825 17. Acute Presentation of Third Ventricular Cavernous Malformation following COVID-19 Infection in a Pregnant Woman: A Case Report. Neurochirurgie 2021; Saberi H, Tanha RR, Derakhshanrad N, Soltaninejad MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771616 18. MANet: A two-stage deep learning method for classification of COVID-19 from Chest X-ray images. Neurocomputing 2021; 443:96-105Xu Y, Lam HK, Jia G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753962 19. Chest computed tomography signs associated with pejorative evolution in COVID-19 patients. Pol J Radiol 2021; 86:e115-e121Auger R, Dujardin PA, Bleuzen A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758637 20. Computed tomography of the chest in patients with COVID-19: what do radiologists want to know? Pol J Radiol 2021; 86:e122-e135Razek A, Fouda N, Fahmy D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758638 21. COVID-19 integrated imaging: our experience and literature review. Pol J Radiol 2021; 86:e78-e86Trovato P, Simonetti I, Rinaldo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758632 22. Value of Bedside Lung Ultrasound in Severe and Critical COVID-19 Pneumonia. Respir. Care 2021; Kong S, Wang J, Li Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758057 23. Magnetic graphene quantum dots facilitate closed-tube one-step detection of SARS-CoV-2 with ultra-low field NMR relaxometry. Sens. Actuators B Chem. 2021; 337:129786Li Y, Ma P, Tao Q et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753963 24. CvDeep-COVID-19 Detection Model. SN Comput Sci 2021; 2:145Ingle VA, Ambad PM. http://www.ncbi.nlm.nih.gov/pubmed/?term=3375414

Immune response (30 articles)

1. Detection of SARS-CoV-2 Specific Memory B cells to Delineate Long-Term COVID-19 Immunity. Allergy 2021; Thieme CJ, Abou-El-Enein M, Fritsche E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764510 2. SARS-CoV-2-specific serological and functional T-cell Immune responses during acute and early COVID-19 convalescence in Solid Organ Transplant patients. Am J Transplant 2021; Favà A, Donadeu L, Sabé N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756051 3. COVID-19-associated multisystem inflammatory syndrome in children presenting uniquely with sinus node dysfunction in the setting of shock. Cardiol. Young 2021:1-3Tomlinson LG, Cohen MI, Levorson RE, Tzeng MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745461 4. Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barré syndrome. Cell Prolif. 2021:e13024Li Z, Huang Z, Li X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751722 5. Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands. Clin Chem 2021; Tang MS, Farnsworth CW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772260 6. Comprehensive analysis of SARS-CoV-2 antibody dynamics in New Zealand. Clin Transl Immunology 2021; 10:e1261Whitcombe AL, McGregor R, Craigie A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747511 7. Immunoglobin G/total antibody testing for SARS-CoV-2: A prospective cohort study of ambulatory patients and health care workers in two Belgian oncology units comparing three commercial tests. Eur. J. Cancer 2021; 148:328-339van Dam P, Huizing M, Roelant E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33773276 8. Peptide microarray based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development. Eur. J. Immunol. 2021; Holenya P, Lange PJ, Reimer U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772767 9. Enrichment of CCR6+CD8+ T cells and CCL20 in the lungs of mechanically ventilated patients with COVID-19. Eur. J. Immunol. 2021; Saris A, Reijnders TDY, Reijm M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768543 10. Perspective: Diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection. Expert Rev. Clin. Immunol. 2021; Ameratunga R, Woon ST, Jordan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745411 11. Physiological and Immunological Causes of the Susceptibility of Chronic Inflammatory Patients to COVID-19 Infection: Focus on Diabetes. Front. Endocrinol. (Lausanne) 2021; 12:576412Rahmani-Kukia N, Abbasi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746897 12. Editorial: Immune Responses to Persistent or Recurrent Antigens: Implications for Immunological Memory and Immunotherapy. Front. Immunol. 2021; 12:643989Caserta S, Pera A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33767711 13. The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients. Front. Immunol. 2021; 12:632814Luo H, Jia T, Chen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763078 14. The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic. Front. Immunol. 2021; 12:637651Shah P, Canziani GA, Carter EP, Chaiken I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767706 15. Endothelial dysfunction in COVID-19 calls for immediate attention: the emerging roles of the endothelium in inflammation caused by SARS-CoV-2. Front Med 2021; Hang W, Chen C, Zhang XA, Wang DW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748924 16. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 2021; Szabo PA, Dogra P, Gray JI et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33765436 17. Prevalence of SARS-CoV-2 Specific Antibodies in Asymptomatic Hemodialysis Patients. Immunol. Invest. 2021:1-12Etemadi J, Bordbar S, Soltani-Zangbar MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752550 18. Severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody: Seroprevalence among contacts of COVID-19 cases. Indian J. Public Health 2021; 65:5-10Prakash O, Solanki B, Sheth JK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753682 19. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19. Int Immunopharmacol 2021; 95:107586Delshad M, Tavakolinia N, Pourbagheri- Sigaroodi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765611 20. Multisystem inflammatory syndrome in children (MIS-C) and retropharyngeal edema: A case series. Int J Pediatr Otorhinolaryngol 2021; 144:110667Daube A, Rickert S, Madan RP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752089 21. Neutrophil-to-Lymphocyte Ratio, derived Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio as risk factors in critically ill COVID-19 patients, a single centered study. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S595-s601Noor A, Akhtar F, Tashfeen S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754514 22. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a non- epidemic region, Japan: A hospital-based study on May, 2020. J Med Virol 2021; Nakamura A, Ando S, Endo H, Sato R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33760273 23. Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19. J. Mol. Cell. Biol. 2021; Yang J, Zhong M, Zhang E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751111 24. Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure. JCI Insight 2021; Demonbreun AR, McDade TW, Pesce LL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755598 25. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection. Kidney Int 2021; Clarke CL, Prendecki M, Dhutia A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774082 26. Point of care ultrasound (POCUS) in diagnosis of proximal deep vein thrombosis among COVID-19 hospitalized patients with a high rate of low molecular weight heparin prophylaxis. Med Clin (Barc) 2021; García-Ceberino PM, Faro-Míguez N, Beltrán-Ávila FJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33773764 27. The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays. Pract Lab Med 2021; 25:e00212Swadźba J, Bednarczyk M, Anyszek T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748381 28. The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development. Probiotics Antimicrob Proteins 2021:1-15Moradi-Kalbolandi S, Majidzadeh AK, Abdolvahab MH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33770348 29. The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein. Virology 2021; 559:1-9Chen X, Rostad CA, Anderson LJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774551 30. Immune dysregulation and system pathology in COVID-19. Virulence 2021; 12:918-936Jamal M, Bangash HI, Habiba M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757410

Management miscellaneous diseases (87 articles)

1. Approach to Headache in Patients with COVID-19. Acta Med Port 2021; Costa A, Abreu P, Pinto M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755547 2. Health-related quality of life of patients with haematologic cancer during COVID-19 and their opinions on telehealth consultations - a Danish single site cross-sectional survey. Acta Oncol. 2021:1-9Ellehuus C, Jeppesen SS, Eckhoff L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764267 3. Impact of temporary closures of emergency departments during the COVID-19 outbreak on clinical outcomes for emergency patients in a metropolitan area. Am J Emerg Med 2021; 47:35-41Lee DE, Ro YS, Ryoo HW, Moon S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756131 4. Effect of patient demographics and COVID-19 on Press Ganey scores in an ophthalmic emergency department. Am J Emerg Med 2021; Patel A, Markatia Z, Sridhar J, Cavuoto KM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757672 5. [Acute psychotic episodes related to the COVID-19 pandemic]. Ann. Med. Psychol. (Paris) 2021; Doufik J, Ouhmou M, Bouraoua I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753949 6. [Dengue at the beginning of the COVID-19 pandemic in Argentina]. Arch. Argent. Pediatr. 2021; 119:131-138Berberian G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749212 7. Preparedness strategies in neonatology units during the COVID-19 pandemic: A survey conducted at maternity centers in Argentina. Arch. Argent. Pediatr. 2021; 119:76-82Geffner SC, Ávila AS, Etcharrán ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749192 8. The COVID-19 Pandemic and Sexual and Reproductive Health and Rights in the Pacific. Asia Pac. J. Public Health 2021:1010539521998854Dawson A, Ekeroma A, Rokoduru A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745282 9. Coronavirus disease-2019 pandemic: Maintaining an adequate and safe supply of blood and blood products. Asian J. Transfus. Sci. 2020; 14:117- 118Shrivastava SR, Shrivastava PS. http://www.ncbi.nlm.nih.gov/pubmed/? term=33767536 10. Unfortunately corona once again. Best Practice Onkologie 2021; 16:64-65. 11. Prospective study of emergency medicine provider wellness across ten academic and community hospitals during the initial surge of the COVID-19 pandemic. BMC Emerg. Med. 2021; 21:36Kelker H, Yoder K, Musey P, Jr. et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761876 12. The impact of the COVID-19 pandemic on child health and the provision of Care in Paediatric Emergency Departments: a qualitative study of frontline emergency care staff. BMC Health Serv. Res. 2021; 21:279Conlon C, McDonnell T, Barrett M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766026 13. Epidemiology of distal radius fractures in children and adults during the COVID-19 pandemic - a two-center study. BMC Musculoskelet. Disord. 2021; 22:306Olech J, Ciszewski M, Morasiewicz P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33771142 14. Impact of COVID-19 on the oral health of adults in Wuhan and China: results of a nationwide online cross-sectional questionnaire survey. BMC Oral Health 2021; 21:162Zhang S, Liu C, Zhang C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33771143 15. The number of patients "worse than death" while waiting for a hip or knee arthroplasty has nearly doubled during the COVID-19 pandemic. Bone Joint J 2021:1-9Clement ND, Scott CEH, Murray JRD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752468 16. A multicentre national study of the effectiveness of virtual fracture clinic management of orthopaedic trauma during the COVID-19 pandemic (MAVCOV): a cross-sectional study protocol. Bone Jt Open 2021; 2:211-215Ng ZH, Downie S, Makaram NS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752474 17. Impact of COVID-19 pandemic on acute spine surgery referrals to UK tertiary spinal unit: any lessons to be learnt? Br. J. Neurosurg. 2021; 35:181-185Ahuja S, Shah P, Mohammed R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764256 18. COVID-legal study: neurosurgeon experience in Britain during the first phase of the COVID-19 pandemic - medico-legal considerations. Br. J. Neurosurg. 2021:1-4Finn R, Ganau M, Jenkinson MD, Plaha P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759667 19. Autologous hematopoietic transplantation following COVID-19 infection. Clin Case Rep 2021; 9:1167-1170Brzycki M, Richard R, Burwick N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768803 20. Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis? Clin. Exp. Metastasis 2021:1-5Ivanyi P, Park-Simon T, Christiansen H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759009 21. Optometry Australia's infection control guidelines 2020. Clin. Exp. Optom. 2021:1-18Hart KM, Stapleton F, Carnt N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33769228 22. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review. Clin Rheumatol 2021; Soy M, Keser G, Atagunduz P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751280 23. Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic. Clin. Ther. 2021; Alfadhli EM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752899 24. Dosimetric Comparisons of Simulation Techniques for Left-Sided Breast Cancer in the COVID-19 Era: Techniques to Reduce Viral Transmission and Respect the Therapeutic Ratio. Cureus 2021; 13:e13354Taylor JM, Song A, Nowak K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747655 25. COVID-19 infection and rheumatoid arthritis: mutual outburst cytokines and remedies. Curr. Med. Res. Opin. 2021:1Elemam NM, Maghazachi AA, Hannawi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754931 26. Impact of the COVID-19 pandemic on acute admissions to a secondary referral hospital in a rural city in Japan: A retrospective study. Disaster Med Public Health Prep 2021:1-5Sato H, Kondo H, Oniki T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762059 27. Is COVID-19 impacting prostate cancer screening? A survey of prostate- specific antigen test requests during a local outbreak. Ejifcc 2021; 32:69- 77Ferrari A, Sanchis-Gomar F, Mattiuzzi C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753976 28. Audiological practice and COVID-19: recommendations that audiological centers can use to maintain the safety and quality of service-expert opinion. Eur Arch Otorhinolaryngol 2021:1-6Rajeswaran R, Tavora-Vieira D, Mertens G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772609 29. MuSK-positive myasthenia may not only be triggered by SARS-CoV-2. Eur. J. Neurol. 2021; Finsterer J, Scorza FA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751712 30. Intravitreal injections during COVID-19 outbreak: Protective measures, total duration of care and perceived quality of care in a tertiary retina center. Eur. J. Ophthalmol. 2021:11206721211003488Denys P, Miere A, Colantuono D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752454 31. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients. Heliyon 2021; 7:e06454Afaghi P, Lapolla MA, Ghandi K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748501 32. Patterns of alcohol and drug utilization in trauma patients during the COVID- 19 pandemic at six trauma centers. Inj Epidemiol 2021; 8:24McGraw C, Salottolo K, Carrick M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752758 33. The effect of the lockdown executive order during the COVID-19 pandemic in recent trauma admissions in Puerto Rico. Inj Epidemiol 2021; 8:22Ruiz-Medina PE, Ramos-Meléndez EO, Cruz-De La Rosa KX et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752760 34. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents 2021:106324Lai CC, Chen SY, Ko WC, Hsueh PR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746045 35. World Tuberculosis Day 2021 Theme - 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic. Int J Infect Dis 2021; Zumla A, Chakaya J, Khan M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746094 36. Characteristics and operation outcomes of neuro-oncology patients after COVID-19 pandemic - A case series. Interdiscip Neurosurg 2021; 25:101172Zou Y, Zhang J, Zhang T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754122 37. The Significance of Pressure Injuries and Purpura in COVID-19 Patients Hospitalized at a Large Urban Academic Medical Center: A Retrospective Cohort Study. J Am Acad Dermatol 2021; Rrapi R, Chand S, Lo JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753253 38. COVID-19: A new barrier to treatment for opioid use disorder in the emergency department. J Am Coll Emerg Physicians Open 2021; 2:e12403Grunvald W, Herrington R, King R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748808 39. COVID-19 and Breast Radiologist Wellness: Impact of Gender, Financial Loss, and Childcare Need. J Am Coll Radiol 2021; Milch HS, Grimm LJ, Plimpton SR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766645 40. COVID-19 Recommendations for Assisted Living: Implications for the Future. J. Am. Med. Dir. Assoc. 2021; Vipperman A, Zimmerman S, Sloane PD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773962 41. Impact of covid 19 pandemic on presentation,treatment and outcome of paediatric surgical emergencies. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S621-s624Ali S, Khan MA, Rehman IU, Uzair M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754519 42. Impact of chemotherapy on lymphocytes and serological memory in recovered COVID-19 patients with acute leukemia. J. Cancer 2021; 12:2450- 2455Liu W, Li Z, He W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758621 43. Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint. J. Cancer 2021; 12:2190-2198Wang W, Guo B, Cui C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758597 44. EACTA/SCA Recommendations for the Cardiac Anesthesia Management of Patients With Suspected or Confirmed COVID-19 Infection: An Expert Consensus From the European Association of Cardiothoracic Anesthesiology and Society of Cardiovascular Anesthesiologists With Endorsement From the Chinese Society of Cardiothoracic and Vascular Anesthesiology. J Cardiothorac Vasc Anesth 2021; Guarracino F, Shernan SK, Tahan ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766471 45. The outcomes and acceptance of pressurized metered-dose inhaler bronchodilators with venturi mask modified spacer in the outpatient emergency department during the COVID-19 pandemic. J. Clin. Pharm. Ther. 2021; Koh HP, Shamsudin NS, Tan MMY, Mohd Pauzi Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768601 46. The Impact of COVID-19 on Access to HIV Prevention Services Among Opioid- Dependent Individuals. J. Community Health 2021:1-7Mistler CB, Curley CM, Rosen AO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770334 47. Continuation of an eating disorders day programme during the COVID-19 pandemic. J Eat Disord 2021; 9:34Plumley S, Kristensen A, Jenkins PE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750463 48. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J. Endocrinol. Invest. 2021:1-14Lisco G, De Tullio A, Jirillo E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765288 49. Rate of Application and Outcome of Non-operative Management of Acute Appendicitis in the Setting of COVID-19: Systematic Review and Meta- analysis. J Gastrointest Surg 2021:1-11Emile SH, Hamid HKS, Khan SM, Davis GN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772399 50. The Treatment of Disability Under Crisis Standards of Care: An Empirical and Normative Analysis of Change Over Time During COVID-19. J. Health Polit. Policy Law 2021; Ne'eman A, Ashley Stein M, Berger ZD, Dorfman D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769474 51. Coronavirus Occurrence in the HIVE Cohort of Michigan Households: Reinfection frequency and serologic responses to seasonal and SARS coronaviruses. J Infect Dis 2021; Petrie JG, Bazzi LA, McDermott AB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755731 52. Behavioural change in Prader-Willi syndrome during COVID-19 pandemic. J. Intellect. Disabil. Res. 2021; Wieting J, Eberlein C, Bleich S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754414 53. Patients' Access to Care During COVID-19 and the Role of Nurse Practitioners in Australia. J. Law Med. 2021; 28:336-345Currie J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768745 54. Impact of COVID-19 on utilization of nonpharmacological and pharmacological treatments for chronic low back pain and clinical outcomes. J Osteopath Med 2021; Licciardone JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770828 55. The Impact of Social Distancing for COVID-19 Upon Diagnosis of Kawasaki Disease. J Pediatric Infect Dis Soc 2021; Shulman S, Geevarghese B, Kim KY, Rowley A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755140 56. Substance use treatment in Appalachian Tennessee amid COVID-19: Challenges and preparing for the future. J. Subst. Abuse Treat. 2021; 124:108270Kedia SK, Schmidt M, Dillon PJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771275 57. Integrated substance use and prenatal care delivery in the era of COVID-19. J. Subst. Abuse Treat. 2021; 124:108273Patton EW, Saia K, Stein MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771277 58. A collision of crises: Addressing an HIV outbreak among people who inject drugs in the midst of COVID-19. J. Subst. Abuse Treat. 2021; 124:108280Taylor JL, Ruiz-Mercado G, Sperring H, Bazzi AR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33771280 59. Increased HIV testing in people who use drugs hospitalized in the first wave of the COVID-19 pandemic. J. Subst. Abuse Treat. 2021; 124:108266Zubiago J, Murphy M, Guardado R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771274 60. Assessing the immediate impact of COVID-19 on surgical oncology practice: Experience from an NCI-designated Comprehensive Cancer Center in the Northeastern United States. J. Surg. Oncol. 2021; Gazivoda V, Greenbaum A, Roshal J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765341 61. Spontaneous Vocal Fold Polyps Remission after Lockdown for Covid-19 Pandemic: Does Vocal Load Matter? J. Voice 2021; Fantini M, Succo G, Tascone M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771429 62. [Treatment of postoperative anterior mediastinitis, sternal osteomyelitis in a patient with a novel coronavirus infection]. Khirurgiia (Mosk.) 2021:53- 57Kabanov MY, Kryukov NA, Binienko MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759469 63. Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges. Leuk Res Rep 2021; 15:100239Roosta Y, Behzadi F, Askari E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747763 64. Mortality and morbidity of curative and palliative anticancer treatments during the COVID-19 pandemic: A multicenter population-based retrospective study. Mol Clin Oncol 2021; 14:82Tashkandi E, Al-Abdulwahab A, Basulaiman B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758663 65. Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown. Neurol Sci 2021:1-6Gonzalez-Martinez A, Planchuelo- Gómez Á, Guerrero Á L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768436 66. The Use of Remote Programming for Spinal Cord Stimulation for Patients With Chronic Pain During the COVID-19 Outbreak in China. Neuromodulation 2021; Han Y, Lu Y, Wang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751731 67. Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology. Oncol. Rev. 2021; 15:510Kobat H, Elkonaissi I, Dorak MT, Nabhani-Gebara S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747366 68. COVID-19 guidelines for the prioritization of operations for malignant thoracic diseases. Pneumologe 2020; 17:394-397Hekmat K, Bruns CJ. 69. Impact of the COVID-19 Pandemic on Rheumatology Nursing Consultation. Reumatol. Clin. 2021; Fernández Sánchez SP, Rodríguez Muñoz F, Laiz A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771437 70. COVID-19 disruption: Family physicians at the forefront. S Afr Fam Pract (2004) 2021; 63:e1-e2Hugo JF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764145 71. 'We are in this together' voices of speech-language pathologists working in South African healthcare contexts during level 4 and level 5 lockdown of COVID-19. S. Afr. J. Commun. Disord. 2021; 68:e1-e12Adams SN, Seedat J, Coutts K, Kater KA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764150 72. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic. Scand. J. Gastroenterol. 2021:1-7Moum KM, Moum B, Opheim R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771086 73. Admissions to Norwegian Hospitals during the COVID-19 Pandemic. Scand J Public Health 2021:14034948211000813Helgeland J, Telle KE, Grøsland M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764202 74. Impact of the SARS-COV-2 outbreak on epidemiology and management of major traumain France: a registry-based study (the COVITRAUMA study). Scand. J. Trauma Resusc. Emerg. Med. 2021; 29:51Moyer JD, James A, Gakuba C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752728 75. Uveitis Specialists Harnessing Disruptive Technology during the COVID-19 Pandemic and Beyond. Semin. Ophthalmol. 2021:1-8Brill D, Papaliodis G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755525 76. How COVID-19 has impacted integrated care practice: lessons from the frontlines. Soc. Work Health Care 2021:1-11Cooper Z, Zerden LS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749534 77. Access to OUD Treatment and Maintenance of Sobriety amid the COVID-19 Pandemic. Subst. Use Misuse 2021:1-5Rahman F, Evans N, Bernhardt J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754956 78. Impact of the COVID-19 pandemic on management and outcomes in acute appendicitis: Should these new practices be the norm? Surgeon 2021; Somers K, Abd Elwahab S, Raza MZ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33750630 79. Ingenuity and Resiliency of Syringe Service Programs on the Front Lines of the Opioid Overdose and COVID-19 Crises. Transl. Res. 2021; Wenger LD, Kral AH, Bluthenthal RN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746108 80. Immune Reconstitution and Severity of COVID-19 among Hematopoietic Cell Transplant Recipients. Transpl Infect Dis 2021:e13606Malek AE, Adachi JA, Mulanovich VE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755273 81. A New Chemical Probe Challenges the Broad Cancer Essentiality of CK2. Trends Pharmacol Sci 2021; Licciardello MP, Workman P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771354 82. Effects of the COVID-19 Pandemic on Psychology and Disease Activity in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis. Turk J Med Sci 2021; Gica Ş, Akkubak Y, Aksoy ZK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33773523 83. Surgical Considerations in the Treatment of Axillary-Subclavian Venous Thrombosis in the Era of COVID-19. Vasc. Endovascular Surg. 2021:15385744211002803Mukherjee D, Kittner J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757394 84. The management of surgical patients in the emergency setting during COVID- 19 pandemic: the WSES position paper. World J Emerg Surg 2021; 16:14De Simone B, Chouillard E, Sartelli M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752721 85. COVID-19: A Time Like No Other in (the Department of) Neurological Surgery. World Neurosurg 2021; 148:256-262Pannullo SC, Guadix SW, Souweidane MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770848 86. The World of Neurosurgery Reimagined Post COVID-19: Crisis ↔ Opportunities. World Neurosurg 2021; 148:251-255Tosi U, Chidambaram S, Schwarz J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770847 87. Neurosurgery in COVID-19 Ground Zero: The Weill Cornell Medicine Experience. World Neurosurg 2021; 148:263-268Winston GM, Garton ALA, Chae JK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770849

Management (58 articles)

1. Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis. Adv. Nutr. 2021; Kazemi A, Mohammadi V, Aghababaee SK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751020 2. Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy. Anaesth Crit Care Pain Med 2021:100841Attallah N, Gupta S, Madhyastha R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746074 3. Lessons From Building a Novel Health Care Model Against COVID-19 in Fukuoka, Japan: Timely Decision-Making and Public-Private Cooperation. Asia Pac. J. Public Health 2021:1010539521999890Matono T, Noda E, Sano T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759574 4. COVID-19 pandemic: the implications of the natural history, challenges of diagnosis and management for care in sub-Saharan Africa. Beni Suef Univ J Basic Appl Sci 2021; 10:16Omo-Aghoja L, Moke EG, Anachuna KK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754124 5. General practice attendances among patients attending a post-COVID-19 clinic: A pilot study. BJGP Open 2021; Broughan JM, McCombe G, Avramovic G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757962 6. Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19. BMC Geriatr. 2021; 21:199Walle-Hansen MM, Ranhoff AH, Mellingsæter M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752614 7. Prioritising 'already-scarce' intensive care unit resources in the midst of COVID-19: a call for regional triage committees in South Africa. BMC Med. Ethics 2021; 22:28Naidoo R, Naidoo K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752662 8. Efficacy of COVID-19 outbreak management in a skilled nursing facility based on serial testing for early detection and control. Braz. J. Infect. Dis. 2021:101570Garibaldi PMM, Ferreira NN, Moraes G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773990 9. Success and complications of endotracheal intubation in critical care settings under COVID-19 protocols. Cjem 2021; Dullemond K, Renschler C, Trojanowski J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751491 10. Antioxidants other than vitamin C may be detected by glucose meters: immediate relevance for patients with disorders targeted by antioxidant therapies. Clin. Biochem. 2021; Grzych G, Pekar JD, Chevalier-Curt MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766514 11. Aggregometry and thromboelastography to identify the timing to trach a COVID-19 patient receiving both antiplatelet therapy and enoxaparin. Clin Case Rep 2021; 9:1049-1054Tescione M, Vadalà E, Marano G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768781 12. A specialised cardiorespiratory team approach in the intensive care management of COVID-19 patients: benefit on mortality, diagnosis and management. Clin Med (Lond) 2021; 21:101-106Anwar A, Ramos-Bascon N, Crerar-Gilbert AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762367 13. Effects of vitamin supplements on clinical cardiovascular outcomes: Time to move on! - A comprehensive review. Clin Nutr ESPEN 2021; 42:1-14Simsek B, Selte A, Egeli BH, Çakatay U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745562 14. Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality. Clin Nutr ESPEN 2021; 42:313-317Tehrani S, Khabiri N, Moradi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745598 15. Renin-Angiotensin-Aldosterone System Blockers Prior to Hospitalization and Their Association With Clinical Outcomes in Coronavirus Disease 2019 (COVID-19). Cureus 2021; 13:e13429Banwait R, Singh D, Blanco A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758716 16. Herbal Medicine in Fighting Against COVID-19: New Battle with an Old Weapon. Curr. Pharm. Biotechnol. 2021; Harwansh RK, Bahadur S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749558 17. Assessment of the Preparedness and Planning of Academic Emergency Departments in India during the COVID-19 Pandemic - A Multicentric Survey. Disaster Med Public Health Prep 2021:1-13Gopinathan V, Asanar S, Krishnan SV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750508 18. Reducing Patient Risk and Enhancing Care Through the Development and Implementation of a New Chest Pain Pathway, Expedited by and for the COVID-19 Era. Ejifcc 2021; 32:27-40Than MP, Pickering JW, Adamson P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753972 19. Perception of level of knowledge, skills, and safety before and after training to perform videolaryngoscopy with the Intubox barrier system for airway management in patients with COVID-19. Emergencias 2021; 33:93-99Adánez Martínez MG, Leal Costa C, García López JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750049 20. The experience of executing preventive measures to protect a nursing home in Taiwan from a COVID-19 outbreak. Eur. Geriatr. Med. 2021; Huang CY, Kuo YH, Chuang ST et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751454 21. Assessing the Indirect Effects of COVID-19 on Healthcare Delivery, Utilization, and Health Outcomes: A Scoping Review. Eur. J. Public Health 2021; Roy CM, Bollman EB, Carson LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755130 22. Negative Association Between Mediterranean Diet Adherence and COVID-19 Cases and Related Deaths in Spain and 23 OECD Countries: An Ecological Study. Front Nutr 2021; 8:591964Greene MW, Roberts AP, Frugé AD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748170 23. Real-time forecasting of COVID-19 bed occupancy in wards and Intensive Care Units. Health Care Manag Sci 2021:1-18Baas S, Dijkstra S, Braaksma A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768389 24. The development and deployment of a model for hospital-level COVID-19 associated patient demand intervals from consistent estimators (DICE). Health Care Manag Sci 2021; Yang L, Zhang T, Glynn P, Scheinker D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751281 25. Use of vitamin/zinc supplements, medicinal plants, and immune boosting drinks during COVID-19 pandemic: A pilot study from Benha city, Egypt. Heliyon 2021; 7:e06538Khabour OF, Hassanein SFM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748511 26. Airway management in children with COVID-19. Hong Kong Med. J. 2021; Leung KKY, Ku SW, Fung RCM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33750741 27. Meeting oxygen requirements of rural India: A self-contained solution. Indian J. Public Health 2021; 65:82-84Madaan N, Paul BC, Guleria R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753697 28. The Use Of Ultrapure Molecular Hydrogen Enriched With Atomic Hydrogen In Apparatuses Of Artificial Lung Ventilation In The Fight Against Virus COVID- 19. Int J Hydrogen Energy 2021; Zolotarenko AD, Zolotarenko AD, Veziroglu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746342 29. OpenMRS as an emergency EMR-How we used a global good to create an emergency EMR in a week. Int. J. Med. Inform. 2021; 149:104433Mamlin BW, Shivers JE, Glober NK, Dick JJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752170 30. Nurses as new heroes of modern times. Int Nurs Rev 2021; Różyk-Myrta A, Brodziak A, Kołat E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761142 31. COVID-19 End-of-life Care: Symptoms and Supportive Therapy Use in an Australian Hospital. Intern. Med. J. 2021; Wong AK, Demediuk L, Tay JY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755283 32. Main Factors Affecting the Readiness and Responsiveness of Healthcare Systems during Epidemic Crises: A Scoping Review on Cases of SARS, MERS, and COVID-19. Iran J Med Sci 2021; 46:81-92Mohammadpour M, Zarifinezhad E, Ghanbarzadegan A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753952 33. Side-effects of COVID-19 on patient care: An INR story. J Appl Lab Med 2021; Pearson LN, Johnson SA, Greene DN et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33760097 34. Knowledge discovery from emergency ambulance dispatch during COVID-19: A case study of Nagoya City, Japan. J. Biomed. Inform. 2021; 117:103743Rashed EA, Kodera S, Shirakami H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753268 35. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Expert Recommendations from The Korean Society for Thoracic and Cardiovascular Surgery. J Chest Surg 2021; 54:2-8Jeong IS, Kim WH, Baek JH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767006 36. The effects of the COVID-19 pandemic on efficiency and airway management. J. Clin. Anesth. 2021; 71:110239Shackleford V, McGuire JA, Uraco AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773160 37. How the Trump Administration's Pandemic Health Care Response Failed Racial Health Equity: Case Studies of Structural Racism and a Call for Equity Mindfulness in Federal Health Policymaking. J. Health Polit. Policy Law 2021; Rosenbaum S, Handley M, Morris R, Casoni M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765139 38. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia. J Infect Public Health 2021; 14:446-453Alharbi M, Kazzaz YM, Hameed T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765595 39. Critical Care Transport of Patients With COVID-19. J. Intensive Care Med. 2021:8850666211001797Frakes MA, Richards JB, Cocchi MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745381 40. Family-centered care management strategies for term and near-term neonates with brief hospitalization in a level III NICU in Shenzhen, China during the time of COVID-19 pandemic. J Matern Fetal Neonatal Med 2021:1-4Yi YZ, Su T, Jia YZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752556 41. Qatar's Primary Health Care Medication Home Delivery Service: A Response Toward COVID-19. J Multidiscip Healthc 2021; 14:651-657Al-Zaidan M, Mohamed Ibrahim MI, Al-Kuwari MG et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762825 42. The Development of a Novel Outpatient Infusion Therapy Center for Treatment of COVID-19 in a Rural Healthcare System. J. Prim. Care Community Health 2021; 12:21501327211007020Malone E, Krien J, Jorgenson B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771055 43. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study. Life Sci 2021:119371Cheng X, Xin S, Chen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745895 44. A national system for monitoring intensive care unit demand and capacity: the Critical Health Resources Information System (CHRIS). Med. J. Aust. 2021; Pilcher D, Coatsworth NR, Rosenow M, McClure J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774832 45. Viral Infectivity in Patients Undergoing Tracheotomy With COVID-19: A Preliminary Study. Otolaryngol Head Neck Surg 2021:1945998211004255George MM, McIntyre CJ, Zhou J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752547 46. 'Necessity is the mother of invention': Specialist palliative care service innovation and practice change in response to COVID-19. Results from a multinational survey (CovPall). Palliat. Med. 2021:2692163211000660Dunleavy L, Preston N, Bajwah S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754892 47. High-dose ACEi might be harmful in COVID-19 patients with serious respiratory distress syndrome by leading to excessive bradykinin receptor activation. Physiol Int 2021; Székács B, Várbíró S, Debreczeni L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764894 48. German recommendations for treatment of critically ill patients with COVID-19 —version 3: S1-guideline. Pneumologe 2020; 17:406-425Kluge S, Janssens U, Welte T et al. 49. COVID-19: The role of intensive care. Public Health Forum 2021; 29:11- 14Hanisch V. 50. Importance of and burden on nursing staff during the corona crisis. Public Health Forum 2021; 29:32-35Schulze S, Holmberg C. 51. Management of COVID-19 in an adolescent demonstrates lasting effects of extreme prematurity on pulmonary function. Respir Med Case Rep 2021; 33:101394Sobelman CS, Valentine SL, Kremer T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758746 52. [Coronavirus disease 2019 (COVID-19): Involuntary admission yes, involuntary treatment no]. Rev Esp Geriatr Gerontol 2021; Gutiérrez Rodríguez J, Valle Calonge E, Díaz García E, Gallego Riestra S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33771360 53. Natural product remedies for COVID-19: A focus on safety. S Afr J Bot 2021; 139:386-398Omokhua-Uyi AG, Van Staden J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753960 54. [COVID-19 epidemic, a challenge successfully overcome by intensive care nurses]. Soins 2021; 66:35-37Constan A, Dransart C, Micaelli D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750556 55. Follow-up care after COVID-19 and its related concerns. Vnitr. Lek. 2021; 67:30- 36Radvan M, Bartečků E, Sýkorová U et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752388 56. Determinants of Antimicrobial Use for Covid-19 Related Symptoms among Nigerians. West Afr. J. Med. 2021; 38:213-221Chukwu EE, Musa AZ, Enwuru C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764727 57. Extracorporeal membrane oxygenation for coronavirus disease 2019- associated acute respiratory distress syndrome: Report of two cases and review of the literature. World J Clin Cases 2021; 9:1953-1967Wen JL, Sun QZ, Cheng Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748247 58. DEGAM strategy paper on long-term management of the COVID-19 pandemic from the point of view of general practice. Z. Allgemeinmed. 2021; 97:44Dank V.

Mental – public health (145 articles)

1. Adult PTSD symptoms and substance use during Wave 1 of the COVID-19 pandemic. Addict Behav Rep 2021; 13:100341Currie CL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763517 2. [The impact of the COVID-19 epidemic on the elderly mental health and psychosocial support.]. Adv Gerontol 2020; 33:1043-1049Bubeyev YA, Kozlov VV, Syrkin LD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774985 3. Social networks and mental health change in older adults after the Covid-19 outbreak. Aging Ment. Health 2021:1-6Litwin H, Levinsky M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749448 4. Is the COVID-19 Pandemic a High-Risk Period for College Student Alcohol Use? A Comparison of Three Spring Semesters. Alcohol. Clin. Exp. Res. 2021; Jaffe AE, Kumar SA, Ramirez JJ, DiLillo D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33755213 5. Psychological distress during the COVID-19 pandemic in Ethiopia: an online cross-sectional study to identify the need for equal attention of intervention. Ann Gen Psychiatry 2021; 20:22Ambelu A, Birhanu Z, Yitayih Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766076 6. [Mortality in schizophrenia: Towards a new health scandal? COVID-19 and schizophrenia]. Ann. Med. Psychol. (Paris) 2021; Fond G, Llorca PM, Lançon C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753948 7. [Psychological and psychopathological issues of conspiracy theories: From the COVID-19 health crisis to the existential crisis]. Ann. Med. Psychol. (Paris) 2021; Poupart F, Bouscail M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746230 8. The role of leisure crafting for emotional exhaustion in telework during the COVID-19 pandemic. Anxiety Stress Coping 2021:1-15Abdel Hadi S, Bakker AB, Häusser JA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769142 9. Variations in mindfulness associated with the COVID-19 outbreak: Differential effects on cognitive failures, intrusive thoughts and rumination. Appl Psychol Health Well Being 2021; Lopez A, Caffò AO, Tinella L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765354 10. "Celebrating old age": an obsolete expression during the COVID-19 pandemic? Medical, social, psychological, and religious consequences of home isolation and loneliness among the elderly. Arch. Med. Sci. 2021; 17:285- 295Burlacu A, Mavrichi I, Crisan-Dabija R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747263 11. Experiences of mental health professionals supporting front-line health and social care workers during COVID-19: qualitative study. BJPsych Open 2021; 7:e70Billings J, Biggs C, Ching BCF et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752774 12. Comparison of psychological symptoms between infected and non-infected COVID-19 health care workers. BMC Psychiatry 2021; 21:170Mohammadian Khonsari N, Shafiee G, Zandifar A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33771122 13. Psychological experiences of healthcare professionals in Sri Lanka during COVID-19. BMC Psychol 2021; 9:49Perera B, Wickramarachchi B, Samanmalie C, Hettiarachchi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761994 14. Brief videoconferencing psychological intervention for reducing COVID-19 related distress: study protocol for a randomized controlled trial. BMC Public Health 2021; 21:474Keyan D, Dawson K, Azevado S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750351 15. Preparedness for self-isolation or quarantine and lockdown in South Africa: results from a rapid online survey. BMC Public Health 2021; 21:580Sifunda S, Mokhele T, Manyaapelo T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757461 16. Characterising the impact of COVID-19 environment on mental health, gender affirming services and socioeconomic loss in a global sample of transgender and non-binary people: a structural equation modelling. BMJ Glob Health 2021; 6Restar AJ, Jin H, Jarrett B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753401 17. The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey. Br. J. Haematol. 2021; Quinn SJ, Anderson LA, Lohfeld L, McShane CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763875 18. Compliance without fear: Individual-level protective behaviour during the first wave of the COVID-19 pandemic. Br. J. Health Psychol. 2021; Jørgensen F, Bor A, Petersen MB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763971 19. [Public health services in the COVID-19 pandemic: strategies and practices in selected European neighbouring countries]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021; Gerlinger T, Schmidt PF, Lückenbach C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748867 20. [Real-time data from medical care settings to guide public health action]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2021:1- 6Grabenhenrich Mph L, Schranz M, Boender S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760934 21. Socio-demographic disparities in knowledge, practices, and ability to comply with COVID-19 public health measures in Canada. Can. J. Public Health. 2021:1- 13Brankston G, Merkley E, Fisman DN et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33761109 22. Impacts of the COVID-19 Pandemic on the Mental Health and Motor Deficits in Cuban Patients with Cerebellar Ataxias. Cerebellum 2021:1-8González-Garcés Y, Domínguez-Barrios Y, Zayas-Hernández A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768478 23. Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands. Clin Infect Dis 2021; Vos ERA, van Boven M, den Hartog G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772265 24. A detailed analysis of ethical considerations for three specific models of teleneuropsychology during and beyond the COVID-19 pandemic. Clin. Neuropsychol. 2021:1-21Scott TM, Marton KM, Madore MR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761834 25. Fear Associated with COVID-19 in Patients with Neovascular Age-Related Macular Degeneration. Clin. Ophthalmol. 2021; 15:1153-1161Rozon JP, Hébert M, Bourgault S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758498 26. Prevalence of COVID 19 Positive Cases Presenting to a Psychiatric Emergency Room. Community Ment. Health J. 2021:1-4Cardenas J, Roach J, Kopelowicz A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770308 27. Public awareness and anxiety during COVID-19 epidemic in China: A cross- sectional study. Compr. Psychiatry 2021; 107:152235Liu Y, Li P, Lv Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765493 28. Inpatient psychiatry unit devoted to COVID-19 patients. Compr. Psychiatry 2021; 107:152237Mahgoub N, Agarkar S, Radosta M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751977 29. Mental health during COVID-19 lockdown in India: Role of psychological capital and internal locus of control. Curr. Psychol. 2021:1-13Alat P, Das SS, Arora A, Jha AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746461 30. Working in lockdown: the relationship between COVID-19 induced work stressors, job performance, distress, and life satisfaction. Curr. Psychol. 2021:1-16Kumar P, Kumar N, Aggarwal P, Yeap JAL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746462 31. Living alone in lockdown: Impact on mental health and coping mechanisms among young working adults. Curr. Psychol. 2021:1-13Raj T, Bajaj A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758485 32. Psychosocial status during the prevalence of COVID-19 disease: the comparison between healthcare workers and general population. Curr. Psychol. 2021:1-9Zakeri MA, Hossini Rafsanjanipoor SM, Sedri N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746463 33. Data on the effects of COVID-19 pandemic on people's expectations about their future. Data Brief 2021; 35:106892Ceccato I, Di Crosta A, Palumbo R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748358 34. Suicidal Risk in Older Patients with Depression During COVID-19 Pandemic: a Case-Control Study. East Asian Arch Psychiatry 2021; 31:3-8Louie LLC, Chan WC, Cheng CPW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753570 35. Negative impact of the first COVID-19 lockdown upon health-related behaviours and psychological wellbeing in people living with severe and complex obesity in the UK. EClinicalMedicine 2021:100796Brown A, Flint SW, Kalea AZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754138 36. Risk and protective factors related to children's symptoms of emotional difficulties and hyperactivity/inattention during the COVID-19-related lockdown in France: results from a community sample. Eur. Child Adolesc. Psychiatry 2021; Moulin F, El-Aarbaoui T, Bustamante JJH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751230 37. Evaluating the impact of COVID-19 on supportive care needs, psychological distress and quality of life in UK cancer survivors and their support network. Eur. J. Cancer Care (Engl.) 2021:e13442Hulbert-Williams NJ, Leslie M, Hulbert- Williams L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764611 38. COVID-19-Related Neuropsychiatric Symptoms in Patients With Alcohol Abuse Conditions During the SARS-CoV-2 Pandemic: A Retrospective Cohort Study Using Real World Data From Electronic Health Records of a Tertiary Hospital. Front. Neurol. 2021; 12:630566Varela Rodríguez C, Arias Horcajadas F, Martín-Arriscado Arroba C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746884 39. Hope May Come From Internet in Times of COVID-19: Building an Online Programme for Grief (LIVIA). Front Psychiatry 2021; 12:626831Berthoud L, Efinger L, Kheyar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767639 40. Mental Health Impacts in Argentinean College Students During COVID-19 Quarantine. Front Psychiatry 2021; 12:557880López Steinmetz LC, Leyes CA, Dutto Florio MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746788 41. Stressful Life Events and Resilience During the COVID-19 Lockdown Measures in Italy: Association With Mental Health Outcomes and Age. Front Psychiatry 2021; 12:635832Rossi R, Jannini TB, Socci V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762980 42. Psychological Profiles of Chinese Patients With Hemodialysis During the Panic of Coronavirus Disease 2019. Front Psychiatry 2021; 12:616016Yang ZH, Pan XT, Chen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746793 43. Psychology, Physical Activity, and Post-pandemic Health: An Embodied Perspective. Front. Psychol. 2021; 12:588931Aguirre-Loaiza H, Mejía-Bolaño A, Cualdrón J, Ospina S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746822 44. Burnout and Its Relationship With Depressive Symptoms in Medical Staff During the COVID-19 Epidemic in China. Front. Psychol. 2021; 12:616369Huo L, Zhou Y, Li S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746836 45. Sport Cyberpsychology in Action During the COVID-19 Pandemic (Opportunities, Challenges, and Future Possibilities): A Narrative Review. Front. Psychol. 2021; 12:621283Hurley OA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746838 46. Pandemic Nightmares: COVID-19 Lockdown Associated With Increased Aggression in Female University Students' Dreams. Front. Psychol. 2021; 12:644636Kilius E, Abbas NH, McKinnon L, Samson DR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746860 47. Parent and Child's Negative Emotions During COVID-19: The Moderating Role of Parental Attachment Style. Front. Psychol. 2021; 12:567483Liang Z, Delvecchio E, Cheng Y, Mazzeschi C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746813 48. The Job Demands and Resources Related to COVID-19 in Predicting Emotional Exhaustion and Secondary Traumatic Stress Among Health Professionals in Spain. Front. Psychol. 2021; 12:564036Moreno-Jiménez JE, Blanco-Donoso LM, Chico-Fernández M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33767642 49. Mood Responses and Regulation Strategies Used During COVID-19 Among Boxers and Coaches. Front. Psychol. 2021; 12:624119Roberts RJ, Lane AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746844 50. Creativity as a Means to Well-Being in Times of COVID-19 Pandemic: Results of a Cross-Cultural Study. Front. Psychol. 2021; 12:601389Tang M, Hofreiter S, Reiter-Palmon R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767644 51. Emotional Creativity Improves Posttraumatic Growth and Mental Health During the COVID-19 Pandemic. Front. Psychol. 2021; 12:600798Zhai HK, Li Q, Hu YX et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746827 52. Presenting or Spinning Facts? Deconstructing the U.S. Centers for Disease Control Statement on the Importance of Reopening Schools Under COVID-19. Front Public Health 2021; 9:645229Benzian H, Johnston M, Stauf N, Niederman R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768087 53. The Association of COVID-19 Pandemic Stress With Health-Related Quality of Life in the Kingdom of Saudi Arabia: A Cross-Sectional Analytical Study. Front Public Health 2021; 9:600330Hawash MM, Alhazmi AH, Wafik W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748057 54. Substance Use in Mild-COVID-19 Patients: A Retrospective Study. Front Public Health 2021; 9:634396Ismael F, Zaramella B, Battagin T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748068 55. Depressive and Anxiety Symptoms of Healthcare Workers in Intensive Care Unit Under the COVID-19 Epidemic: An Online Cross-Sectional Study in China. Front Public Health 2021; 9:603273Peng X, Meng X, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748059 56. Validating the Psychosocial Functioning during COVID-19 Questionnaire among a Sample of Informal Caregivers. Gerontol Geriatr Med 2021; 7:2333721421997200Arnold T, Kunicki ZJ, Rogers BG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748339 57. Art during tough times: reflections from an art-based health promotion initiative during the COVID-19 pandemic. Glob Health Promot 2021:1757975921998638Abdullahi I, Chana NK, Zenone M, Ardiles P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765878 58. The impact of lockdown policy on depressive symptoms among pregnant women in China: mediating effects of internet use and family support. Glob Health Res Policy 2021; 6:11Zhou Y, Wang R, Liu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771230 59. 'Now my life is stuck!': Experiences of adolescents and young people during COVID-19 lockdown in South Africa. Glob Public Health 2021:1-17Gittings L, Toska E, Medley S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750269 60. A longitudinal study of mental health before and during COVID-19 lockdown in the French population. Global Health 2021; 17:29Ramiz L, Contrand B, Rojas Castro MY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752717 61. Social representations of the coronavirus and causal perception of its origin: The role of reasons for fear. Health (London) 2021:13634593211005172Rateau P, Tavani JL, Delouvée S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752462 62. Real-time forecasting of COVID-19 bed occupancy in wards and Intensive Care Units. Health Care Manag Sci 2021:1-18Baas S, Dijkstra S, Braaksma A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768389 63. 'Reluctant pioneer': A qualitative study of doctors' experiences as patients with long COVID. Health Expect. 2021; Taylor AK, Kingstone T, Briggs TA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749957 64. Role of neighborhood social support in stress coping and psychological wellbeing during the COVID-19 pandemic: Evidence from Hubei, China. Health Place 2021; 69:102532Chen X, Zou Y, Gao H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752161 65. Role of community-based measures in adherence to self-protective behaviors during first wave of COVID-19 pandemic in Saudi Arabia. Health Promot Perspect 2021; 11:69-79Al-Shammary AA, Hassan SU, Zahra A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758758 66. Loneliness and not living alone is what impacted on the healthcare professional's mental health during the COVID-19 outbreak in Spain. Health Soc Care Community 2021; Cabello M, Izquierdo A, Leal I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761161 67. Moral Distress Entangled: Patients and Providers in the COVID-19 Era. HEC Forum 2021:1-9Vittone S, Sotomayor CR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774782 68. The impact of the COVID-19 pandemic on students' feelings at high school, undergraduate, and postgraduate levels. Heliyon 2021; 7:e06465Camacho- Zuñiga C, Pego L, Escamilla J, Hosseini S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768174 69. Behavioural insights and attitudes on community masking during the initial spread of COVID-19 in Hong Kong. Hong Kong Med. J. 2021; Tam VCW, Tam SY, Khaw ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762440 70. Influence of Online Social Support on the Public's Belief in Overcoming COVID-19. Inf. Process. Manag. 2021; 58:102583Yao Z, Tang P, Fan J, Luan J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746338 71. Mental health and preventive behaviour of pregnant women in China during the early phase of the COVID-19 period. Infect Dis Poverty 2021; 10:37Wang Q, Mo PKH, Song B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761984 72. A comparative study of strategies for containing the COVID-19 pandemic in Gulf Cooperation Council countries and the European Union. Inform Med Unlocked 2021; 23:100547Alanezi F, Althumairi A, Aljaffary A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754126 73. COVID-19 fear and compliance in preventive measures precautions in workers during the COVID-19 pandemic. Int. Arch. Occup. Environ. Health 2021; Kabasakal E, Özpulat F, Akca A, Özcebe LH. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751223 74. Depression and its relationship with quality of life in frontline psychiatric clinicians during the COVID-19 pandemic in China: a national survey. Int J Biol Sci 2021; 17:683-688Zhang HH, Zhao YJ, Wang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767580 75. Psychological effects of the COVID-19 outbreak on nurses working in tertiary women's and children's hospitals from Sichuan, China: A cross-sectional study. Int J Disaster Risk Reduct 2021; 58:102188He Q, Ren J, Wang G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754121 76. Disaster management of the psychological impact of the COVID-19 pandemic. Int. J. Emerg. Med. 2021; 14:19Sheek-Hussein M, Abu-Zidan FM, Stip E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761863 77. Policy disparities in response to the first wave of COVID-19 between China and Germany. Int J Equity Health 2021; 20:86Zhang Y, Shi L, Chen H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766049 78. The health workforce: Central to an effective response to the COVID-19 pandemic in the European Region. Int. J. Health Plann. Manage. 2021; Zapata T, Buchan J, Azzopardi-Muscat N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33763920 79. Role of social distancing in tackling COVID-19 during the first wave of pandemic in Nordic region: Evidence from daily deaths, infections and needed hospital resources. Int J Nurs Sci 2021; Amiri A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758674 80. Multinational dietary changes and anxiety during the coronavirus pandemic- findings from Israel. Isr J Health Policy Res 2021; 10:28Kaufman-Shriqui V, Navarro DA, Raz O, Boaz M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757598 81. COVID-19 quarantine: Psychological impact and support for children and parents. Ital. J. Pediatr. 2021; 47:58Demaria F, Vicari S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750452 82. Nurses' burnout and associated risk factors during the COVID-19 pandemic: A systematic review and meta-analysis. J. Adv. Nurs. 2021; Galanis P, Vraka I, Fragkou D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764561 83. Anxiety reported by US adults in 2019 and during the 2020 COVID-19 pandemic: Population-based evidence from two nationally representative samples. J. Affect. Disord. 2021; 286:296-300Daly M, Robinson E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756307 84. Socioeconomic inequality in child mental health during the COVID-19 pandemic: First evidence from China. J. Affect. Disord. 2021; 287:8-14Li W, Wang Z, Wang G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761325 85. Urbanization level and neighborhood deprivation, not COVID-19 case numbers by residence area, are associated with severe psychological distress and new- onset suicidal ideation during the COVID-19 pandemic. J. Affect. Disord. 2021; 287:89-95Okubo R, Yoshioka T, Nakaya T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774320 86. A first look at perceived stress in southeastern university students during the COVID-19 pandemic. J. Am. Coll. Health 2021:1-4Hathaway ED, Peyer KL, Doyle KA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760712 87. Changes in stress predict worse mental health outcomes for college students than does loneliness; evidence from the COVID-19 pandemic. J. Am. Coll. Health 2021:1-4Krendl AC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759704 88. Mental health impacts of COVID-19 lockdown on US college students: Results of a photoelicitation project. J. Am. Coll. Health 2021:1-11Olson R, Fryz R, Essemiah J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760715 89. Racial and ethnic minority disparities in COVID-19 related health, health beliefs and behaviors, and well-being among students. J. Am. Coll. Health 2021:1-7Trammell Ph DJ, Joseph Ph DN, Harriger Ph DJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759734 90. The experiences of mothers of children and young people with intellectual disabilities during the first COVID-19 lockdown period. J Appl Res Intellect Disabil 2021; Rogers G, Perez-Olivas G, Stenfert Kroese B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759291 91. Influence of anxiety and resilience on depression among hospital nurses: A comparison of nurses working with confirmed and suspected patients in the COVID-19 and non-COVID-19 units. J. Clin. Nurs. 2021; Doo EY, Kim M, Lee S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756003 92. Nurses' exposure to violence and their professional commitment during the COVID-19 pandemic. J. Clin. Nurs. 2021; Özkan Şat S, Akbaş P, Yaman Sözbir Ş. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761158 93. Will We Ever Again Conduct in-Person Psychotherapy Sessions? Factors Associated with the Decision to Provide in-Person Therapy in the Age of COVID-19. J Contemp Psychother 2021:1-8Shklarski L, Abrams A, Bakst E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746247 94. The opportunities out of uncertainty. J. Eval. Clin. Pract. 2021; Sacco A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755284 95. The Fear of COVID-19 Infection in Older People. J. Geriatr. Psychiatry Neurol. 2021:8919887211002651Gokseven Y, Ozturk GZ, Karadeniz E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745357 96. Psychopathology in Elderly COVID-19 Survivors and Controls. J. Geriatr. Psychiatry Neurol. 2021:8919887211002664Mowla A, Ghaedsharaf M, Pani A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745373 97. State Policy and Mental Health Outcomes under COVID-19. J. Health Polit. Policy Law 2021; Sances MW, Campbell AL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33765132 98. COVID-19: Public Health Emergency Powers and Accountability Mechanisms in Australia. J. Law Med. 2021; 28:346-369O'Brien P, Waters E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768746 99. COVID-19 Exposure and Family Impact Scales: Factor Structure and Initial Psychometrics. J. Pediatr. Psychol. 2021; Kazak AE, Alderfer M, Enlow PT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749794 100. Self-harm and the COVID-19 pandemic: A study of factors contributing to self- harm during lockdown restrictions. J. Psychiatr. Res. 2021; 137:437-443Hawton K, Lascelles K, Brand F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774538 101. Prevalence, risk and protective factors associated with suicidal ideation during the COVID-19 pandemic in U.S. military veterans with pre-existing psychiatric conditions. J. Psychiatr. Res. 2021; 137:351-359Na PJ, Tsai J, Hill ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756377 102. Quarantine for the coronavirus disease (COVID-19) in Wuhan city: Support, understanding, compliance and psychological impact among lay public. J. Psychosom. Res. 2021; 144:110420Lin Y, Hu Z, Alias H, Wong LP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770568 103. Predictive Factors of Spiritual Quality of Life during the COVID-19 Pandemic: A Multivariate Analysis. J Relig Health 2021:1-19Cherblanc J, Bergeron-Leclerc C, Maltais D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759072 104. Sákit Pighati and Pag-asa: A Pastoral Reflection on Suffering During the COVID-19 Pandemic in the Philippines. J Relig Health 2021:1-22Cordero DA, Jr. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772688 105. Psychological Distress Among a Tunisian Community Sample During the COVID-19 Pandemic: Correlations with Religious Coping. J Relig Health 2021:1- 16Fekih-Romdhane F, Cheour M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33772687 106. Combating Contagion and Injustice: The Shared Work for Public Health and Faith Communities During COVID-19. J Relig Health 2021:1-10Williams JTB, Miller A, Nussbaum AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772686 107. Neighborhood Social Cohesion and Inequalities in COVID-19 Diagnosis Rates by Area-Level Black/African American Racial Composition. J. Urban Health 2021:1-11Ransome Y, Ojikutu BO, Buchanan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759068 108. Psychological impact of the coronavirus 2019 (COVID-19) pandemic on nurses. Jpn. J. Nurs. Sci. 2021:e12417Al Maqbali M, Al Khadhuri J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749144 109. Urgent and Massive Investment in US Public Health Infrastructure Will Help to Stop the Spread of SARS-CoV-2 Virus and Deaths from COVID-19. Kans J Med 2021; 14:84-86Raghuveer TS, Kriesel D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33763186 110. Effect of COVID-19 confinement on the mental status of patients with systemic lupus erythematosus. Med Clin (Engl Ed) 2021; Santos-Ruiz A, Montero-López E, Ortego-Centeno N, Peralta-Ramírez MI. http://www.ncbi.nlm.nih.gov/pubmed/? term=33754127 111. Reduced suicidal presentations to emergency departments during the COVID- 19 outbreak in Queensland, Australia. Med. J. Aust. 2021; Sveticic J, Stapelberg NJ, Turner K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763854 112. Mental Well-Being in Patients with Transfusion-Dependent Anemias and Hemochromatosis during the SARS-CoV-2 Pandemic. Mediterr. J. Hematol. Infect. Dis. 2021; 13:e2021024Piperno R, Bertazioli G, Ravasi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747405 113. A Brief Online Mindfulness-Based Group Intervention for Psychological Distress Among Chinese Residents During COVID-19: a Pilot Randomized Controlled Trial. Mindfulness (N Y) 2021:1-11Zhang H, Zhang A, Liu C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758629 114. Care of patients with mental illness and SARS-CoV-2 infection at the Department of Psychiatry and Psychotherapy LMU Munich, Germany. MMW- Fortschritte der Medizin 2020; 162:3-9Adorjan K, Koller G, Falkai P, Pogarell O. 115. These corona regulations are now further valid until the end of the quarter. MMW-Fortschritte der Medizin 2021; 163:31Zimmermann GW. 116. Care difficulties and burden during COVID-19 pandemic lockdowns among caregivers of people with schizophrenia: A cross-sectional study. Neuropsychopharmacol Rep 2021; Yasuma N, Yamaguchi S, Ogawa M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764671 117. Anxiety, depression, trauma-related, and sleep disorders among healthcare workers duirng the COVID-19 pandemic: a systematic review and meta- analysis. Neurosci. Biobehav. Rev. 2021; Marvaldi M, Mallet J, Dubertret C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774085 118. COVID-19 dynamics considering the influence of hospital infrastructure: an investigation into Brazilian scenarios. Nonlinear Dyn 2021:1-22Pacheco P, Savi MA, Savi PV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746362 119. The association between prior physical fitness and depression in young adults during the COVID-19 pandemic-a cross-sectional, retrospective study. PeerJ 2021; 9:e11091Dun Y, Ripley-Gonzalez JW, Zhou N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763311 120. Sex differences in maladaptive emotional and behavioral responses to COVID- 19: What is the role of personality? Pers. Individ. Dif. 2021; 178:110834DeGrace S, Baptist-Mohseni N, Single A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758454 121. Policymakers as safe havens: The relationship between adult attachment style, COVID-19 fear, and regulation compliance. Pers. Individ. Dif. 2021; 177:110832Segal S, Sharabany R, Maaravi Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746323 122. Factors associated with antenatal depression during the COVID-19 (SARS- CoV2) pandemic: A cross-sectional study in a cohort of Turkish pregnant women. Perspect. Psychiatr. Care 2021; Korukcu O, Ozkaya M, Boran OF, Bakacak M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772802 123. Evaluating the effects of shelter-in-place policies during the COVID-19 pandemic. Proc Natl Acad Sci U S A 2021; 118Berry CR, Fowler A, Glazer T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766888 124. Urgent Psychiatric Consultations at Mental Health Center during COVID-19 Pandemic: Retrospective Observational Study. Psychiatr. Q. 2021:1-19Di Lorenzo R, Fiore G, Bruno A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33772425 125. Canadian Adolescents' Internalized Symptoms in Pandemic Times: Association with Sociodemographic Characteristics, Confinement Habits, and Support. Psychiatr. Q. 2021:1-17Tardif-Grenier K, Archambault I, Dupéré V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768414 126. Brief psychotic disorder with delusion content related to the COVID-19 outbreak. Psychiatriki 2021; Marouda K, Mantonakis L, Kollias K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759811 127. [Violence in intimate partnerships and mental problems in children and adolescents]. Psychotherapeut (Berl) 2021:1-8Clemens V, Köhler-Dauner F, Keller F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758468 128. COVID-19 and social inequality. Public Health Forum 2021; 29:2-4Knöchelmann A, Richter M. 129. Inclusionary and diversity-sensitive Public Health in the COVID-19 response. Public Health Forum 2021; 29:22-26Tallarek M, Spallek J. 130. Temporary hospitals in times of the COVID pandemic. An example and a practical view. Rev. Esp. Quimioter. 2021; Candel FJ, Canora J, Zapatero A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752321 131. Depression, Anxiety, and Stress Symptoms and Its Associated Factors Among Residents of Gondar Town During the Early Stage of COVID-19 Pandemic. Risk Manag. Healthc. Policy 2021; 14:1073-1083Akalu TY, Gelaye KA, Bishaw MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758560 132. Greatest changes in objective sleep architecture during COVID-19 lockdown in night-owls with increased REM sleep. Sleep 2021; Pépin JL, Bailly S, Mordret E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769511 133. Efficacy of simplified-cognitive behavioral therapy for insomnia(S- CBTI) among female COVID-19 patients with insomnia symptom in Wuhan mobile cabin hospital. Sleep Breath 2021:1-7He J, Yang L, Pang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754249 134. Social Study Resources and Social Wellbeing Before and During the Intelligent COVID-19 Lockdown in The Netherlands. Soc Indic Res 2021:1-23van Zyl LE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758461 135. Sentiment analysis on the impact of coronavirus in social life using the BERT model. Soc Netw Anal Min 2021; 11:33Singh M, Jakhar AK, Pandey S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758630 136. Sleep characteristics of U.S. adults before and during the COVID-19 pandemic. Soc. Sci. Med. 2021; 276:113849Hisler GC, Twenge JM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773474 137. The well-being and perspectives of community-based behavioral health staff during the COVID-19 pandemic. Soc. Work Health Care 2021:1-14Morse GA, Dell NA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769214 138. cAIR: Implementation of peer response support for frontline health care workers facing the COVID-19 pandemic. Soc. Work Health Care 2021:1-10Rubin EW, Rassman A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761837 139. The Psychological Impact of the COVID-19 Pandemic Affected Decision- Making Processes. Span. J. Psychol. 2021; 24:e16Romero-Rivas C, Rodriguez- Cuadrado S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745483 140. COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism. Thromb Res 2021; 202:77-83Kirchberger I, Berghaus TM, von Scheidt W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33773325 141. Disruptions in the management and care of university students with preexisting mental health conditions during the COVID-19 pandemic. Transl. Behav. Med. 2021; Ligus K, Fritzson E, Hennessy EA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749756 142. Fear of COVID-19 and its associations with perceived personal and family benefits and harms in Hong Kong. Transl. Behav. Med. 2021; Sit SM, Lam TH, Lai AY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755146 143. Interferon system deficiencies exacerbating severe pandemic virus infections. Trends Microbiol. 2021; Stertz S, Hale BG. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757684 144. Effects of the COVID-19 Pandemic on Psychology and Disease Activity in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis. Turk J Med Sci 2021; Gica Ş, Akkubak Y, Aksoy ZK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33773523 145. Prenatal stress, health, and health behaviours during the COVID-19 pandemic: An international survey. Women Birth 2021; Pope J, Olander EK, Leitao S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757750

Meta-analyses - systematic reviews (21 articles)

1. Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis. Adv. Nutr. 2021; Kazemi A, Mohammadi V, Aghababaee SK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751020 2. Are saliva and deep throat sputum as reliable as common respiratory specimens for SARS-CoV-2 detection? A systematic review and meta-analysis. Am. J. Infect. Control 2021; Khiabani K, Amirzade-Iranaq MH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774101 3. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm. Med. 2021; 21:97So M, Kabata H, Fukunaga K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752639 4. Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Aden governorate, Yemen. BMJ Glob Health 2021; 6Koum Besson ES, Norris A, Bin Ghouth AS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758012 5. Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data. Cancer Lett. 2021; 508:30-46Kong X, Qi Y, Huang J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757803 6. COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2021; 33:100789Gerayeli FV, Milne S, Cheung C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758801 7. Covid-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis. Eur. J. Clin. Invest. 2021:e13559Gabbai-Armelin PR, de Oliveira AB, Ferrisse TM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33772772 8. Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis. F1000Res 2021; 10:73Nugroho CW, Suryantoro SD, Yuliasih Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763201 9. Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 8:647917Gratz J, Wiegele M, Maleczek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768106 10. The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis. Front Public Health 2021; 9:624559Teshome A, Adane A, Girma B, Mekonnen ZA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748066 11. Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta-analysis. Indian J. Hematol. Blood Transfus. 2021:1-19Prasad M, Seth T, Elavarasi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746378 12. COVID-19 autopsies of Istanbul. Ir. J. Med. Sci. 2021:1-13Arslan MN, Büyük Y, Ziyade N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755916 13. COVID-19 quarantine: Psychological impact and support for children and parents. Ital. J. Pediatr. 2021; 47:58Demaria F, Vicari S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750452 14. Nurses' burnout and associated risk factors during the COVID-19 pandemic: A systematic review and meta-analysis. J. Adv. Nurs. 2021; Galanis P, Vraka I, Fragkou D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764561 15. Continuation of an eating disorders day programme during the COVID-19 pandemic. J Eat Disord 2021; 9:34Plumley S, Kristensen A, Jenkins PE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750463 16. The characteristics of gastrointestinal symptoms in patients with severe COVID-19: a systematic review and meta-analysis. J. Gastroenterol. 2021:1- 12Hayashi Y, Wagatsuma K, Nojima M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33759041 17. IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta- regression. J Infect 2021; Tharmarajah E, Buazon A, Patel V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745918 18. The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metabolism 2021:154753Bassatne A, Basbous M, Chakhtoura M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774074 19. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis. Sci. Prog. 2021; 104:368504211000906Giri M, Puri A, Wang T, Guo S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752530 20. The efficacy of remote virtual care in comparison to traditional clinical visits for elective orthopaedic patients: A meta-analysis of prospective randomised controlled trials. Surgeon 2021; McDonnell JM, Ahern DP, Ross TD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762159 21. Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis. Ther. Adv. Respir. Dis. 2021; 15:17534666211007214Abeldaño Zuñiga RA, Coca SM, Abeldaño GF, González- Villoria RAM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765902

Mortality (22 articles)

1. Excess mortality in the United States in 2020: Forecasting and Anomaly Detection. Am. J. Infect. Control 2021; Wiemken TL, Rutschman AS, Niemotka S, Prener CG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774102 2. COVID-19 Mortality in California Based on Death Certificates: Disproportionate Impacts Across Racial/Ethnic Groups and Nativity. Ann. Epidemiol. 2021; Garcia E, Eckel SP, Chen Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746033 3. Finding the real COVID-19 case-fatality rates for SAARC countries. Biosaf Health 2021; Shah MRT, Ahammed T, Anjum A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748737 4. Cognitive Processing Therapy With an Older Woman Veteran During COVID- 19: A Case Study. Cogn. Behav. Pract. 2021; Sitz AL, Cogan CM, Davis JL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746499 5. COVID-19 deaths correlate with blood glucose level: The German Diabetes Society warns. Deutsche Apotheker Zeitung 2021; 161. 6. No cytokine storm thanks to alpha-1 blockers?: Tamsulosin and co. could reduce mortality of COVID-19 patients. Deutsche Apotheker Zeitung 2021; 161Bruhn C. 7. The J-shaped relationship between body mass index and mortality in patients with COVID-19: A dose-response meta-analysis. Diabetes Obes. Metab. 2021; Huang HK, Bukhari K, Peng CC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33764660 8. Regional Differences in Mortality Rates During the COVID-19 Epidemic in Italy. Disaster Med Public Health Prep 2020:1-7Azzolina D, Lorenzoni G, Silvestri L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750493 9. Correlates of in-hospital COVID-19 deaths: a competing risks survival time analysis of retrospective mortality data. Disaster Med Public Health Prep 2021:1- 27Goel A, Raizada A, Agrawal A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762056 10. Survival analysis and risk factors in COVID-19 patients. Disaster Med Public Health Prep 2021:1-15Lu W, Yu S, Liu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762058 11. Area-level indicators of income and total mortality during the COVID-19 pandemic. Eur. J. Public Health 2021; Colombo FR, Alicandro G, La Vecchia C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749735 12. Postmortem radiologic and pathologic findings in COVID-19: The Toronto experience with pre-hospitalization deaths in the community. Forensic Sci. Int. 2021; 322:110755Williams AS, Dmetrichuk JM, Kim P, Pollanen MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774384 13. Clinical characteristics and risk factors for mortality in cancer patients with COVID-19. Front Med 2021:1-11Liang J, Jin G, Liu T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754280 14. Unprecedented Reduction in Air Pollution and Corresponding Short-term Premature Mortality Associated with COVID-19 Lockdown in Delhi, India. J. Air Waste Manag. Assoc. 2021; Maji KJ, Namdeo A, Bell M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764280 15. Isaric 4c Mortality Score As A Predictor Of In-Hospital Mortality In Covid-19 Patients Admitted In Ayub Teaching Hospital During First Wave Of The Pandemic. J. Ayub Med. Coll. Abbottabad 2021; 33:20-25Ali R, Qayyum F, Ahmed N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774948 16. Clinical Characteristics, Mortality and Associated risk factors in COVID-19 patients reported in ten major hospitals of Khyber Pakhtunkhwa, Pakistan. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S633-s639UlHaq Z, Shahzad M, Khattak MI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754522 17. Risk of COVID-19 Infection, Hospitalization, and Mortality in Patients with Psoriasis Treated by Interleukin-17 Inhibitors. J Dermatolog Treat 2021:1- 28Kridin K, Schonmann Y, Solomon A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33759683 18. Acute kidney injury and mortality risk in older adults with COVID-19. J Nephrol 2021; Xu H, Garcia-Ptacek S, Annetorp M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751497 19. Excess Deaths Among Blacks and Latinx Compared to Whites During Covid- 19. J Racial Ethn Health Disparities 2021; Laurencin CT, Wu ZH, McClinton A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751484 20. Obesity, ethnicity and risk of critical care, mechanical ventilation and mortality in patients admitted to hospital with COVID-19: Analysis of the ISARIC CCP- UK cohort. Obesity (Silver Spring) 2021; Yates T, Zaccardi F, Islam N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755331 21. COVID-19 deaths among nurses: a cross-sectional study. Occup. Med. (Lond.) 2021; Keles E, Bektemur G, Baydili KN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33760072 22. Fatality and risk factors for severe courses of COVID-19 pneumonia. Pneumologe 2020; 17:385-393Flick H. Online – IT – Apps (52 articles)

1. Medical Histopathology Laboratories: Remote Teaching in Response to COVID-19 Pandemic. Acad Pathol 2021; 8:2374289521998049Sharma R, King TS, Hanson ER, Fiebelkorn K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763534 2. Telemedicine in allergology: practical aspects: A position paper of the Association of German Allergists (AeDA). Allergo J Int 2021:1-11Dramburg S, Walter U, Becker S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758744 3. Telemedicine for ear diseases with the smartphone otoscopes via WeChat in the COVID-19 era. Am. J. Otolaryngol. 2021; 42:102997Dai Z, Wang Y, Hang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770717 4. Brief videoconferencing psychological intervention for reducing COVID-19 related distress: study protocol for a randomized controlled trial. BMC Public Health 2021; 21:474Keyan D, Dawson K, Azevado S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750351 5. COVID-19: are the elderly prepared for virtual healthcare? BMJ Health Care Inform 2021; 28Ezzat A, Sood H, Holt J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753327 6. Feasibility of an online platform delivery of pulmonary rehabilitation for individuals with chronic respiratory disease. BMJ Open Respir Res 2021; 8Lewis A, Knight E, Bland M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762360 7. New digital models of care in ophthalmology, during and beyond the COVID-19 pandemic. Br J Ophthalmol 2021; Tham YC, Husain R, Teo KYC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753407 8. Twitter-based analysis reveals differential COVID-19 concerns across areas with socioeconomic disparities. Comput. Biol. Med. 2021; 132:104336Su Y, Venkat A, Yadav Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761419 9. Measuring the Patients' Satisfaction About Telemedicine Used in Saudi Arabia During COVID-19 Pandemic. Cureus 2021; 13:e13382Abdel Nasser A, Mohammed Alzahrani R, Aziz Fellah C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33754105 10. Is It Time to Consider Implementation of Telemedicine in Current Oral Health Care Services? Disaster Med Public Health Prep 2021:1-2Ilhan B, Bayrakdar IS, Baydar O, Guneri P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769240 11. Stigma against COVID-19 among health care workers in Indonesia. Disaster Med Public Health Prep 2021:1-12Yufika A, Pratama R, Anwar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762053 12. Socially-supportive norms and mutual aid of people who use opioids: An analysis of Reddit during the initial COVID-19 pandemic. Drug Alcohol Depend. 2021:108672Bunting AM, Frank D, Arshonsky J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757708 13. Virtual voice clinics in the COVID-19 era: have they been helpful? Eur Arch Otorhinolaryngol 2021:1-6Watters C, Miller B, Kelly M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760954 14. Media representation of older people's vulnerability during the COVID-19 pandemic in China. Eur J Ageing 2021:1-10Zhang J, Liu X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758584 15. Exploring Pediatric Tele-Rheumatology Practices During COVID-19: A Survey of the PRCOIN Network. Front Pediatr 2021; 9:642460Goh YI, Bullock DR, Taylor J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748049 16. Evaluating Patients' and Neonatologists' Satisfaction With the Use of Telemedicine for Neonatology Prenatal Consultations During the COVID-19 Pandemic. Front Pediatr 2021; 9:642369Lapadula MC, Rolfs S, Szyld EG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748048 17. Hope May Come From Internet in Times of COVID-19: Building an Online Programme for Grief (LIVIA). Front Psychiatry 2021; 12:626831Berthoud L, Efinger L, Kheyar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767639 18. A content analysis of newspaper coverage of COVID-19 pandemic for developing a pandemic management framework. Heliyon 2021; 7:e06544Zafri NM, Afroj S, Nafi IM, Hasan MMU. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758786 19. A global pandemic in the time of viral memes: COVID-19 vaccine misinformation and disinformation on TikTok. Hum Vaccin Immunother 2021:1- 5Basch CH, Meleo-Erwin Z, Fera J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33764283 20. A comparative online survey on the intention to get COVID-19 vaccine between Greek and Cypriot healthcare personnel: is the country a predictor? Hum Vaccin Immunother 2021:1-8Raftopoulos V, Iordanou S, Katsapi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754953 21. Influence of Online Social Support on the Public's Belief in Overcoming COVID-19. Inf. Process. Manag. 2021; 58:102583Yao Z, Tang P, Fan J, Luan J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746338 22. A Survey of Provider-Reported Use and Perceived Effectiveness of Medications for Symptom Management in Telemedicine and Outpatient Visits for Mild COVID-19. Infect Dis Ther 2021; O'Keefe JB, Newsom LC, Taylor TH, Jr. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748931 23. Protecting providers and patients: results of an Internet survey of health care workers' risk perceptions and ethical concerns during the COVID-19 pandemic. Int. J. Emerg. Med. 2021; 14:18O'Neal L, Heisler M, Mishori R, Haar RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761867 24. Prioritizing people and rapid learning in times of crisis: A virtual learning initiative to support health workers during the COVID-19 pandemic. Int. J. Health Plann. Manage. 2021; Engelbrecht B, Gilson L, Barker P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764595 25. Exploring parental experiences of virtual paediatric neurodevelopmental consultations. Ir. J. Med. Sci. 2021:1-2Finnegan R, Flynn A, Flanagan O. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755915 26. Prevalence of Internet-based addictive behaviors during COVID-19 pandemic: a systematic review. J. Addict. Dis. 2021:1-27Masaeli N, Farhadi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749537 27. The impact of Internet use during COVID-19 lockdown in Rwanda: a potential public health threat. J. Addict. Dis. 2021:1-5Ngamije J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771088 28. Telemedicine access and higher educational attainment. J. Am. Coll. Health 2021:1-4Hollowell A, Swartz JJ, Proudman R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33759736 29. Undergraduate students' perception and satisfaction regarding online learning system amidst COVID-19 Pandemic in Pakistan. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S644-s650Ansar F, Ali W, Khattak A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754524 30. Interest in aesthetics during COVID-19 pandemic: A Google trends analysis. J Cosmet Dermatol 2021; Elsaie ML, Youssef EA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759331 31. Application of photogrammetry in forensic pathology education of medical students in response to COVID-19. J. Forensic Sci. 2021; Tóth D, Petrus K, Heckmann V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764562 32. Attachment-based family therapy in the age of telehealth and COVID-19. J. Marital Fam. Ther. 2021; Levy S, Mason S, Russon J, Diamond G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749898 33. Transition of Nurse Practitioner Faculty Practice and Student Clinicals to Telehealth: Response to the COVID-19 Pandemic. J. Nurse Pract. 2021; 17:317- 321Diegel-Vacek L, Cotler K, Reising V, Corbridge SJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746647 34. Five Steps to Integrating Telehealth Into APRN Curricula. J. Nurse Pract. 2021; 17:322-325Guenther J, Branham S, Calloway S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746648 35. Telemedicine increases access to buprenorphine initiation during the COVID- 19 pandemic. J. Subst. Abuse Treat. 2021; 124:108272Wang L, Weiss J, Ryan EB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771276 36. Utilizing a health information exchange to facilitate COVID-19 VA primary care follow-up for Veterans diagnosed in the community. JAMIA Open 2021; 4:ooab020Sherman RL, Judon KM, Koufacos NS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748690 37. Digital health highlights 2020: Digitalization in the year of the pandemic. Kardiologe 2021; 15:153-159Reich C, Meder B. 38. Incidence of SARS-CoV-2 infection in close contacs. Telephone follow-up in Primary Care. Med Clin (Engl Ed) 2021; Baena-Díez JM, Pinnegar HP, Paredes- Millán MK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763599 39. Designing and Implementing a Novel Virtual Rounds Curriculum for Medical Students' Internal Medicine Clerkship During the COVID-19 Pandemic. MedEdPORTAL 2021; 17:11106Sukumar S, Zakaria A, Lai CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768143 40. Virtual visits for chronic neurologic disorders during COVID-19 pandemic. Neurol Sci 2021:1-4Rosellini I, Vianello M, Ghazaryan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774762 41. eLearning in Physical Therapy: Lessons Learned From Transitioning a Professional Education Program to Full eLearning During the COVID-19 Pandemic. Phys Ther 2021; Ng L, Seow KC, Mac Donald L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751113 42. Remote Forensic Psychological Assessment in Civil Cases: Considerations for Experts Assessing Harms from Early Life Abuse. Psychol. Inj. Law 2021:1- 15Goldenson J, Josefowitz N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758640 43. [Monitoring and telematic control of people with kidney transplant and suspected COVID-19 infection.]. Rev. Esp. Salud Publica 2021; 95Bach-Pascual A, Pedreira-Robles G, Pérez-Sáez MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33749667 44. Use of bot and content flags to limit the spread of misinformation among social networks: a behavior and attitude survey. Soc Netw Anal Min 2021; 11:32Lanius C, Weber R, MacKenzie WI, Jr. http://www.ncbi.nlm.nih.gov/pubmed/? term=33747252 45. Virtual family town hall: An innovative multi-family telehealth intervention during COVID-19. Soc. Work Health Care 2021:1-11Morey C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759733 46. The efficacy of remote virtual care in comparison to traditional clinical visits for elective orthopaedic patients: A meta-analysis of prospective randomised controlled trials. Surgeon 2021; McDonnell JM, Ahern DP, Ross TD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762159 47. Understanding Telemedicine's "New Normal": Variations in Telemedicine Use by Specialty Line and Patient Demographics. Telemed J E Health 2021; Drake C, Lian T, Cameron B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769092 48. COVID-19 and slowdown of residents' activity: Feedback from a novel e- learning event and overview of the literature. Urologia 2021:3915603211001253Calcagnile T, Sighinolfi MC, Sarchi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749385 49. Urologic Education in the Era of COVID-19: Results from a Webinar-Based Reconstructive Urology Lecture Series. Urology 2021; Omil-Lima D, Fernstrum A, Gupta K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766718 50. Telehealth Adoption Across Neurosurgical Subspecialties at a Single Academic Institution During the COVID-19 Pandemic. World Neurosurg 2021; Leung C, Wadhwa H, Sklar M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746106 51. Trends in neurosurgical teleconsultation services across the globe during COVID-19 pandemic. World Neurosurg 2021; Tandon V, Raheja A, Mishra S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757889 52. Online teaching in family medicine: A challenge. Z. Allgemeinmed. 2021; 97:88- 91Lukaschek K, Sanftenberg L, Friemel C et al

Other – Miscellaneous (80 articles)

1. When people do not 'Zol': Reduced emergency centre attendance of patients with chronic obstructive pulmonary disease during coronavirus disease 2019 lockdown with the accompanying tobacco sales ban in South Africa. Afr J Prim Health Care Fam Med 2021; 13:e1-e3Saieva P, Jenkins LS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764140 2. The effects of trained observers (dofficers) and audits during a facility-wide COVID-19 outbreak: a mixed-methods quality improvement analysis. Am. J. Infect. Control 2021; Picard C, Edlund M, Keddie C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774100 3. Lived experiences of frontline workers and leaders during COVID-19 outbreaks in long-term care: A qualitative study. Am. J. Infect. Control 2021; Yau B, Vijh R, Prairie J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762181 4. Shaping more resilient and just food systems: Lessons from the COVID-19 Pandemic. Ambio 2021; 50:782-793Sanderson Bellamy A, Furness E, Nicol P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748902 5. Prediction-based analysis on power consumption gap under long-term emergency: A case in China under COVID-19. Appl Energy 2021; 283:116339Huang L, Liao Q, Qiu R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753961 6. Supply chain design to tackle coronavirus pandemic crisis by tourism management. Appl Soft Comput 2021; 104:107217Motevalli-Taher F, Paydar MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746656 7. Injustice for the sake of public health: Freeing prisoners in Portugal during the COVID-19 pandemic. Bioethics 2021; Cordeiro-Rodrigues L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751606 8. The changing climates of global health. BMJ Glob Health 2021; 6Cousins T, Pentecost M, Alvergne A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758015 9. Symptom cluster is associated with prolonged return-to-play in symptomatic athletes with acute respiratory illness (including COVID-19): a cross-sectional study-AWARE study I. Br. J. Sports Med. 2021; Schwellnus M, Sewry N, Snyders C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753345 10. Healthy nutritional behavior during COVID-19 lockdown: A cross-sectional study. Clin Nutr ESPEN 2021; 42:132-137Al-Domi H, Al-Dalaeen A, Al-Rosan S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745566 11. Trajectories of eating behavior during COVID-19 lockdown: Longitudinal analyses of 22,374 adults. Clin Nutr ESPEN 2021; 42:158-165Herle M, Smith AD, Bu F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745572 12. The prevalence of malnutrition and analysis of related factors among adult patients with the Coronavirus Disease 2019 (COVID 19) in a tertiary government hospital: The MalnutriCoV study. Clin Nutr ESPEN 2021; 42:98- 104Larrazabal RB, Jr., Perez BMB, Masamayor EMI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745628 13. Are history of dietary intake and food habits of patients with clinical symptoms of COVID 19 different from healthy controls? A case-control study. Clin Nutr ESPEN 2021; 42:280-285Mohseni H, Amini S, Abiri B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745593 14. The 25th Anniversary of Laser Vision Correction in the United States. Clin. Ophthalmol. 2021; 15:1163-1172Joffe SN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762815 15. COVID-19 Pandemic and Balance of Constitutional Rights. Clin. Ter. 2021; 172:119-122Cioffi A, Ruggiero M, Rinaldi R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33763685 16. Risk and the Republican National Convention: Application of the Novel COVID-19 Operational Risk Assessment. Disaster Med Public Health Prep 2021:1-6Callaway D, Runge J, Mullen L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762039 17. Discrimination and Bias in State Triage Protocols Towards Populations with Intellectual Disabilities During the COVID-19 Pandemic. Disaster Med Public Health Prep 2021:1-10Felt AB, Mitcham D, Hathcock M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762036 18. Assessment of US Public School District Policies for Pandemic Preparedness and Implications for COVID-19 Response Activities. Disaster Med Public Health Prep 2020:1-7Kersten CA, Chamberlain AT, Jones SE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750506 19. Exclusion of SARS-CoV-2 from Two Maine Overnight Camps July-August 2020. Disaster Med Public Health Prep 2021:1-10Kowalsky RH, Fine S, Eisenberg M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762061 20. COVID-19 at War: the Joint Forces Operation in Ukraine. Disaster Med Public Health Prep 2021:1-20Quinn JM, Dhabalia TJ, Roslycky LL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762057 21. The Role of Celebrities During the COVID-19 Pandemic in Iran: Opportunity or Threat? Disaster Med Public Health Prep 2020:1-2Yoosefi Lebni J, Irandoost SF, Mehedi N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764286 22. Exploring eating and exercise-related indicators during COVID-19 quarantine in Portugal: concerns and routine changes in women with different BMI. Eat Weight Disord 2021; Coimbra M, Paixão C, Ferreira C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751463 23. The interplay between environmental exposures and COVID-19 risks in the health of children. Environ. Health 2021; 20:34Sly PD, Trottier BA, Bulka CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771185 24. Changes in health status, workload, and lifestyle after starting the COVID-19 pandemic: a web-based survey of Japanese men and women. Environ. Health Prev. Med. 2021; 26:37Suka M, Yamauchi T, Yanagisawa H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752603 25. Stronger secondary pollution processes despite decrease in gaseous precursors: A comparative analysis of summer 2020 and 2019 in Beijing. Environ Pollut 2021; 279:116923Li H, Ma Y, Duan F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751950 26. The impacts of COVID-19 lockdown on PM(10) and SO(2) concentrations and association with human mobility across Turkey. Environ. Res. 2021:111018Orak NH, Ozdemir O. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745929 27. Does air pollution upsurge in megacities after Covid-19 lockdown? A spatial approach. Environ. Res. 2021; 197:111052Shehzad K, Xiaoxing L, Ahmad M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753079 28. Impact of the COVID-19 lockdown period on surface water quality in the Meriç- Ergene River Basin, Northwest Turkey. Environ. Res. 2021; 197:111051Tokatlı C, Varol M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753075 29. COVID-19-Induced Lockdowns Indicate the Short-Term Control Effect of Air Pollutant Emission in 174 Cities in China. Environ. Sci. Technol. 2021; Lu D, Zhang J, Xue C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769804 30. Intravitreal injections during COVID-19 outbreak: Protective measures, total duration of care and perceived quality of care in a tertiary retina center. Eur. J. Ophthalmol. 2021:11206721211003488Denys P, Miere A, Colantuono D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752454 31. Disease History and Life History Predict Behavioral Control of the COVID-19 Pandemic. Evol Psychol 2021; 19:14747049211000714Lu HJ, Liu YY, O J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752457 32. An interview with Luc Provost, CEO of B Medical Systems By Felicity Poole, Commissioning Editor. Expert Rev Vaccines 2021; Provost L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749475 33. State-level COVID-19 Outbreak and Stock Returns. Financ Res Lett 2021:102002Pham AV, Adrian C, Garg M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758580 34. Surveying the impact of the coronavirus (COVID-19) on the poultry supply chain: A mixed methods study. Food Control 2021; 126:108084Palouj M, Lavaei Adaryani R, Alambeigi A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758470 35. Assessment of the Immediate and Potential Long-Term Effects of COVID-19 Outbreak on Socioeconomics, Agriculture, Security of Food and Dietary Intake in Nigeria. Food Ethics 2021; 6:5Obayelu AE, Obayelu OA, Bolarinwa KK, Oyeyinka RA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758778 36. The Impact of Lockdown During the COVID-19 Outbreak on Dietary Habits in Various Population Groups: A Scoping Review. Front Nutr 2021; 8:626432Bennett G, Young E, Butler I, Coe S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748175 37. The Timing, Nature and Extent of Social Media Marketing by Unhealthy Food and Drinks Brands During the COVID-19 Pandemic in New Zealand. Front Nutr 2021; 8:645349Gerritsen S, Sing F, Lin K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748177 38. Changes in Food Consumption During the COVID-19 Pandemic: Analysis of Consumer Survey Data From the First Lockdown Period in Denmark, Germany, and Slovenia. Front Nutr 2021; 8:635859Janssen M, Chang BPI, Hristov H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763443 39. The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the COVID-19 Pandemic-Perspectives of NECPAM Members. Front Psychiatry 2021; 12:634515Dannatt L, Ransing R, Calvey T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762979 40. Sporting Resilience During COVID-19: What Is the Nature of This Adversity and How Are Competitive Elite Athletes Adapting? Front. Psychol. 2021; 12:611261Gupta S, McCarthy PJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746833 41. Analysis of the Tradeoff Between Health and Economic Impacts of the Covid- 19 Epidemic. Front Public Health 2021; 9:620770Lasaulce S, Zhang C, Varma V, Morărescu IC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748065 42. [Gender invisibility in the COVID-19 management: who are the policy decision- makers during the pandemic?]. Gac. Sanit. 2021; Bacigalupe A, Cabezas- Rodríguez A, Giné-March A, Jiménez M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757690 43. The necropolitics of COVID-19: Race, class and slow death in an ongoing pandemic. Glob Public Health 2021:1-13Sandset T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761846 44. Does a Public Health Crisis Justify More Research with Incarcerated People? Hastings Cent Rep 2021; Reiter K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33755216 45. Global health diplomacy at the intersection of trade and health in the COVID- 19 era. Health Promot Perspect 2021; 11:1-4Chattu VK, Pooransingh S, Allahverdipour H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758749 46. Dam if You Do, Dam if You Don't: Politics and Floods in the Shadow of COVID- 19 in Sudan. Health Secur 2021; Modber M, Ahmadi A, Mogessie YG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756083 47. COVID-19, a critical juncture in China's wildlife protection? Hist Philos Life Sci 2021; 43:46Xu J, Mei F, Lu C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768363 48. Current perspectives of biomedical waste management in context of COVID- 19". Indian J. Med. Microbiol. 2021; Capoor MR, Parida A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766404 49. Unprecedented Reduction in Air Pollution and Corresponding Short-term Premature Mortality Associated with COVID-19 Lockdown in Delhi, India. J. Air Waste Manag. Assoc. 2021; Maji KJ, Namdeo A, Bell M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764280 50. How has the pandemic lockdown changed our daily facial skin care habits? J Cosmet Dermatol 2021; Scieszko E, Budny E, Rotsztejn H, Erkiert-Polguj A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751765 51. Water science under the global epidemic of COVID-19: Bibliometric tracking on COVID-19 publication and further research needs. J Environ Chem Eng 2021; 9:105357Ji B, Zhao Y, Wei T, Kang P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33747765 52. Effect of COVID-19 pandemic on medical waste management: a case study. J Environ Health Sci Eng 2021:1-6Kalantary RR, Jamshidi A, Mofrad MMG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758671 53. Impact of outdoor and indoor meteorological conditions on the COVID-19 transmission in the western region of Saudi Arabia. J. Environ. Manage. 2021; 288:112392Habeebullah TM, Abd El-Rahim IHA, Morsy EA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765578 54. Afforestation, reforestation and new challenges from COVID-19: Thirty-three recommendations to support civil society organizations (CSOs). J. Environ. Manage. 2021; 287:112277Mohan M, Rue HA, Bajaj S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756214 55. Changes in smoking behavior since the declaration of the COVID-19 state of emergency in Japan : A cross sectional study from the Osaka health app. J. Epidemiol. 2021; Koyama S, Tabuchi T, Okawa S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746148 56. Exposure Profile of SARS-CoV-2 in Canadian Food Sources. J. Food Prot. 2021; Rose-Martel M, Tompkins E, Rutley R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33770187 57. Americans' View of the Impact of COVID-19: Perspectives on Racial Impacts and Equity. J. Health Polit. Policy Law 2021; Carman K, Chandra A, Miller C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765152 58. Compounding Racialized Vulnerability: COVID-19 in Prisons, Jails, and Migrant Detention Centers. J. Health Polit. Policy Law 2021; Denney MGT, Garibaldo Valdez R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765154 59. Unsanitized and Unfair: How COVID-19 Bailout Funds Refuel Inequity in the U.S. Health Care System. J. Health Polit. Policy Law 2021; Grogan CM, Gusmano MK, Lin YA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765137 60. Human Rights of Forced Migrants During the COVID-19 Pandemic: An Opportunity for Mobilization and Solidarity. J Hum Rights Soc Work 2021:1- 13Libal K, Harding S, Popescu M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758779 61. Robots do not get the coronavirus: The COVID-19 pandemic and the international division of labor. J Int Bus Stud 2021:1-10Brakman S, Garretsen H, van Witteloostuijn A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758437 62. Workers' Compensation, Return to Work, Behavioural Health and COVID-19 in Australia. J. Law Med. 2021; 28:546-566Guthrie R, Aurbach R, Ciccarelli M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768758 63. How can we weather a virus storm? Health prediction inspired by meteorology could be the answer. J Transl Med 2021; 19:102Buizza R, Capobianco E, Moretti PF, Vineis P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750382 64. The Intersection of Work and Home Challenges Faced by Physician Mothers During the Coronavirus Disease 2019 Pandemic: A Mixed-Methods Analysis. J Womens Health (Larchmt) 2021; Halley MC, Mathews KS, Diamond LC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761277 65. Lockdown measures and air quality: evidence from Italian provinces. Lett Spat Resour Sci 2021:1-10Malpede M, Percoco M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758625 66. The behavioral immune system and conservatism as predictors of disease- avoidant attitudes during the COVID-19 pandemic. Pers. Individ. Dif. 2021; 178:110857Kempthorne JC, Terrizzi JA, Jr. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758455 67. SARS-CoV-2-pandemic in Germany: Economic importance for the German health care system. Public Health Forum 2021; 29:5-7Greß S, Jesberger C. 68. Clinical Adjustments During COVID-19 for Outpatient Substance Use Treatment in a Sample of Men Who Have Sex With Men. Public Health Rep. 2021:333549211006984Arnold T, Rogers BG, Schierberl Scherr A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765394 69. Household time activities, food waste, and diet quality: the impact of non- marginal changes due to COVID-19. Rev Econ Househ 2021:1-30Scharadin B, Yu Y, Jaenicke EC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746659 70. Legal and Health Response to COVID-19 in the Arab Countries. Risk Manag. Healthc. Policy 2021; 14:1141-1154Falah Hasan H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758566 71. Predictors of Health-Care Workers' Unwillingness to Continue Working During the Peak of COVID-19 in Western Ethiopia: An Extended Parallel-Process Model Study. Risk Manag. Healthc. Policy 2021; 14:1165-1173Woyessa AH, Oluma A, Palanichamy T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762859 72. Clustering Patterns Connecting COVID-19 Dynamics and Human Mobility Using Optimal Transport. Sankhya B (2008) 2021:1-18Nielsen F, Marti G, Ray S, Pyne S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746458 73. Marginal warming associated with a COVID-19 quarantine and the implications for disease transmission. Sci Total Environ 2021; 780:146579Miller PW, Reesman C, Grossman MK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774300 74. Ozone profile retrievals from TROPOMI: Implication for the variation of tropospheric ozone during the outbreak of COVID-19 in China. Sci Total Environ 2021; 764:142886Zhao F, Liu C, Cai Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757247 75. Supporting families struggling with food insecurity during the COVID-19 pandemic: An innovative cross-sector collaboration. Soc. Work Health Care 2021:1-9Fuss AA, Bloch HI, Dean-Assael K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752580 76. COVID-19 effects on shared-biking in New York, Boston, and Chicago. Transp Res Interdiscip Perspect 2021; 9:100282Padmanabhan V, Penmetsa P, Li X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748743 77. Residual antimicrobial agents in food originating from animals. Trends Food Sci Technol 2021; 111:141-150Hassan MM, El Zowalaty ME, Lundkvist Å et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746363 78. Women and Minorities Encouraged to Apply (Not Stay). Trends Genet. 2021; Windsor LC, Crawford KF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771351 79. A comprehensive interdisciplinary view at the Return to Sport after COVID-19 infection. Vnitr. Lek. 2021; 67:14-21Hrdlička F, Větvička J, Bendová V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752396 80. Analysis of plastic waste reduction and recycling in Taiwan. Waste Manag. Res. 2021:734242x21996821Tsai WT. http://www.ncbi.nlm.nih.gov/pubmed/? term=33749391

Pathology (11 articles) 1. Does air pollution upsurge in megacities after Covid-19 lockdown? A spatial approach. Environ. Res. 2021; 197:111052Shehzad K, Xiaoxing L, Ahmad M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753079 2. Postmortem radiologic and pathologic findings in COVID-19: The Toronto experience with pre-hospitalization deaths in the community. Forensic Sci. Int. 2021; 322:110755Williams AS, Dmetrichuk JM, Kim P, Pollanen MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774384 3. Corrigendum: Protecting Healthcare Workers Amid the COVID-19 Crisis: A Safety Protocol in Wuhan. Front Public Health 2021; 9:660323Liu Y, Yang S, Hung M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763403 4. Post COVID-19 large pneumatocele: clinical and pathological perspectives. Interact. Cardiovasc. Thorac. Surg. 2021; Hamad AM, El-Saka HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764376 5. COVID-19 autopsies of Istanbul. Ir. J. Med. Sci. 2021:1-13Arslan MN, Büyük Y, Ziyade N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755916 6. Cytologic findings in effusions from patients with SARS-CoV-2 infection. J Am Soc Cytopathol 2021; Cantley RL, Hrycaj S, Konopka K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753013 7. Aerosol formation due to a dental procedure: insights leading to the transmission of diseases to the environment. J R Soc Interface 2021; 18:20200967Mirbod P, Haffner EA, Bagheri M, Higham JE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757291 8. Histopathological features in fatal COVID-19 acute respiratory distress syndrome. Med. Intensiva 2021; Merdji H, Mayeur S, Schenck M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766409 9. Detection methods for SARS-CoV-2 in tissue. Pathologe 2021:1-8von Stillfried S, Boor P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770236 10. Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study. Thorax 2021; Pérez-Mies B, Gómez-Rojo M, Carretero-Barrio I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758071 11. Immune dysregulation and system pathology in COVID-19. Virulence 2021; 12:918-936Jamal M, Bangash HI, Habiba M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757410

Protection (33 articles)

1. Time for a renewed focus on the role of cleaners in achieving safe health care in low- and middle-income countries. Antimicrob Resist Infect Control 2021; 10:59Storr J, Kilpatrick C, Lee K. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762000 2. The Cupola: an additional layer of protection for providers working in the oropharyngeal region. BMC Res. Notes 2021; 14:115Villa A, Grenon M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766095 3. Beyond PPE: a mixed qualitative-quantitative study capturing the wider issues affecting doctors' well-being during the COVID-19 pandemic. BMJ Open 2021; 11:e050223Cubitt LJ, Im YR, Scott CJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753449 4. Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant. Build. Environ. 2021; 196:107788Li Y, Qian H, Hang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746341 5. Concerns with and recommendations for COVID-19 research related to asymptomatic infection and mask wearing. Clin Infect Dis 2021; Escandón K, Ulrich AK, Chou R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754646 6. Death by hand sanitizer: syndemic methanol poisoning in the age of COVID- 19. Clin. Toxicol. (Phila.) 2021:1-6Holzman SD, Larsen J, Kaur R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755514 7. Dermatological findings in patients admitting to dermatology clinic after using face masks during Covid-19 pandemia: A new health problem. Dermatol Ther 2021:e14934Esra İ D, Ferit K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751746 8. Mask wearing hesitancy during the COVID-19 pandemic in south Iran. Disaster Med Public Health Prep 2021:1-12Asadi-Pooya AA, Nezafat A, Sadeghian S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750513 9. Public knowledge and adherence to hand hygienic guidelines for the prevention of SARS-CoV-2 transmission: A cross-sectional survey from Pakistan. Disaster Med Public Health Prep 2021:1-16Yaseen MO, Saif A, Khan TM, Yaseen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762050 10. Effective Nasal Disinfection as an Overlooked Strategy in Our Fight against COVID-19. Ear Nose Throat J 2021:1455613211002929Ferrer G, Sanchez- Gonzalez MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765853 11. Risk for Fomite-Mediated Transmission of SARS-CoV-2 in Child Daycares, Schools, Nursing Homes, and Offices. Emerg Infect Dis 2021; 27:1229- 1231Kraay ANM, Hayashi MAL, Berendes DM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755002 12. How face masks influence the sinonasal quality of life during the COVID-19 pandemic. Eur Arch Otorhinolaryngol 2021:1-7Primov-Fever A, Amir O, Roziner I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772607 13. Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19. Eur. J. Clin. Pharmacol. 2021:1-19Suzy H, Levi H, Guido V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772626 14. Intravitreal injections during COVID-19 outbreak: Protective measures, total duration of care and perceived quality of care in a tertiary retina center. Eur. J. Ophthalmol. 2021:11206721211003488Denys P, Miere A, Colantuono D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752454 15. Noncompliance with Masking as a Coalitional Signal to US Conservatives in a Pandemic. Evol Psychol Sci 2021:1-7Boykin K, Brown M, Macchione AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747752 16. Corrigendum: Protecting Healthcare Workers Amid the COVID-19 Crisis: A Safety Protocol in Wuhan. Front Public Health 2021; 9:660323Liu Y, Yang S, Hung M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763403 17. COVID-19 transmission following outpatient endoscopy during pandemic acceleration phase involving SARS-CoV-2 VOC 202012/01 variant in UK. Gut 2021; Hayee B, Bhandari P, Rees CJ, Penman I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762432 18. COVID-19 and the reenactment of mass masking in South Korea. Hist Philos Life Sci 2021; 43:44Kim H, Choi H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768345 19. Spatial analysis of the impact of UVGI technology in occupied rooms using ray-tracing simulation. Indoor Air 2021; Hou M, Pantelic J, Aviv D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772881 20. Protecting providers and patients: results of an Internet survey of health care workers' risk perceptions and ethical concerns during the COVID-19 pandemic. Int. J. Emerg. Med. 2021; 14:18O'Neal L, Heisler M, Mishori R, Haar RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761867 21. Mask use, risk mitigation behaviours and pandemic fatigue during the COVID- 19 pandemic in five cities in Australia, the UK and USA: a cross-sectional survey. Int J Infect Dis 2021; MacIntyre CR, Nguyen PY, Chughtai AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771668 22. The Application of Hazard Vulnerability Analysis in the Prevention and Control of COVID-19 in Medical Institutions. Iran J. Public Health 2021; 50:271-279Ma L, Zou S, Liu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747990 23. Can ozone inactivate SARS-CoV-2? A review of mechanisms and performance on viruses. J. Hazard. Mater. 2021; 415:125658Bayarri B, Cruz-Alcalde A, López- Vinent N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752085 24. Use of Chlorhexidine to Eradicate Oropharyngeal SARS-CoV-2 in COVID-19 Patients. J Med Virol 2021; Hanna Huang Y, Huang JT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755218 25. Preparedness and attitude toward personal protective equipment among house officers during COVID-19 pandemic in Egypt. J Public Health (Oxf) 2021; Ahmed Sayed A, Mostafa Ahmed M, Talaat Elsayed I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765145 26. Mask is a must: the need of protection and safety against COVID-19. J Public Health (Oxf) 2021; Punsalan MLD, Salunga AT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765146 27. Can povidone Iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update. Jpn. Dent. Sci. Rev. 2021; Chopra D, Sivaraman K, Radhakrishnan R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33747261 28. Risk of COVID-19 Infection in Healthcare Workers Exposed During Use of Non- invasive Ventilation in a Tertiary Care Hospital in Oman. Oman Med. J. 2021; 36:e236Al Lawati A, Khamis F, Al Habsi S, Al Dalhami K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768967 29. Viral Infectivity in Patients Undergoing Tracheotomy With COVID-19: A Preliminary Study. Otolaryngol Head Neck Surg 2021:1945998211004255George MM, McIntyre CJ, Zhou J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752547 30. Engineering laminated paper for SARS-CoV-2 medical gowns. Polymer (Guildf) 2021; 222:123643Hossain L, Maliha M, Barajas-Ledesma R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758430 31. Evaluation of supercritical CO(2) sterilization efficacy for sanitizing personal protective equipment from the coronavirus SARS-CoV-2. Sci Total Environ 2021; 780:146519Bennet D, Harris AF, Lacombe J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774282 32. COVID-19 infection risk by open and laparoscopic surgical smoke: A systematic review of the literature. Surgeon 2021; Antunes D, Lami M, Chukwudi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757651 33. Negative Pressure Assisted Micro-Environment Surgical Hood (NEPA-MESH): A novel cost-effective device to minimize aerosol contamination during neurosurgical procedures, in times of COVID-19. World Neurosurg 2021; Patir R, Sreenivasan SA, Vaishya S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746105

Pulmonary disease (18 articles)

1. Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section. Allergy 2021; Eguiluz-Gracia I, van den Berge M, Boccabella C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772815 2. A rare complication of Covid-19: Spontaneous pneumothorax following pneumomediastinum; case report. Am J Emerg Med 2021; Bozan Ö, Atiş Ş E, Çekmen B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750666 3. Implications of pre-existing asthma on COVID-19 pathogenesis. Am J Physiol Lung Cell Mol Physiol 2021; Ramakrishnan RK, Al Heialy S, Hamid Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759572 4. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm. Med. 2021; 21:97So M, Kabata H, Fukunaga K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752639 5. Pneumomediastinum in patients with SARS-CoV-2 treated with non-invasive ventilation. BMJ Case Rep. 2021; 14Thein OS, Niazi M, Ali A, Sahal A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758053 6. Letter to the editor: Respiratory rehabilitation in elderly patients with COVID- 19: A randomized controlled study. Complement. Ther. Clin. Pract. 2021:101368Bressi B, Paltrinieri S, Fugazzaro S, Costi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762161 7. Reduction of Severe Exacerbations of COPD during COVID-19 Pandemic in Portugal: A Protective Role of Face Masks? Copd 2021:1-9Faria N, Costa MI, Gomes J, Sucena M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764237 8. COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2021; 33:100789Gerayeli FV, Milne S, Cheung C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758801 9. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 2021; Szabo PA, Dogra P, Gray JI et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33765436 10. Post COVID-19 large pneumatocele: clinical and pathological perspectives. Interact. Cardiovasc. Thorac. Surg. 2021; Hamad AM, El-Saka HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764376 11. Hemopneumothorax as an Unusual and Delayed Complication of Coronavirus Disease 2019 Pneumonia. J Chest Surg 2021; Sayan M, Turk MS, Ozkan D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767017 12. Recurrent COVID-19 in Hemodialysis: A Case Report of 2 Possible Reinfections. Kidney Med 2021; Krishna VN, Ahmad M, Overton ET, Jain G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748738 13. Early stage nonclinical pulmonary disorder in COVID-19 may present asymptomatic and fuel the contagion. Mil Med Res 2021; 8:22Adedokun KA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761986 14. Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacol. Ther. 2021:107839Liu G, Philp AM, Corte T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774068 15. Pneumonia in old age. Pneumologe 2021; Frohnhofen H, Stieglitz S. 16. [Pneumonia in old age]. Pneumologe (Berl) 2021:1-6Frohnhofen H, Stieglitz S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746676 17. COVID-19 Vaccination in Asthma Patients Treated with Biologicals: Statement of the Austrian Society of Pneumology and German Respiratory Society. Pneumologie 2021; Idzko M, Buhl R, Eber E et al. 18. [COVID-19, severe asthma, and biologic]. Rev. Mal. Respir. 2021; Underner M, Taillé C, Peiffer G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771438

Renal disease (17 articles)

1. Mass Screening Is Associated with Low Rates of Acute Kidney Injury among COVID-19 Patients in Hong Kong. Am. J. Nephrol. 2021:1-12Chan KW, Hung IF, Tsang OT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765681 2. Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy. Anaesth Crit Care Pain Med 2021:100841Attallah N, Gupta S, Madhyastha R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746074 3. COVID-19 progression in kidney transplant recipients: a single-center case series. CEN Case Rep 2021:1-6Rahimzadeh H, Keykhaei M, Razeghi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770414 4. Renal failure and lung hemorrhage as a presentation of COVID-19 infection, a case report. Clin Case Rep 2021; 9:1123-1129Zamani N, Aloosh O, Ahsant S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768795 5. Estimated Impact of Novel Coronavirus-19 and Transplant Center Inactivity on ESRD-related Patient Mortality in the United States. Clin. Transplant. 2021:e14292Peters TG, Bragg-Gresham JL, Klopstock AC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749935 6. Heterogeneous Recommendations for School Attendance in Children With Chronic Kidney Diseases During the COVID-19 Pandemic in Europe. Front Pediatr 2021; 9:646595Schild R, Hopf L, Loos S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748050 7. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail. Rev. 2021:1-11Castiello T, Georgiopoulos G, Finocchiaro G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761041 8. Prevalence of SARS-CoV-2 Specific Antibodies in Asymptomatic Hemodialysis Patients. Immunol. Invest. 2021:1-12Etemadi J, Bordbar S, Soltani-Zangbar MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752550 9. Successful automated peritoneal dialysis (APD) in a COVID-19 positive chronic kidney disease (CKD) stage 5 patient with acalculous pancreatitis with NO detectable virus in the dialysate effluent. Indian J. Med. Microbiol. 2020; Abraham G, Rohit A, Mathew M, Parthasarathy R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745748 10. Acute kidney injury and mortality risk in older adults with COVID-19. J Nephrol 2021; Xu H, Garcia-Ptacek S, Annetorp M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751497 11. Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors. Kidney Blood Press. Res. 2021:1-5Cahova M, Kveton M, Petr V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756485 12. The COVID-19 Epidemic: Management and Outcomes of Hemodialysis and Peritoneal Dialysis Patients in Stockholm, Sweden. Kidney Blood Press. Res. 2021:1-7Smolander J, Bruchfeld A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774645 13. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection. Kidney Int 2021; Clarke CL, Prendecki M, Dhutia A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774082 14. Looking back and moving forward. Kidney Int 2021; 99:787-790Ronco P, Rovin BH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745543 15. Outcome and Determinants of Outcome of COVID-19 Infection amongst Hemodialysis Patients: Findings from a National Dialysis Network Program in India. Kidney Int Rep 2021; Kakkanattu TJ, Sankarasubbaiyan S, Yadav AK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748552 16. [Monitoring and telematic control of people with kidney transplant and suspected COVID-19 infection.]. Rev. Esp. Salud Publica 2021; 95Bach-Pascual A, Pedreira-Robles G, Pérez-Sáez MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33749667 17. Impact of Impaired Kidney Function on Outcomes of Nigerians with COVID-9 Infection: Report of Two Cases from the University College Hospital, Ibadan. West Afr. J. Med. 2021; 38:292-296Raji YR, Ajayi SO, Abiola BI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767423

Reviews (38 articles)

1. Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy. Biomed. Pharmacother. 2021; 138:111518Mirtaleb MS, Mirtaleb AH, Nosrati H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774315 2. How do we share data in COVID-19 research? A systematic review of COVID- 19 datasets in PubMed Central Articles. Brief. Bioinform. 2021; 22:800-811Zuo X, Chen Y, Ohno-Machado L, Xu H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757278 3. COVID-19: Prolonged viral shedding in an HIV patient with literature review of risk factors for prolonged viral shedding and its implications for isolation strategies. Clin Case Rep 2021; 9:1397-1401Yousaf M, Hameed M, Alsoub H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768853 4. Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations. Clin. Nutr. 2021; 40:1637-1643Cava E, Neri B, Carbonelli MG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765600 5. Effects of vitamin supplements on clinical cardiovascular outcomes: Time to move on! - A comprehensive review. Clin Nutr ESPEN 2021; 42:1-14Simsek B, Selte A, Egeli BH, Çakatay U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745562 6. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review. Clin Rheumatol 2021; Soy M, Keser G, Atagunduz P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751280 7. Mucosal Respiratory Syndrome: A Systematic Literature Review. Dermatology 2021:1-7De Luigi G, Meoli M, Zgraggen L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774629 8. CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine. Drug Metab Pers Ther 2021; Salem Hareedy M, Rashad SM, Hetta HF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770833 9. Assessing the Indirect Effects of COVID-19 on Healthcare Delivery, Utilization, and Health Outcomes: A Scoping Review. Eur. J. Public Health 2021; Roy CM, Bollman EB, Carson LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755130 10. A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms. Excli j 2021; 20:339- 365Langarizadeh MA, Ranjbar Tavakoli M, Abiri A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746666 11. Coronavirus (SARS-CoV-2) in gastroenterology and its current epidemiological situation: An updated review until January 2021. Excli j 2021; 20:366-385Nabil A, Elshemy MM, Uto K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746667 12. Sonographic Diagnosis of COVID-19: A Review of Image Processing for Lung Ultrasound. Front Big Data 2021; 4:612561McDermott C, Łącki M, Sainsbury B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748752 13. Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives. Front Mol Biosci 2021; 8:604447Vivekanandhan K, Shanmugam P, Barabadi H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33763450 14. The Impact of Lockdown During the COVID-19 Outbreak on Dietary Habits in Various Population Groups: A Scoping Review. Front Nutr 2021; 8:626432Bennett G, Young E, Butler I, Coe S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748175 15. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come? Front. Pharmacol. 2021; 12:632677Indari O, Jakhmola S, Manivannan E, Jha HC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762954 16. Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review. Front. Pharmacol. 2020; 11:585331Lem FF, Opook F, Lee DJH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746739 17. Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials. Futur J Pharm Sci 2021; 7:67Raju R, V P, Biatris PS, J S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754123 18. Politics of disease control in Africa and the critical role of global health diplomacy: A systematic review. Health Promot Perspect 2021; 11:20-31Chattu VK, Knight WA, Adisesh A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758752 19. Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies. Hypertens. Res. 2021; Kai H, Kai M, Niiyama H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750913 20. One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms. Int. J. Audiol. 2021:1-11Almufarrij I, Munro KJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750252 21. A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase. Int. J. Biol. Macromol. 2021; Khan S, Attar F, Bloukh SH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766591 22. Main Factors Affecting the Readiness and Responsiveness of Healthcare Systems during Epidemic Crises: A Scoping Review on Cases of SARS, MERS, and COVID-19. Iran J Med Sci 2021; 46:81-92Mohammadpour M, Zarifinezhad E, Ghanbarzadegan A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753952 23. Basics of Developing a COVID-19 Reopening Roadmap: A Systematic Scoping Review. Iran J. Public Health 2021; 50:232-244Askarian M, Groot G, Taherifard E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747987 24. Prevalence of Internet-based addictive behaviors during COVID-19 pandemic: a systematic review. J. Addict. Dis. 2021:1-27Masaeli N, Farhadi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749537 25. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications. J Am Coll Surg 2021; Meizoso JP, Moore HB, Moore EE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766727 26. SARS-CoV2 Outbreak: Emergence, transmission and clinical features of human coronaviruses. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S710- s713Imran M, Yasmeen R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754539 27. Cardiac surgery outcome during the COVID-19 pandemic: a retrospective review of the early experience in nine UK centres. J. Cardiothorac. Surg. 2021; 16:43Sanders J, Akowuah E, Cooper J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33752706 28. Outcomes of diagnosed COVID-19 cancer patients: concerning results of a systematic review. J. Chemother. 2021:1-10Nahshon C, Segev Y, Schmidt M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769233 29. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J. Endocrinol. Invest. 2021:1-14Lisco G, De Tullio A, Jirillo E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765288 30. Can ozone inactivate SARS-CoV-2? A review of mechanisms and performance on viruses. J. Hazard. Mater. 2021; 415:125658Bayarri B, Cruz-Alcalde A, López- Vinent N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752085 31. JMM Profile: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). J. Med. Microbiol. 2021; 70Inglis TJJ, Mathee K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759741 32. Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges. Leuk Res Rep 2021; 15:100239Roosta Y, Behzadi F, Askari E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747763 33. Nervous System Involvement in COVID-19: a Review of the Current Knowledge. Mol. Neurobiol. 2021; Norouzi M, Miar P, Norouzi S, Nikpour P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765290 34. The virology of SARS-CoV-2. Pneumologe 2020; 17:378-384Hoehl S, Ciesek S. 35. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models. Rev Med Virol 2021; Egilmezer E, Rawlinson WD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763936 36. Extracorporeal membrane oxygenation for coronavirus disease 2019- associated acute respiratory distress syndrome: Report of two cases and review of the literature. World J Clin Cases 2021; 9:1953-1967Wen JL, Sun QZ, Cheng Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748247 37. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J. Diabetes 2021; 12:215-237Viswanathan V, Puvvula A, Jamthikar AD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758644 38. One year of COVID - An end in sight? Z. Allgemeinmed. 2021; 97:1-3Kochen MM, Kaduszkiewicz H, Niebling W, Rabady S.

Risk factors (63 articles)

1. Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis. Adv. Nutr. 2021; Kazemi A, Mohammadi V, Aghababaee SK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751020 2. Association of body mass index with severity and mortality of COVID-19 pneumonia: a two-center, retrospective cohort study from Wuhan, China. Aging (Albany NY) 2021; 13Wu X, Li C, Chen S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761466 3. Implications of pre-existing asthma on COVID-19 pathogenesis. Am J Physiol Lung Cell Mol Physiol 2021; Ramakrishnan RK, Al Heialy S, Hamid Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759572 4. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality. Ann Intensive Care 2021; 11:50Lim A, Radujkovic A, Weigand MA, Merle U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751264 5. Risk assessment and management among frontline nurses in the context of the COVID-19 virus in the northern region of the Kingdom of Saudi Arabia. Appl. Nurs. Res. 2021; 58:151410Albaqawi HM, Pasay-An E, Mostoles R, Jr., Villareal S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745558 6. Significance of Chronic Diseases and Smoking Behavior in the Development of Acute Respiratory Distress Syndrome Among Hospitalized COVID-19 Patients in Indonesia. Asia Pac. J. Public Health 2021:10105395211002624Rachmawati E, Listiowati E, Kurniawan DW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754841 7. COVID-19 Pandemic Prevalence and Risk Factors for Depression Among Health Care Workers in South Asia. Asia Pac. J. Public Health 2021:10105395211002324Saeed R, Amin F, Talha M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754839 8. Coronavirus disease 2019 (COVID-19): diagnosis and prognosis. Blood Genom 2020; 4:96-107Wang X, Zhou Y, Liu L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768219 9. Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients. BMC Infect. Dis. 2021; 21:299Li G, Du L, Cao X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761881 10. Evaluation of glycemic traits in susceptibility to COVID-19 risk: a Mendelian randomization study. BMC Med 2021; 19:72Au Yeung SL, Zhao JV, Schooling CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757497 11. Does endometriosis increase susceptibility to COVID-19 infections? A case- control study in women of reproductive age. BMC Womens Health 2021; 21:119Moazzami B, Chaichian S, Samie S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752656 12. Predictors of clinical deterioration in patients with suspected COVID-19 managed in a 'virtual hospital' setting: a cohort study. BMJ Open 2021; 11:e045356Francis NA, Stuart B, Knight M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757955 13. Association between socioeconomic status and self-reported, tested and diagnosed COVID-19 status during the first wave in the Northern Netherlands: a general population-based cohort from 49 474 adults. BMJ Open 2021; 11:e048020Zhu Y, Duan MJ, Dijk HH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33753448 14. Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients. Clin Chem Lab Med 2021; Ponti G, Roli L, Oliva G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768762 15. Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality. Clin Nutr ESPEN 2021; 42:313-317Tehrani S, Khabiri N, Moradi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745598 16. COVID-19 deaths correlate with blood glucose level: The German Diabetes Society warns. Deutsche Apotheker Zeitung 2021; 161. 17. Survival analysis and risk factors in COVID-19 patients. Disaster Med Public Health Prep 2021:1-15Lu W, Yu S, Liu H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762058 18. CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine. Drug Metab Pers Ther 2021; Salem Hareedy M, Rashad SM, Hetta HF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770833 19. COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2021; 33:100789Gerayeli FV, Milne S, Cheung C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758801 20. E-gene RT-PCR Crossing Point Value and Other Biochemical Parameters as Useful Markers of Death Risk in COVID-19 Patients. Ejifcc 2021; 32:98- 104Bellés-Bellés A, Bernal M, Gómez-Arbonés J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753979 21. Rare variants increase the risk of severe COVID-19. Elife 2021; 10van de Veerdonk FL, Netea MG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752797 22. Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID- 19 Patients, Atlanta, Georgia, USA, March-April 2020. Emerg Infect Dis 2021; 27:1164-1168Pettrone K, Burnett E, Link-Gelles R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754981 23. Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with Coronavirus disease 2019 (COVID-19). Endocr. J. 2021; Okauchi Y, Matsuno K, Nishida T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762519 24. Association between urinary per- and poly-fluoroalkyl substances and COVID- 19 susceptibility. Environ Int 2021; 153:106524Ji J, Song L, Wang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773143 25. An innovative index for assessing vulnerability of employees of different occupations from the COVID-19 pandemic in Iran. Environ. Res. 2021:111039Abtahi M, Gholamnia R, Bagheri A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745932 26. PM(10) correlates with COVID-19 infections 15 days later in Arequipa, Peru. Environ. Sci. Pollut. Res. Int. 2021:1-7Wannaz ED, Larrea Valdivia AE, Reyes Larico JA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761077 27. DNA genotyping of the ABO gene showed a significant association of the A- group (A1/A2 variants) with severe COVID-19. Eur J Intern Med 2021; Gómez J, Albaiceta GM, García-Clemente M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33750629 28. Diabetes is associated with higher mortality and severity in hospitalized patients with COVID-19. Excli j 2021; 20:444-453Moghaddam Tabrizi F, Rasmi Y, Hosseinzadeh E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746672 29. Prediction of Sepsis in COVID-19 Using Laboratory Indicators. Front Cell Infect Microbiol 2020; 10:586054Tang G, Luo Y, Lu F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747973 30. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification. Front. Immunol. 2021; 12:653489Grolmusz VK, Bozsik A, Papp J, Patócs A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763088 31. The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients. Front. Immunol. 2021; 12:632814Luo H, Jia T, Chen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763078 32. Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment. Front. Immunol. 2021; 12:598799Wu J, Shen J, Han Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746945 33. Proteinuria as a Biomarker for COVID-19 Severity. Front. Physiol. 2021; 12:611772Ouahmi H, Courjon J, Morand L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767630 34. Smoking Is Correlated With the Prognosis of Coronavirus Disease 2019 (COVID-19) Patients: An Observational Study. Front. Physiol. 2021; 12:634842Peng F, Lei S, Zhang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762967 35. Clinical characteristics and risk factors for disease severity and mortality of COVID-19 patients with diabetes mellitus in Kazakhstan: A nationwide study. Heliyon 2021; 7:e06561Dyusupova A, Faizova R, Yurkovskaya O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763618 36. Variants in ACE2 and TMPRSS2 Genes Are Not Major Determinants of COVID- 19 Severity in UK Biobank Subjects. Hum. Hered. 2021:1-3Curtis D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752217 37. Olfactory Dysfunction is Associated with More Severe Clinical Course in COVID-19. Indian J Otolaryngol Head Neck Surg 2021:1-6Tabari A, Golpayegani G, Tabari A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747891 38. The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19. Int Immunopharmacol 2021; 95:107586Delshad M, Tavakolinia N, Pourbagheri- Sigaroodi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765611 39. Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge. Int Immunopharmacol 2021; 95:107579Hong LX, Liu L, Lin A, Yan WH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756229 40. A super learner ensemble of 14 statistical learning models for predicting COVID-19 severity among patients with cardiovascular conditions. Intell Based Med 2021:100030Ehwerhemuepha L, Danioko S, Verma S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748802 41. Exertional hypoxia in patients without resting hypoxia is an early predictor of moderate to severe COVID-19. Intern Emerg Med 2021:1-7Bhasin A, Bregger M, Kluk M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770368 42. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19. iScience 2021:102322Andolfo I, Russo R, Lasorsa VA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748697 43. Isaric 4c Mortality Score As A Predictor Of In-Hospital Mortality In Covid-19 Patients Admitted In Ayub Teaching Hospital During First Wave Of The Pandemic. J. Ayub Med. Coll. Abbottabad 2021; 33:20-25Ali R, Qayyum F, Ahmed N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774948 44. Neutrophil-to-Lymphocyte Ratio, derived Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio as risk factors in critically ill COVID-19 patients, a single centered study. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S595-s601Noor A, Akhtar F, Tashfeen S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754514 45. Who is at a Higher Risk? A brief review of Recent Evidence on comorbidities in children infected with COVID-19. J. Ayub Med. Coll. Abbottabad 2020; 32(Suppl 1):S695-s700Qamar MA, Sajid MI, Dhillon RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754534 46. Risk stratification by long non-coding RNAs profiling in COVID-19 patients. J Cell Mol Med 2021; Cheng J, Zhou X, Feng W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759345 47. Factors Associated with Perceived Susceptibility to COVID-19 Among Urban and Rural Adults in Alabama. J. Community Health 2021; Scarinci IC, Pandya VN, Kim YI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751308 48. Risk Factors for Hospitalization Among Patients with COVID-19 at a Community Ambulatory Clinic in Massachusetts During the Initial Pandemic Surge. J Immigr Minor Health 2021:1-6Smati H, Cohen PA, Nagda DV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772419 49. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score. J Immunother Cancer 2021; 9Dettorre GM, Dolly S, Loizidou A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33753569 50. Co-morbidity and blood group type risk in coronavirus disease 2019 patients: A case-control study. J Infect Public Health 2021; 14:550-554Badedi M, Makrami A, Alnami A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756193 51. COVID-19 infection, inception and immunity: Observations and recommendations in the light of vitamin D? J Infect Public Health 2021; 14:444- 445Dixit V, Garg B, Mehta N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751982 52. COVID-19 and Menstrual Status: Is Menopause an Independent Risk Factor for SARS Cov-2? J Midlife Health 2020; 11:240-249Mishra N, Sharma R, Mishra P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767566 53. Pulmonary artery trunk enlargement on admission as a predictor of mortality in in-hospital patients with COVID-19. Jpn J Radiol 2021; Zhu QQ, Gong T, Huang GQ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751417 54. Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity. Life Sci 2021; 276:119410Posadas-Sánchez R, Sánchez-Muñoz F, Martin CAG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774023 55. Elevated P-Selectin in Severe Covid-19: Considerations for Therapeutic Options. Mediterr. J. Hematol. Infect. Dis. 2021; 13:e2021016Agrati C, Bordoni V, Sacchi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747397 56. The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metabolism 2021:154753Bassatne A, Basbous M, Chakhtoura M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774074 57. Obesity, ethnicity and risk of critical care, mechanical ventilation and mortality in patients admitted to hospital with COVID-19: Analysis of the ISARIC CCP- UK cohort. Obesity (Silver Spring) 2021; Yates T, Zaccardi F, Islam N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755331 58. Fatality and risk factors for severe courses of COVID-19 pneumonia. Pneumologe 2020; 17:385-393Flick H. 59. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection. Public Health 2021; 193:113-115Murillo-Zamora E, Mendoza-Cano O, Delgado-Enciso I, Hernandez-Suarez CM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774512 60. A comprehensive insight into the role of zinc deficiency in the renin- angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients. Saudi J. Biol. Sci. 2021; Gouda AS, Adbelruhman FG, Elbendary RN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746538 61. Risk factors and frequency of COVID-19 among healthcare workers at a tertiary care centre in India: a case-control study. Trans. R. Soc. Trop. Med. Hyg. 2021; Dev N, Meena RC, Gupta DK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33763687 62. Interferon system deficiencies exacerbating severe pandemic virus infections. Trends Microbiol. 2021; Stertz S, Hale BG. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757684 63. A possible role for ST2 as prognostic biomarker for COVID-19. Vascul. Pharmacol. 2021:106857Ragusa R, Basta G, Del Turco S, Caselli C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746068

Safety (22 articles)

1. Efficacy and safety of Levamisole treatment in clinical presentations of non- hospitalized patients with COVID-19: a double-blind, randomized, controlled trial. BMC Infect. Dis. 2021; 21:297Roostaei Firozabad A, Meybodi ZA, Mousavinasab SR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761870 2. Lateral ST-elevation myocardial infarction after donation of COVID-19 convalescent plasma in a naïve donor. BMJ Case Rep. 2021; 14Shams P, Tipoo FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762295 3. Liver and kidney function in patients with Covid-19 treated with remdesivir. Br. J. Clin. Pharmacol. 2021; van Laar SA, de Boer MGJ, Gombert-Handoko KB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763917 4. Death by hand sanitizer: syndemic methanol poisoning in the age of COVID- 19. Clin. Toxicol. (Phila.) 2021:1-6Holzman SD, Larsen J, Kaur R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33755514 5. Is COVID-19 an Independent Risk Factor for Heparin-Induced Thrombocytopenia? Cureus 2021; 13:e13425Madala S, Krzyzak M, Dehghani S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758713 6. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging 2021:1-10Cohen D, Krauthammer SH, Wolf I, Even-Sapir E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774684 7. The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection. Front. Pharmacol. 2021; 12:615695Nobile B, Durand M, Olié E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33767623 8. A case of COVID-19 diagnosed with favipiravir induced drug fever based on positive drug-induced lymphocyte stimulation test. Int J Infect Dis 2021; Murai Y, Kawasuji H, Takegoshi Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746092 9. SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? J Am Soc Nephrol 2021; Heldman MR, Limaye AP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762353 10. QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19. J. Clin. Pharm. Ther. 2021; Koh HM, Chong PF, Tan JN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768612 11. Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts. J Eur Acad Dermatol Venereol 2021; Ring J, Worm M, Wollenberg A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752263 12. Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence. J Multidiscip Healthc 2021; 14:659-663Magala Ssekandi A, Sserwanja Q, Olal E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758509 13. Allergic reactions to COVID-19 vaccinations - What otorhinolaryngologists should know - Part 1: Immunological principles of allergies to vaccines, immune mechanisms of allergic and pseudoallergic reactions; Part 2: Characteristics of the mRNA vaccines BNT 162b2 and mRNA-1273 for the prevention of COVID-19 and associated immune phenomena; Part 3: Practical aspects of prevention, diagnosis and treatment of allergies to COVID-19 vaccines. Laryngo- Rhino- Otologie 2021; Klimek L, Chaker AM, Cuevas M. 14. Curious case of steroid responsive diffuse anterior horn cell disease associated with COVID-19 infection. Neurol Sci 2021; Nanda S, Handa R, Anand R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751257 15. QTc prolongation in COVID-19 patients treated with Hydroxychloroquine, Chloroquine, Azithromycin, or Lopinavir/Ritonavir: A systematic review and meta-analysis. Pharmacoepidemiol. Drug Saf. 2021; Diaz-Arocutipa C, Brañez- Condorena A, Hernandez AV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772933 16. Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients. Pharmacogenomics 2021; Biswas M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759544 17. High-dose ACEi might be harmful in COVID-19 patients with serious respiratory distress syndrome by leading to excessive bradykinin receptor activation. Physiol Int 2021; Székács B, Várbíró S, Debreczeni L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764894 18. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic. Scand. J. Gastroenterol. 2021:1-7Moum KM, Moum B, Opheim R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771086 19. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19- induced moderate pneumonia: study protocol for a randomized, double- blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials 2021; 22:199Gaborit B, Vanhove B, Vibet MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750432 20. In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity. Vascul. Pharmacol. 2021:106856Maiti S, Banerjee A, Kanwar M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746069 21. Fatal coincidence of inapparent SARS-CoV-2 infection and drug toxicity in the field of immunosuppression in a 33-year old woman. Vnitr. Lek. 2021; 67:51- 56Faktorová X, Horniaková L, Sedlačko J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752392 22. May polyethylene glycol be the cause of anaphylaxis to mRNA COVID-19 vaccines? World Allergy Organ J 2021:100532Giavina-Bianchi P, Kalil J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747340

Treatment options (72 articles)

1. Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy. Biomed. Pharmacother. 2021; 138:111518Mirtaleb MS, Mirtaleb AH, Nosrati H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774315 2. Efficacy and safety of Levamisole treatment in clinical presentations of non- hospitalized patients with COVID-19: a double-blind, randomized, controlled trial. BMC Infect. Dis. 2021; 21:297Roostaei Firozabad A, Meybodi ZA, Mousavinasab SR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761870 3. Lateral ST-elevation myocardial infarction after donation of COVID-19 convalescent plasma in a naïve donor. BMJ Case Rep. 2021; 14Shams P, Tipoo FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762295 4. Liver and kidney function in patients with Covid-19 treated with remdesivir. Br. J. Clin. Pharmacol. 2021; van Laar SA, de Boer MGJ, Gombert-Handoko KB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763917 5. Dual inhibition of CB(1) R and iNOS as a potential novel approach to the pharmacological management of acute and long COVID-19. Br. J. Pharmacol. 2021; Cinar R, Iyer MR, Kunos G. http://www.ncbi.nlm.nih.gov/pubmed/? term=33769552 6. Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection. Chemotherapy 2021:1-9Spagnolello O, Pinacchio C, Santinelli L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756475 7. Remdesivir: An antiviral still seeking a raison d'être. Clin Infect Dis 2021; Cummins NW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749746 8. Structural insights on the interaction potential of natural leads against major protein targets of SARS-CoV-2: Molecular modelling, docking and dynamic simulation studies. Comput. Biol. Med. 2021; 132:104325Skariyachan S, Gopal D, Muddebihalkar AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751995 9. ACE2 as a key target for treatment of COVID-19 related cardiovascular diseases: current progress and prospect. Curr. Drug Targets 2021; Li S, Cai B, Ma W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745431 10. Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication. Cytokine 2021; 142:155496Gowda P, Patrick S, Joshi SD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33773396 11. And how is therapy doing? - The development of drugs against COVID-19 leads a shadowy existence. Deutsche Apotheker Zeitung 2021; 161Blasius H. 12. No cytokine storm thanks to alpha-1 blockers?: Tamsulosin and co. could reduce mortality of COVID-19 patients. Deutsche Apotheker Zeitung 2021; 161Bruhn C. 13. Are high-dose vitamin C and zinc ineffective?: Study with COVID-19 patients prematurely stopped for lack of effect. Deutsche Apotheker Zeitung 2021; 161Jungmayr P. 14. Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19. Diabetes Metab. J. 2021; Rhee SY, Lee J, Nam H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752274 15. Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control. Drug Deliv Transl Res 2021; Yang KC, Lin JC, Tsai HH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748879 16. Potential Anti-Coronavirus Agents and the Pharmacologic Mechanisms. Drug Des. Devel. Ther. 2021; 15:1213-1223Yang Y, Cui X, Wei H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762818 17. CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine. Drug Metab Pers Ther 2021; Salem Hareedy M, Rashad SM, Hetta HF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770833 18. Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial. EBioMedicine 2021; 66:103288Liesenborghs L, Spriet I, Jochmans D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752127 19. Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19). Emergent Mater 2021:1-21Ertas YN, Mahmoodi M, Shahabipour F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748672 20. A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms. Excli j 2021; 20:339- 365Langarizadeh MA, Ranjbar Tavakoli M, Abiri A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746666 21. COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development. Exp. Biol. Med. (Maywood) 2021:1535370221999989Jogalekar MP, Veerabathini A, Patel AB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757336 22. Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: An observational prospective open label user survey. Expert Rev. Anti Infect. Ther. 2021; Shmuel K, Dalia M, Tair L, Yaakov N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33759682 23. Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis. F1000Res 2021; 10:73Nugroho CW, Suryantoro SD, Yuliasih Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763201 24. Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages. Faseb j 2021; 35:e21441Recchiuti A, Patruno S, Mattoscio D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749902 25. A small molecule compound berberine as an orally active therapeutic candidate against COVID-19 and SARS: A computational and mechanistic study. Faseb j 2021; 35:e21360Wang ZZ, Li K, Maskey AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749932 26. Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients. Front Genet 2021; 12:626642Biswas N, Kumar K, Mallick P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767730 27. Vitamin D in Corona Virus Disease 2019 (COVID-19) Related Multisystem Inflammatory Syndrome in Children (MIS-C). Front. Immunol. 2021; 12:648546Feketea G, Vlacha V, Bocsan IC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763085 28. Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2. Front. Microbiol. 2020; 11:592908Eweas AF, Alhossary AA, Abdel-Moneim AS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746908 29. Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives. Front Mol Biosci 2021; 8:604447Vivekanandhan K, Shanmugam P, Barabadi H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33763450 30. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come? Front. Pharmacol. 2021; 12:632677Indari O, Jakhmola S, Manivannan E, Jha HC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762954 31. Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review. Front. Pharmacol. 2020; 11:585331Lem FF, Opook F, Lee DJH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746739 32. Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2- Induced Immunopathology. Front. Pharmacol. 2021; 12:622554Pala D, Pistis M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767626 33. The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis. Front Public Health 2021; 9:624559Teshome A, Adane A, Girma B, Mekonnen ZA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748066 34. Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials. Futur J Pharm Sci 2021; 7:67Raju R, V P, Biatris PS, J S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754123 35. Potential of CRISPR/Cas13 System in Treatment and Diagnosis of COVID-19. Glob Med Genet 2021; 8:7-10Khodavirdipour A, Piri M, Jabbari S, Khalaj-Kondori M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748818 36. Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis. Heliyon 2021; 7:e06515Bhowmik D, Nandi R, Prakash A, Kumar D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748510 37. Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity 2021; Zheng H, Rao AM, Dermadi D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765435 38. Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta-analysis. Indian J. Hematol. Blood Transfus. 2021:1-19Prasad M, Seth T, Elavarasi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746378 39. Investigation of structural, treatment and clinical characteristics of COVID-19 along with the challenges caused by its prevalence. Infect Disord Drug Targets 2021; Doagooyan M, Alavizadeh SH, Akhtari J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749564 40. An overview of some potential immunotherapeutic options against COVID-19. Int Immunopharmacol 2021; 95:107516Bayat M, Asemani Y, Mohammadi MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765610 41. The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm. Int Immunopharmacol 2021; 95:107571Zimecki M, Actor JK, Kruzel ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765614 42. Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases. Int J Clin Pharm 2021; Koufakis T, Pavlidis AN, Metallidis S, Kotsa K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751323 43. A case of COVID-19 diagnosed with favipiravir induced drug fever based on positive drug-induced lymphocyte stimulation test. Int J Infect Dis 2021; Murai Y, Kawasuji H, Takegoshi Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33746092 44. A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19. Int. J. Med. Sci. 2021; 18:1866-1876Zhang X, Gao R, Zhou Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746604 45. Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19. J Biomol Struct Dyn 2021:1-17Jafari Porzani S, Konur O, Nowruzi B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749496 46. In silico screening of therapeutic potentials from Strychnos nux-vomica against the dimeric main protease (M(pro)) structure of SARS-CoV-2. J Biomol Struct Dyn 2021:1-19Kumar B, Parasuraman P, Murthy TPK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759690 47. Possible Therapeutic Use of Natural Compounds Against COVID-19. J Cell Signal 2021; 2:63-79Khan N, Chen X, Geiger JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768214 48. Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2021; 1171:122641Nguyen R, Goodell JC, Shankarappa PS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33756448 49. QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19. J. Clin. Pharm. Ther. 2021; Koh HM, Chong PF, Tan JN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768612 50. Study on the mechanism of active components of Liupao tea on 3CL(pro) based on HPLC-DAD fingerprint and molecular docking technique. J. Food Biochem. 2021:e13707Ni WJ, Chen XX, Wei SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760271 51. IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta- regression. J Infect 2021; Tharmarajah E, Buazon A, Patel V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745918 52. Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study. J Korean Med Sci 2021; 36:e83Joo EJ, Ko JH, Kim SE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754512 53. Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence. J Multidiscip Healthc 2021; 14:659-663Magala Ssekandi A, Sserwanja Q, Olal E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758509 54. Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection. J. Pharm. Pract. 2021:8971900211000691Meanwatthana J, Majam T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759631 55. Melatonin multifaceted pharmacological actions on melatonin receptors converging to abrogate COVID-19. J. Pineal Res. 2021:e12732Reynolds JL, Dubocovich ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759236 56. Role of vitamin D supplementation in aging patients with COVID-19. Maturitas 2021; Shakoor H, Feehan J, Al Dhaheri AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757717 57. The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis. Metabolism 2021:154753Bassatne A, Basbous M, Chakhtoura M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774074 58. Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking. Nat Prod Res 2021:1-6Wang WX, Zhang YR, Luo SY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769143 59. Curious case of steroid responsive diffuse anterior horn cell disease associated with COVID-19 infection. Neurol Sci 2021; Nanda S, Handa R, Anand R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751257 60. SUMO: a novel target for anti-coronavirus therapy. Pathog Glob Health 2021:1- 8Ryu HY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769223 61. QTc prolongation in COVID-19 patients treated with Hydroxychloroquine, Chloroquine, Azithromycin, or Lopinavir/Ritonavir: A systematic review and meta-analysis. Pharmacoepidemiol. Drug Saf. 2021; Diaz-Arocutipa C, Brañez- Condorena A, Hernandez AV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772933 62. Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients. Pharmacogenomics 2021; Biswas M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759544 63. Plant-derived chemicals as potential inhibitors of SARS-CoV-2 main protease (6LU7), a virtual screening study. Phytother. Res. 2021; Sisakht M, Mahmoodzadeh A, Darabian M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33759279 64. Comparison of clinical manifestations, pre-existing comorbidities, complications and treatment modalities in severe and non-severe COVID-19 patients: A systemic review and meta-analysis. Sci. Prog. 2021; 104:368504211000906Giri M, Puri A, Wang T, Guo S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752530 65. Clinical effectiveness of drugs in hospitalized patients with COVID-19: a systematic review and meta-analysis. Ther. Adv. Respir. Dis. 2021; 15:17534666211007214Abeldaño Zuñiga RA, Coca SM, Abeldaño GF, González- Villoria RAM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33765902 66. Respiratory viral infections in the elderly. Ther. Adv. Respir. Dis. 2021; 15:1753466621995050Watson A, Wilkinson TMA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749408 67. Deterrents in recruitment of COVID-19 convalescent plasma donors: Experience from a hospital-based blood centre in India. Transfus. Med. 2021; Dhiman Y, Coshic P, Pandey HC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33749020 68. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19- induced moderate pneumonia: study protocol for a randomized, double- blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials 2021; 22:199Gaborit B, Vanhove B, Vibet MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750432 69. Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster- randomized trial. Trials 2021; 22:224Tan DHS, Chan AK, Jüni P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752741 70. The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein. Virology 2021; 559:1-9Chen X, Rostad CA, Anderson LJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774551 71. A molecular docking study of SARS-CoV-2 main protease against phytochemicals of Boerhavia diffusa Linn. for novel COVID-19 drug discovery. Virusdisease 2021:1-9Rutwick Surya U, Praveen N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758772 72. Respiratory delivery of favipiravir-tocilizumab combination through mucoadhesive protein-lipidic nanovesicles: prospective therapeutics against COVID-19. Virusdisease 2021:1-6Thakur V, Ratho RK, Panda JJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=3374834

Trials (11 articles)

1. The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19. Clin Infect Dis 2021; Eckstein L, Rid A, Kamuya D, Shah SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758912 2. Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial. EBioMedicine 2021; 66:103288Liesenborghs L, Spriet I, Jochmans D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752127 3. COVID-19 Vaccination on Brazil and the Crocodile Side-effect. Ethics Med Public Health 2021:100654Boschiero MN, Palamim CVC, Marson FAL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758776 4. Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials. Futur J Pharm Sci 2021; 7:67Raju R, V P, Biatris PS, J S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754123 5. Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China. Hum Vaccin Immunother 2021:1-8Akel KB, Masters NB, Shih SF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769209 6. Human Challenge Trials: Ethical and Legal Issues for COVID-19 Research. J. Law Med. 2021; 28:311-322Freckelton I. http://www.ncbi.nlm.nih.gov/pubmed/? term=33768743 7. The evolution of clinical trials in response to COVID-19. Med. J. Aust. 2021; Sarah A, Dean O, Berk M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749864 8. The time is now: role of pragmatic clinical trials in guiding response to global pandemics. Trials 2021; 22:229Almufleh A, Joseph J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761968 9. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19- induced moderate pneumonia: study protocol for a randomized, double- blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials 2021; 22:199Gaborit B, Vanhove B, Vibet MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33750432 10. Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster- randomized trial. Trials 2021; 22:224Tan DHS, Chan AK, Jüni P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752741 11. Rapid commentary: Ethical implications for clinical trialists and patients associated with COVID-19 research. World J Psychiatry 2021; 11:58- 62Delanerolle G, Rathod S, Elliot K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33747803

Vaccines (49 articles)

1. Implementation of a pharmacist-led COVID-19 vaccination clinic at a community teaching hospital. Am. J. Health Syst. Pharm. 2021; Andrade J, Slaby M, DeAngelis J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772261 2. COVID-19 vaccines: a race against time. Anaesth Crit Care Pain Med 2021:100848Peiffer-Smadja N, Rozencwajg S, Kherabi Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774261 3. Even vaccinated against COVID-19, we must continue to wear a mask. Anaesth Crit Care Pain Med 2021:100849Zahar JR, Allaouchiche B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771754 4. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann. Rheum. Dis. 2021; Boyarsky BJ, Ruddy JA, Connolly CM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33757968 5. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort. Ann. Rheum. Dis. 2021; Geisen UM, Berner DK, Tran F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762264 6. New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals. Biosci Trends 2021; Chen J, Lu H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746183 7. COVID-19 vaccine research focusses on safety, efficacy, immunoinformatics, and vaccine production and delivery: a bibliometric analysis based on VOSviewer. Biosci Trends 2021; Chen Y, Cheng L, Lian R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746182 8. Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report. BMC Pediatr. 2021; 21:138Paul G, Chad R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752624 9. Will AstraZeneca be able to provide clinical trial data on its COVID-19 vaccine efficacy in older adults? Br. J. Clin. Pharmacol. 2021; Dal-Ré R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760277 10. COVID-19 vaccines and vaccine administration. Br J Nurs 2021; 30:344- 349Gordon C, Porteous D, Unsworth J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33769885 11. Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19. Chem. Eng. J. 2021; 418:129392Zheng B, Peng W, Guo M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33762883 12. The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19. Clin Infect Dis 2021; Eckstein L, Rid A, Kamuya D, Shah SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758912 13. Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19. Clin Infect Dis 2021; McEllistrem MC, Clancy CJ, Buehrle DJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768222 14. A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review. Clin Rheumatol 2021; Soy M, Keser G, Atagunduz P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751280 15. Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel. Curr. Med. Res. Opin. 2021:1Hughes K, Gogineni V, Lewis C, Deshpande A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33760673 16. COVID-19 Vaccine: Risk of Inequality and Failure of Public Health Strategies. Ethics Med Public Health 2021:100653Cioffi A, Cioffi F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758775 17. SARS-CoV-2 vaccines for cancer patients: a call to action. Eur. J. Cancer 2021; 148:316-327Corti C, Crimini E, Tarantino P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33770576 18. A Single Subcutaneous or Intranasal Immunization with Adenovirus-Based SARS-CoV-2 Vaccine Induces Robust Humoral and Cellular Immune Responses in Mice. Eur. J. Immunol. 2021; Kim E, Weisel FJ, Balmert SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772778 19. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging 2021:1-10Cohen D, Krauthammer SH, Wolf I, Even-Sapir E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774684 20. Robust antibody responses in 70-80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021. Euro Surveill 2021; 26Subbarao S, Warrener LA, Hoschler K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33769252 21. Global justice and the COVID-19 vaccine: Limitations of the public goods framework. Glob Public Health 2021:1-10Saksena N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764847 22. A global pandemic in the time of viral memes: COVID-19 vaccine misinformation and disinformation on TikTok. Hum Vaccin Immunother 2021:1- 5Basch CH, Meleo-Erwin Z, Fera J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33764283 23. BCG vaccination potential for COVID-19: an analytical approach. Hum Vaccin Immunother 2021:1-3Kelleni MT. http://www.ncbi.nlm.nih.gov/pubmed/? term=33769207 24. Factors associated with the willingness and acceptance of SARS-CoV-2 vaccine from adult subjects in China. Hum Vaccin Immunother 2021:1-10Liu D, Luo L, Xie F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33759691 25. A comparative online survey on the intention to get COVID-19 vaccine between Greek and Cypriot healthcare personnel: is the country a predictor? Hum Vaccin Immunother 2021:1-8Raftopoulos V, Iordanou S, Katsapi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754953 26. Mosaic vaccination schedule: an unexpected card to play against SARS-CoV- 2? Infect Dis Now 2021; Matteo R, Nard Francesca D, Simona P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748805 27. Interim estimates in null models of COVID-19 vaccine effectiveness. Int J Infect Dis 2021; Lisewski AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33746095 28. Lessons learned from frontline skilled nursing facility staff regarding COVID- 19 vaccine hesitancy. J Am Geriatr Soc 2021; Berry SD, Johnson KS, Myles L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764497 29. Immunogenicity of the BNT162b2 vaccine in frail or disabled Nursing Home residents: COVID-A Study. J Am Geriatr Soc 2021; Salmerón Ríos S, Mas Romero M, Cortés Zamora EB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33768521 30. SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? J Am Soc Nephrol 2021; Heldman MR, Limaye AP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33762353 31. Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts. J Eur Acad Dermatol Venereol 2021; Ring J, Worm M, Wollenberg A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752263 32. No Populations Left Behind: Vaccine Hesitancy and Equitable Diffusion of Effective COVID-19 Vaccines. J Gen Intern Med 2021:1-4Webb Hooper M, Nápoles AM, Pérez-Stable EJ. http://www.ncbi.nlm.nih.gov/pubmed/? term=33754319 33. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world. J Hepatol 2021; Crespo J, Lazarus JV, Iruzubieta P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757805 34. Super-rapid race for saving lives by developing COVID-19 vaccines. J. Integr. Bioinform. 2021; 18:27-43Uttarilli A, Amalakanti S, Kommoju PR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33761582 35. Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J. Obstet. Gynaecol. Res. 2021; Hayakawa S, Komine-Aizawa S, Takada K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754418 36. "COVID arm": A reaction to the Moderna vaccine. JAAD Case Rep 2021; Wei N, Fishman M, Wattenberg D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748377 37. Allergic reactions to COVID-19 vaccinations - What otorhinolaryngologists should know - Part 1: Immunological principles of allergies to vaccines, immune mechanisms of allergic and pseudoallergic reactions; Part 2: Characteristics of the mRNA vaccines BNT 162b2 and mRNA-1273 for the prevention of COVID-19 and associated immune phenomena; Part 3: Practical aspects of prevention, diagnosis and treatment of allergies to COVID-19 vaccines. Laryngo- Rhino- Otologie 2021; Klimek L, Chaker AM, Cuevas M. 38. Negative vaccine attitudes and intentions to vaccinate against Covid-19 in relation to smoking status: a population survey of UK adults. Nicotine Tob Res 2021; Jackson SE, Paul E, Brown J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751125 39. COVID-19 Vaccination in Asthma Patients Treated with Biologicals: Statement of the Austrian Society of Pneumology and German Respiratory Society. Pneumologie 2021; Idzko M, Buhl R, Eber E et al. 40. The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development. Probiotics Antimicrob Proteins 2021:1-15Moradi-Kalbolandi S, Majidzadeh AK, Abdolvahab MH et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33770348 41. COVID 19 vaccination of persons with schizophrenia in India - Need for imperative action! Schizophr Res 2021; 231:49-50Suhas S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752107 42. On BCG Vaccine Protection from COVID-19: A Review. SN Compr Clin Med 2021:1-11Bagheri N, Montazeri H. http://www.ncbi.nlm.nih.gov/pubmed/? term=33748676 43. A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19. SN Compr Clin Med 2021:1-23Cimolai N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754135 44. Respiratory viral infections in the elderly. Ther. Adv. Respir. Dis. 2021; 15:1753466621995050Watson A, Wilkinson TMA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749408 45. A behavioral economics perspective on the COVID-19 vaccine amid public mistrust. Transl. Behav. Med. 2021; Saleska JL, Choi KR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764463 46. U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic. Vaccine 2021; Guidry JPD, Perrin PB, Laestadius LI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745729 47. COVID-19 vaccine intentions in the United States, a social-ecological framework. Vaccine 2021; Latkin C, Dayton LA, Yi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771392 48. The social experience of participation in a COVID-19 vaccine trial: Subjects' motivations, others' concerns, and insights for vaccine promotion. Vaccine 2021; Wentzell E, Racila AM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33745730 49. May polyethylene glycol be the cause of anaphylaxis to mRNA COVID-19 vaccines? World Allergy Organ J 2021:100532Giavina-Bianchi P, Kalil J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33747340

Women – pregnancy (33 articles)

1. Supporting parents as essential care partners in neonatal units during the SARS-CoV-2 pandemic. Acta Paediatr 2021; van Veenendaal NR, Deierl A, Bacchini F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772861 2. Pneumothorax in Neonates Born to COVID-19-Positive Mothers: Fact or Fortuity? AJP Rep 2021; 11:e49-e53Kamity R, Nayak A, Dumpa V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767908 3. Social Determinants of Health and Coronavirus Disease 2019 in Pregnancy: Condensation: Social determinants of health, including neighborhood characteristics such as household income and educational attainment, are associated with SARS-CoV-2 infection and severity of COVID-19 in pregnancy. Am J Obstet Gynecol MFM 2021:100349Prasannan L, Rochelson B, Shan W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757936 4. Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report. BMC Pediatr. 2021; 21:138Paul G, Chad R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752624 5. Does endometriosis increase susceptibility to COVID-19 infections? A case- control study in women of reproductive age. BMC Womens Health 2021; 21:119Moazzami B, Chaichian S, Samie S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752656 6. Preterm care during the COVID-19 pandemic: A comparative risk analysis of neonatal deaths averted by kangaroo mother care versus mortality due to SARS-CoV-2 infection. EClinicalMedicine 2021:100733Minckas N, Medvedev MM, Adejuyigbe EA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748724 7. The great crime recovery: Crimes against women during, and after, the COVID- 19 lockdown in Mexico. Econ. Hum. Biol. 2021; 41:100991Hoehn-Velasco L, Silverio-Murillo A, de la Miyar JRB. http://www.ncbi.nlm.nih.gov/pubmed/? term=33774434 8. Gender issues during the times of Covid-19 pandemic. Eur. J. Neurol. 2021; Grisold W, Moro E, Ferretti MT et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33751757 9. Communication with fertility patients during the COVID-19 pandemic- let's talk about it. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021; 260:154-158Karavani G, Chill HH, Meirman C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774596 10. Chlorine Solutions for a Safe Method of Decontamination of Breast Pump Milk Collection Kits Before and After the Coronavirus Disease 2019 Pandemic. Front Nutr 2021; 8:574311Rigourd V, Mouadh B, Poupon J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748168 11. Evaluating Patients' and Neonatologists' Satisfaction With the Use of Telemedicine for Neonatology Prenatal Consultations During the COVID-19 Pandemic. Front Pediatr 2021; 9:642369Lapadula MC, Rolfs S, Szyld EG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33748048 12. COVID-19 and pregnancy: Case series with diabetes co-morbidity from the registry study ‘Covid-19 Related Obstetric and Neonatal Outcome Study‘ (CRONOS). Gynakologe 2021; Kleinwechter H, Groten T, Schäfer-Graf U et al. 13. Survey of fertility counselling provision in UK licensed treatment centres during the first phase of the COVID-19 pandemic. Hum. Fertil. (Camb.) 2021:1- 11Pericleous-Smith A, Dark S, McCluskey G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33749479 14. Investigation of SARS-CoV-2 RNA in Milk Produced by Women with COVID-19 and Follow-Up of Their Infants: A Preliminary Study. Int J Clin Pract 2021:e14175Kilic T, Kilic S, Kırıcı Berber N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33763939 15. Maternal mortality from COVID 19 among South African pregnant women. J Matern Fetal Neonatal Med 2021:1-3Basu JK, Chauke L, Magoro T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752563 16. Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City. J Matern Fetal Neonatal Med 2021:1-5Hernández-Cruz RG, Sánchez-Cobo D, Acevedo-Gallegos S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771080 17. Fetal and placental infection with SARS-CoV-2 in early pregnancy. J Med Virol 2021; Valdespino-Vázquez MY, Helguera-Repetto CA, León-Juárez M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33764543 18. COVID-19 and Menstrual Status: Is Menopause an Independent Risk Factor for SARS Cov-2? J Midlife Health 2020; 11:240-249Mishra N, Sharma R, Mishra P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33767566 19. Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence. J Multidiscip Healthc 2021; 14:659-663Magala Ssekandi A, Sserwanja Q, Olal E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758509 20. Neonatal nursing during the COVID-19 global pandemic: A thematic analysis of personal reflections. J. Neonatal Nurs. 2021; Shaw C, Gallagher K, Petty J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33758571 21. Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J. Obstet. Gynaecol. Res. 2021; Hayakawa S, Komine-Aizawa S, Takada K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754418 22. Integrated substance use and prenatal care delivery in the era of COVID-19. J. Subst. Abuse Treat. 2021; 124:108273Patton EW, Saia K, Stein MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771277 23. The Impact of Coronavirus Disease 2019 (COVID-19) on Dual-Physician Couples: A Disproportionate Burden on Women Physicians. J Womens Health (Larchmt) 2021; Soares A, Thakker P, Deych E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33751922 24. Journal fur Gynakologische Endokrinologie 2021; 31Fischl F. 25. The impact of COVID-19 on prenatal care in the United States: Qualitative analysis from a survey of 2519 pregnant women. Midwifery 2021; 98:102991Javaid S, Barringer S, Compton SD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33774388 26. Acute Presentation of Third Ventricular Cavernous Malformation following COVID-19 Infection in a Pregnant Woman: A Case Report. Neurochirurgie 2021; Saberi H, Tanha RR, Derakhshanrad N, Soltaninejad MJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771616 27. Sex differences in maladaptive emotional and behavioral responses to COVID- 19: What is the role of personality? Pers. Individ. Dif. 2021; 178:110834DeGrace S, Baptist-Mohseni N, Single A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33758454 28. Factors associated with antenatal depression during the COVID-19 (SARS- CoV2) pandemic: A cross-sectional study in a cohort of Turkish pregnant women. Perspect. Psychiatr. Care 2021; Korukcu O, Ozkaya M, Boran OF, Bakacak M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33772802 29. A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19. SN Compr Clin Med 2021:1-23Cimolai N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33754135 30. Women and Minorities Encouraged to Apply (Not Stay). Trends Genet. 2021; Windsor LC, Crawford KF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33771351 31. Perspectives of pregnant women during the COVID-19 pandemic: A qualitative study. Women Birth 2021; Atmuri K, Sarkar M, Obudu E, Kumar A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33766506 32. Midwives' experiences of providing maternity care during the COVID-19 pandemic in Australia. Women Birth 2021; Bradfield Z, Hauck Y, Homer CSE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33752996 33. Prenatal stress, health, and health behaviours during the COVID-19 pandemic: An international survey. Women Birth 2021; Pope J, Olander EK, Leitao S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33757750

to subscribe click here

mailing address is: [email protected]

© P.J. Lansberg